. 2018 Jan; 378(2):158-168.
doi: 10.1056/NEJMra1703481.

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Michael A Postow 1 Robert Sidlow 1 Matthew D Hellmann 1 
  • PMID: 29320654
  •     1045 citations

No abstract available

Inflammatory tenosynovitis and enthesitis induced by immune checkpoint inhibitor treatment.
Jun Inamo, Yuko Kaneko, Tsutomu Takeuchi.
Clin Rheumatol, 2018 Feb 20; 37(4). PMID: 29455266
Autoimmune Polyendocrine Syndromes.
Eystein S Husebye, Mark S Anderson, Olle Kämpe.
N Engl J Med, 2018 Mar 22; 378(12). PMID: 29562162    Free PMC article.
Highly Cited. Review.
Triggers of inflammatory myopathy: insights into pathogenesis.
Brittany L Adler, Lisa Christopher-Stine.
Discov Med, 2018 Mar 27; 25(136). PMID: 29579414    Free PMC article.
Clinical assessment of immune-related adverse events.
Aaron Sosa, Esther Lopez Cadena, +2 authors, Rafael Rosell.
Ther Adv Med Oncol, 2018 Apr 07; 10. PMID: 29623110    Free PMC article.
[Treatment with PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors : Immune-mediated side effects].
M-O Grimm, H Oppel-Heuchel, S Foller.
Urologe A, 2018 Apr 18; 57(5). PMID: 29663063
Immune checkpoint receptors: homeostatic regulators of immunity.
Antonio Riva, Shilpa Chokshi.
Hepatol Int, 2018 May 10; 12(3). PMID: 29740793    Free PMC article.
Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature.
Devis Benfaremo, Lucia Manfredi, Michele Maria Luchetti, Armando Gabrielli.
Curr Drug Saf, 2018 May 11; 13(3). PMID: 29745339    Free PMC article.
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events.
Heinz Läubli, Catharina Balmelli, +10 authors, Sacha I Rothschild.
J Immunother Cancer, 2018 May 24; 6(1). PMID: 29789020    Free PMC article.
Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer.
Nicholas Borcherding, Ryan Kolb, +3 authors, Weizhou Zhang.
J Mol Biol, 2018 May 26; 430(14). PMID: 29800567    Free PMC article.
Immune Checkpoint Inhibitor-Associated Myocarditis.
Sarju Ganatra, Tomas G Neilan.
Oncologist, 2018 May 29; 23(8). PMID: 29802219    Free PMC article.
Highly Cited.
Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action.
Tomas G Neilan, Mace L Rothenberg, +9 authors, Checkpoint Inhibitor Safety Working Group.
Oncologist, 2018 May 29; 23(8). PMID: 29802220    Free PMC article.
Highly Cited.
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap.
Wantong Song, Limei Shen, +7 authors, Leaf Huang.
Nat Commun, 2018 Jun 10; 9(1). PMID: 29884866    Free PMC article.
Highly Cited.
Myocarditis with tremelimumab plus durvalumab combination therapy for endometrial cancer: A case report.
Syed S Mahmood, Carol L Chen, +3 authors, Vicky Makker.
Gynecol Oncol Rep, 2018 Jun 21; 25. PMID: 29922709    Free PMC article.
Vasculitis associated with immune checkpoint inhibitors-a systematic review.
Anisha Daxini, Keri Cronin, Antoine G Sreih.
Clin Rheumatol, 2018 Jun 21; 37(9). PMID: 29923081
Systematic Review.
Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment.
Elizabeth A Comen, Robert L Bowman, Maria Kleppe.
Front Cell Dev Biol, 2018 Jun 28; 6. PMID: 29946544    Free PMC article.
Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future.
Mark A Perazella, Anushree C Shirali.
J Am Soc Nephrol, 2018 Jul 01; 29(8). PMID: 29959196    Free PMC article.
Highly Cited. Review.
Endocrine, Sexual Function, and Infertility Side Effects of Immune Checkpoint Inhibitor Therapy for Genitourinary Cancers.
Akshay Sood, Daniel Cole, +5 authors, Shaheen Alanee.
Curr Urol Rep, 2018 Jul 05; 19(9). PMID: 29971696
Toxicities and outcomes: Do steroids matter?
Douglas B Johnson.
Cancer, 2018 Jul 06; 124(18). PMID: 29975416    Free PMC article.
Cancer immune checkpoint blockade therapy and its associated autoimmune cardiotoxicity.
Jiu-Cheng Zhang, Wei-Dong Chen, +6 authors, Hua Zhu.
Acta Pharmacol Sin, 2018 Jul 12; 39(11). PMID: 29991709    Free PMC article.
Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab.
Dante A Suffredini, Jung-Min Lee, +4 authors, Michael A Solomon.
BMC Pulm Med, 2018 Jul 13; 18(1). PMID: 29996818    Free PMC article.
Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells.
Matthieu Sawaf, Jean-Daniel Fauny, +4 authors, Fanny Monneaux.
JCI Insight, 2018 Jul 13; 3(13). PMID: 29997289    Free PMC article.
Sick sinus syndrome associated with anti-programmed cell death-1.
Chien-Yi Hsu, Yu-Wen Su, San-Chi Chen.
J Immunother Cancer, 2018 Jul 18; 6(1). PMID: 30012209    Free PMC article.
Nivolumab induced vitiligo-like lesions in a patient with metastatic squamous cell carcinoma of the lung.
Kazumi Nishino, Shuichi Ohe, +8 authors, Fumio Imamura.
J Thorac Dis, 2018 Aug 03; 10(6). PMID: 30069410    Free PMC article.
Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma.
Suma Shah, Anastasie Dunn-Pirio, +3 authors, Christopher Eckstein.
Case Rep Neurol Med, 2018 Aug 04; 2018. PMID: 30073101    Free PMC article.
Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade.
Kentaro Tanaka, Toyoshi Yanagihara, +15 authors, Isamu Okamoto.
Oncotarget, 2018 Aug 11; 9(55). PMID: 30093971    Free PMC article.
Treatment of Complications from Immune Checkpoint Inhibition in Patients with Lung Cancer.
Beatriz Wills, Julie R Brahmer, Jarushka Naidoo.
Curr Treat Options Oncol, 2018 Aug 14; 19(9). PMID: 30101402    Free PMC article.
Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literature.
Andrés Laserna, Sudhakar Tummala, +2 authors, Cristina Gutiérrez.
SAGE Open Med Case Rep, 2018 Aug 18; 6. PMID: 30116528    Free PMC article.
Management of Brain Metastases in the New Era of Checkpoint Inhibition.
Adam Lauko, Bicky Thapa, Vyshak Alva Venur, Manmeet S Ahluwalia.
Curr Neurol Neurosci Rep, 2018 Aug 20; 18(10). PMID: 30121715
PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity.
Halis Kaan Akturk, Aimon Alkanani, +2 authors, Aaron W Michels.
J Clin Endocrinol Metab, 2018 Aug 21; 103(10). PMID: 30124874    Free PMC article.
Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis.
Qiaoyun Tan, Shuxia Liu, +2 authors, Yuankai Shi.
Thorac Cancer, 2018 Aug 29; 9(10). PMID: 30151899    Free PMC article.
A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.
Prabhakaran Kumar, Palash Bhattacharya, Bellur S Prabhakar.
J Autoimmun, 2018 Sep 04; 95. PMID: 30174217    Free PMC article.
Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab.
Guacimara Ortega Sanchez, Kathleen Jahn, +2 authors, Heinz Läubli.
J Immunother Cancer, 2018 Sep 05; 6(1). PMID: 30176946    Free PMC article.
Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors.
Sabina Sandigursky, Adam Mor.
Curr Rheumatol Rep, 2018 Sep 08; 20(10). PMID: 30191417    Free PMC article.
Immune Checkpoint Inhibition in Head and Neck Cancer.
Martin David Forster, Michael-John Devlin.
Front Oncol, 2018 Sep 14; 8. PMID: 30211111    Free PMC article.
Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis.
Haritha G Reddy, Bryan J Schneider, Andrew W Tai.
Clin Transl Gastroenterol, 2018 Sep 20; 9(9). PMID: 30228268    Free PMC article.
Neurological complications of immune checkpoint inhibitors: what happens when you 'take the brakes off' the immune system.
Marinos C Dalakas.
Ther Adv Neurol Disord, 2018 Sep 25; 11. PMID: 30245744    Free PMC article.
Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma.
Eduard Teixidor, Elia Sais, +7 authors, Joaquim Bosch-Barrera.
Oncotarget, 2018 Sep 27; 9(68). PMID: 30250648    Free PMC article.
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series.
Kendall F Moseley, Jarushka Naidoo, +7 authors, Laura C Cappelli.
J Immunother Cancer, 2018 Oct 12; 6(1). PMID: 30305172    Free PMC article.
The Protein Expression of PDL1 Is Highly Correlated with Those of eIF2α and ATF4 in Lung Cancer.
Liang-Che Chang, Tzu-Ping Chen, Wei-Ke Kuo, Chung-Ching Hua.
Dis Markers, 2018 Oct 12; 2018. PMID: 30305853    Free PMC article.
[Liver injury induced by immune checkpoint inhibitor-therapy : Example of an immune-mediated drug side effect].
B K Straub, D A Ridder, +2 authors, J M Schattenberg.
Pathologe, 2018 Oct 13; 39(6). PMID: 30310977
A severe case of neuro-Sjögren's syndrome induced by pembrolizumab.
Jaqueline Ghosn, Alex Vicino, +3 authors, Michel Obeid.
J Immunother Cancer, 2018 Oct 24; 6(1). PMID: 30348223    Free PMC article.
Identification and validation of a tumor-infiltrating Treg transcriptional signature conserved across species and tumor types.
Angela M Magnuson, Evgeny Kiner, +8 authors, Christophe Benoist.
Proc Natl Acad Sci U S A, 2018 Oct 24; 115(45). PMID: 30348759    Free PMC article.
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma.
Alessandra Lopes, Kevin Vanvarenberg, +5 authors, Gaëlle Vandermeulen.
Sci Rep, 2018 Oct 26; 8(1). PMID: 30356111    Free PMC article.
The Role of PD-1 Checkpoint Inhibition in Gynecologic Malignancies.
Christine Garcia, Kari L Ring.
Curr Treat Options Oncol, 2018 Nov 07; 19(12). PMID: 30397772
Oncologic Emergencies-The Old, the New, and the Deadly.
Krishna Thandra, Zuhair Salah, Sanjay Chawla.
J Intensive Care Med, 2018 Nov 10; 35(1). PMID: 30411648    Free PMC article.
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.
Joe-Elie Salem, Ali Manouchehri, +10 authors, Javid J Moslehi.
Lancet Oncol, 2018 Nov 18; 19(12). PMID: 30442497    Free PMC article.
Highly Cited.
Immune checkpoint inhibitor-related acral vasculitis.
Thibault Comont, Vincent Sibaud, +2 authors, Odile Beyne-Rauzy.
J Immunother Cancer, 2018 Nov 18; 6(1). PMID: 30446009    Free PMC article.
Clinical and molecular characteristics associated with the efficacy of PD-1/PD-L1 inhibitors for solid tumors: a meta-analysis.
Yi Ming Weng, Min Peng, +2 authors, Qi Bin Song.
Onco Targets Ther, 2018 Nov 23; 11. PMID: 30464501    Free PMC article.
Immune-related adverse events of immune checkpoint inhibitors: a brief review.
G Myers.
Curr Oncol, 2018 Nov 23; 25(5). PMID: 30464684    Free PMC article.
Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma.
Tomas Jelinek, Bruno Paiva, Roman Hajek.
Front Immunol, 2018 Dec 07; 9. PMID: 30505301    Free PMC article.
Challenges and unanswered questions for the next decade of immune-oncology research in NSCLC.
Niki Karachaliou, Manuel Fernandez-Bruno, Jillian Wilhelmina Paulina Bracht, Rafael Rosell.
Transl Lung Cancer Res, 2018 Dec 07; 7(6). PMID: 30505714    Free PMC article.
Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma.
Stefania Oliva, Rossella Troia, +2 authors, Francesca Gay.
Front Immunol, 2018 Dec 13; 9. PMID: 30538704    Free PMC article.
Immunotherapy for High Grade Gliomas: A Clinical Update and Practical Considerations for Neurosurgeons.
Jacob S Young, Fara Dayani, +2 authors, Manish K Aghi.
World Neurosurg, 2019 Jan 25;. PMID: 30677574    Free PMC article.
Cancer Site and Adverse Events Induced by Immune Checkpoint Inhibitors: A Retrospective Analysis of Real-life Experience at a Single Institution.
Ammar Sukari, Misako Nagasaka, +9 authors, Shirish Gadgeel.
Anticancer Res, 2019 Feb 04; 39(2). PMID: 30711957    Free PMC article.
Targeting immune cells for cancer therapy.
Sin Yee Gun, Sharon Wei Ling Lee, Je Lin Sieow, Siew Cheng Wong.
Redox Biol, 2019 Mar 29; 25. PMID: 30917934    Free PMC article.
Highly Cited. Review.
Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis.
Hamzah Abu-Sbeih, Faisal S Ali, +16 authors, Yinghong Wang.
J Clin Oncol, 2019 Jun 05; 37(30). PMID: 31163011    Free PMC article.
Highly Cited.
Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study.
Pradhum Ram, Andrew Tiu, +2 authors, Mahek Shah.
Heart Fail Rev, 2019 Jun 09; 24(6). PMID: 31175492
Pembrolizumab-associated bronchiolitis in an elderly lung cancer patient required the treatment with an inhaled corticosteroid, erythromycin and bronchodilators.
Takafumi Yamaya, Hwang Moon Hee, +7 authors, Yasuo Nishizaka.
Respir Med Case Rep, 2019 Jun 15; 28. PMID: 31198678    Free PMC article.
Immune checkpoint inhibitor-induced Type 1 diabetes: a systematic review and meta-analysis.
H K Akturk, D Kahramangil, +3 authors, A W Michels.
Diabet Med, 2019 Jun 15; 36(9). PMID: 31199005    Free PMC article.
Highly Cited. Systematic Review.
Immunometabolism: A new target for improving cancer immunotherapy.
Chunqing Guo, Shixian Chen, +5 authors, Xiang-Yang Wang.
Adv Cancer Res, 2019 Jun 17; 143. PMID: 31202359    Free PMC article.
Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review.
Shoko Murakami, Tatsuya Nagano, +7 authors, Yoshihiro Nishimura.
Intern Med, 2019 Jun 28; 58(19). PMID: 31243239    Free PMC article.
Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer.
Yara van Holstein, Ellen Kapiteijn, +3 authors, Nienke A de Glas.
Drugs Aging, 2019 Jul 19; 36(10). PMID: 31317421    Free PMC article.
Inhaled Submicron Particle Paclitaxel (NanoPac) Induces Tumor Regression and Immune Cell Infiltration in an Orthotopic Athymic Nude Rat Model of Non-Small Cell Lung Cancer.
James Verco, William Johnston, +7 authors, Gere diZerega.
J Aerosol Med Pulm Drug Deliv, 2019 Jul 28; 32(5). PMID: 31347939    Free PMC article.
Lessons Learned from Checkpoint Blockade Targeting PD-1 in Multiple Myeloma.
Alexander M Lesokhin, Susan Bal, Ashraf Z Badros.
Cancer Immunol Res, 2019 Aug 03; 7(8). PMID: 31371317    Free PMC article.
Novel Delivery Systems for Checkpoint Inhibitors.
Purushottam Lamichhane, Rahul Deshmukh, +8 authors, Narottam Lamichhane.
Medicines (Basel), 2019 Aug 03; 6(3). PMID: 31373327    Free PMC article.
Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes.
Aanika Balaji, Jiajia Zhang, +16 authors, Jarushka Naidoo.
J Oncol Pract, 2019 Aug 07; 15(9). PMID: 31386608    Free PMC article.
Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology
Marc P Bonaca, Benjamin A Olenchock, +17 authors, Javid Moslehi.
Circulation, 2019 Aug 08; 140(2). PMID: 31390169    Free PMC article.
Highly Cited. Review.
Equibalancing immune-related adverse events and anticancer activity of immune checkpoint inhibitors.
Sharvesh Raj Seeruttun.
Thorac Cancer, 2019 Aug 29; 10(10). PMID: 31456312    Free PMC article.
Anti-PD-1-Induced Pneumonitis Is Associated with Persistent Imaging Abnormalities in Melanoma Patients.
Douglas B Johnson, Kevin B Taylor, +10 authors, Richard G Abramson.
Cancer Immunol Res, 2019 Aug 30; 7(11). PMID: 31462410    Free PMC article.
Sex Differences in Cancer Immunotherapy Efficacy, Biomarkers, and Therapeutic Strategy.
Shixiang Wang, Li An Cowley, Xue-Song Liu.
Molecules, 2019 Sep 07; 24(18). PMID: 31487832    Free PMC article.
Highly Cited. Review.
Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor-related Pneumonitis. An Official American Thoracic Society Research Statement.
Catherine R Sears, Tobias Peikert, +11 authors, M Patricia Rivera.
Am J Respir Crit Care Med, 2019 Sep 14; 200(6). PMID: 31518182    Free PMC article.
Trends and Challenges in Tumor Anti-Angiogenic Therapies.
József Jászai, Mirko H H Schmidt.
Cells, 2019 Sep 22; 8(9). PMID: 31540455    Free PMC article.
Highly Cited. Review.
Immune Checkpoints as Promising Targets for the Treatment of Idiopathic Pulmonary Fibrosis?
JanWillem Duitman, Tom van den Ende, C Arnold Spek.
J Clin Med, 2019 Sep 29; 8(10). PMID: 31561518    Free PMC article.
Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab.
Yeonghee Eun, In Young Kim, +5 authors, Jaejoon Lee.
Sci Rep, 2019 Oct 03; 9(1). PMID: 31575933    Free PMC article.
Classical Hodgkin's Lymphoma in the Era of Immune Checkpoint Inhibition.
Valli De Re, Laura Caggiari, +2 authors, Maurizio Mascarin.
J Clin Med, 2019 Oct 05; 8(10). PMID: 31581738    Free PMC article.
The Role of Immune Checkpoint Receptors in Regulating Immune Reactivity in Lupus.
Kun-Lin Lu, Ming-Ying Wu, +4 authors, Chun-Bing Chen.
Cells, 2019 Oct 11; 8(10). PMID: 31597242    Free PMC article.
The Relative Risk of Immune-Related Liver Dysfunction of PD-1/PD-L1 Inhibitors Versus Chemotherapy in Solid Tumors: A Meta-Analysis of Randomized Controlled Trials.
Siyao Deng, Qinyan Yang, +2 authors, Shun Lu.
Front Pharmacol, 2019 Oct 15; 10. PMID: 31607917    Free PMC article.
Systematic Review.
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases.
Isabella Lupi, Alessandro Brancatella, +7 authors, Claudio Marcocci.
Endocrinol Diabetes Metab Case Rep, 2019 Oct 15; 2019. PMID: 31610523    Free PMC article.
Combination of checkpoint inhibitors with radiotherapy in esophageal squamous cell carcinoma treatment: A novel strategy.
Xiu-Yong Liao, Chao-Yuan Liu, +2 authors, Tao Zhang.
Oncol Lett, 2019 Oct 16; 18(5). PMID: 31612012    Free PMC article.
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.
Katherine A Michaelis, Mason A Norgard, +12 authors, Daniel L Marks.
Nat Commun, 2019 Oct 17; 10(1). PMID: 31615993    Free PMC article.
Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells.
Ronald Anderson, Annette J Theron, Bernardo L Rapoport.
Front Immunol, 2019 Oct 17; 10. PMID: 31616428    Free PMC article.
Pericardial effusion under nivolumab: case-reports and review of the literature.
Anastasia Saade, Audrey Mansuet-Lupo, +5 authors, Laurence Weiss.
J Immunother Cancer, 2019 Oct 20; 7(1). PMID: 31627742    Free PMC article.
The Diverse Function of PD-1/PD-L Pathway Beyond Cancer.
Weiting Qin, Lipeng Hu, +4 authors, Xu Wang.
Front Immunol, 2019 Oct 23; 10. PMID: 31636634    Free PMC article.
Highly Cited. Review.
[The Use of Glucocorticoid in the Management of Adverse Effects Related to Immunocheckpoint Inhibitors].
Hanping Wang, Jiaxin Zhou, +4 authors, Li Zhang.
Zhongguo Fei Ai Za Zhi, 2019 Oct 28; 22(10). PMID: 31650942    Free PMC article.
[Clinical Diagnosis and Treatment Recommendations for Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor].
Xiaoxiao Guo, Hanping Wang, +6 authors, Li Zhang.
Zhongguo Fei Ai Za Zhi, 2019 Oct 28; 22(10). PMID: 31650944    Free PMC article.
[Management of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors].
Jiaxin Zhou, Qian Wang, +8 authors, Li Zhang.
Zhongguo Fei Ai Za Zhi, 2019 Oct 28; 22(10). PMID: 31650952    Free PMC article.
[Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events].
Junling Zhuang, Jingting Zhao, +10 authors, Li Zhang.
Zhongguo Fei Ai Za Zhi, 2019 Oct 28; 22(10). PMID: 31650953    Free PMC article.
The dark side of immunotherapy: challenges facing the new hope in cancer treatment.
Eduard Teixidor, Joaquim Bosch-Barrera.
Ann Transl Med, 2019 Oct 28; 7(Suppl 6). PMID: 31656762    Free PMC article.
Adverse Events of Concurrent Immune Checkpoint Inhibitors and Antiangiogenic Agents: A Systematic Review.
Ling Gao, Xi Yang, Cheng Yi, Hong Zhu.
Front Pharmacol, 2019 Nov 05; 10. PMID: 31680957    Free PMC article.
Systematic Review.
Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy.
Xiao Han, Shufang Shen, +6 authors, Chao Wang.
Sci Adv, 2019 Nov 05; 5(10). PMID: 31681841    Free PMC article.
Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD.
Yuzo Suzuki, Naoki Inui, +17 authors, Takafumi Suda.
Int J Chron Obstruct Pulmon Dis, 2019 Nov 07; 14. PMID: 31686799    Free PMC article.
Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field.
Iliana Doycheva, Paul J Thuluvath.
J Clin Exp Hepatol, 2019 Nov 07; 9(5). PMID: 31695249    Free PMC article.
Budesonide treatment for microscopic colitis from immune checkpoint inhibitors.
Michael S Hughes, Gabriel E Molina, +5 authors, Michael Dougan.
J Immunother Cancer, 2019 Nov 09; 7(1). PMID: 31699151    Free PMC article.
Immune-Based Therapies in Acute Leukemia.
Matthew T Witkowski, Audrey Lasry, William L Carroll, Iannis Aifantis.
Trends Cancer, 2019 Nov 11; 5(10). PMID: 31706508    Free PMC article.
Chlorin e6-Conjugated and PEGylated Immune Checkpoint Inhibitor Nanocomposites for Pulmonary Metastatic Colorectal Cancer.
Young-Il Jeong, So Young Yoo, Jeong Heo, Dae Hwan Kang.
ACS Omega, 2019 Nov 19; 4(20). PMID: 31737818    Free PMC article.
Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa.
Ahmad Yatim, Gérôme Bohelay, +6 authors, Frédéric Caux.
Front Med (Lausanne), 2019 Nov 22; 6. PMID: 31750309    Free PMC article.
Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers.
Musalula Sinkala, Nicola Mulder, Darren Patrick Martin.
Commun Biol, 2019 Nov 23; 2. PMID: 31754644    Free PMC article.
Hospitalization as an Opportunity to Optimize Glycemic Control in Oncology Patients.
Amy Hiestand, James Flory, Ritika Chitkara.
Curr Diab Rep, 2019 Nov 30; 19(12). PMID: 31776685
A Case of Severe Seronegative Inflammatory Arthritis due to Nivolumab and Review of the Literature.
Bicky Thapa, Asad Ali, +2 authors, Cassandra Calabrese.
Case Rep Rheumatol, 2019 Nov 30; 2019. PMID: 31781462    Free PMC article.
Hyperprogressive Disease in Lung Cancer with Transformation of Adenocarcinoma to Small-cell Carcinoma during Pembrolizumab Therapy.
Komugi Okeya, Yukio Kawagishi, +3 authors, Shinichi Takeda.
Intern Med, 2019 Jul 23; 58(22). PMID: 31327828    Free PMC article.
Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient.
Vincent Pillonel, Vincent Dunet, +5 authors, Veronica Aedo-Lopez.
J Immunother Cancer, 2019 Dec 04; 7(1). PMID: 31791418    Free PMC article.
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study.
Guillaume Manson, Alexandre Thibault Jacques Maria, +29 authors, Jean-Marie Michot.
J Immunother Cancer, 2019 Dec 05; 7(1). PMID: 31796119    Free PMC article.
Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis.
Puyuan Xing, Fan Zhang, +7 authors, Junling Li.
J Immunother Cancer, 2019 Dec 06; 7(1). PMID: 31801636    Free PMC article.
Systematic Review.
Management of rheumatic complications of ICI therapy: a rheumatology viewpoint.
Jan Leipe, Xavier Mariette.
Rheumatology (Oxford), 2019 Dec 10; 58(Suppl 7). PMID: 31816078    Free PMC article.
Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy.
Marie Kostine, Marie-Elise Truchetet, Thierry Schaeverbeke.
Rheumatology (Oxford), 2019 Dec 10; 58(Suppl 7). PMID: 31816082    Free PMC article.
Setting the scene - a future 'epidemic' of immune-related adverse events in association with checkpoint inhibitor therapy.
Maria V Bermudez, Sophie Papa.
Rheumatology (Oxford), 2019 Dec 10; 58(Suppl 7). PMID: 31816083    Free PMC article.
Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management.
Yu-Wen Zhou, Ya-Juan Zhu, +6 authors, Ji-Yan Liu.
Front Pharmacol, 2019 Dec 19; 10. PMID: 31849640    Free PMC article.
The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.
Harish Seethapathy, Sophia Zhao, +10 authors, Meghan E Sise.
Clin J Am Soc Nephrol, 2019 Nov 02; 14(12). PMID: 31672794    Free PMC article.
Highly Cited.
Acute Kidney Injury with Immune Checkpoint Inhibitors: A Push beyond Case Reports.
Christopher A Carlos, Raymond K Hsu.
Clin J Am Soc Nephrol, 2019 Nov 02; 14(12). PMID: 31672795    Free PMC article.
The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors.
Daniel E Meyers, Igor Stukalin, +9 authors, Don G Morris.
Cancers (Basel), 2019 Nov 07; 11(11). PMID: 31684111    Free PMC article.
New Frontiers for Molecular Pathology.
Joanna Domagala-Kulawik.
Front Med (Lausanne), 2019 Dec 24; 6. PMID: 31867335    Free PMC article.
Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells.
Natsumi Maeda, Takumi Maruhashi, +3 authors, Taku Okazaki.
J Biol Chem, 2019 Nov 15; 294(52). PMID: 31723031    Free PMC article.
Preferences of Canadian patients and physicians for adjuvant treatments for melanoma.
D Stellato, M Thabane, C Eichten, T E Delea.
Curr Oncol, 2020 Jan 04; 26(6). PMID: 31896946    Free PMC article.
Management of immune checkpoint inhibitor-related rheumatic adverse events.
Jiaxin Zhou, Hanping Wang, +8 authors, Li Zhang.
Thorac Cancer, 2019 Nov 26; 11(1). PMID: 31762209    Free PMC article.
Systematic Review.
Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism.
Shivani Patel, Venessa Chin, Jerry R Greenfield.
Endocrinol Diabetes Metab Case Rep, 2019 Dec 13; 2019. PMID: 31829972    Free PMC article.
CTLA-4 correlates with immune and clinical characteristics of glioma.
Fangkun Liu, Jing Huang, +3 authors, Zhixiong Liu.
Cancer Cell Int, 2020 Jan 09; 20. PMID: 31911758    Free PMC article.
Occurrence of an Abscopal Radiation Recall Phenomenon in a Glioblastoma Patient Treated with Nivolumab and Re-Irradiation.
Wouter O van Seggelen, Filip Y De Vos, +2 authors, Joost J C Verhoeff.
Case Rep Oncol, 2020 Jan 09; 12(3). PMID: 31911775    Free PMC article.
Health care utilization and steroid-refractory toxicities from immune checkpoint inhibitors.
Laura X Wang, Henry T Quach, +4 authors, Douglas B Johnson.
Cancer, 2019 Oct 04; 126(2). PMID: 31580492    Free PMC article.
Incidence of Immune Checkpoint Inhibitor-Associated Diabetes: A Meta-Analysis of Randomized Controlled Studies.
Jingli Lu, Jing Yang, +3 authors, Xiaojian Zhang.
Front Pharmacol, 2020 Jan 11; 10. PMID: 31920646    Free PMC article.
Systematic Review.
Severe Immune-Related Pneumonitis With PD-1 Inhibitor After Progression on Previous PD-L1 Inhibitor in Small Cell Lung Cancer: A Case Report and Review of the Literature.
Xiuju Liang, Yaping Guan, +4 authors, Jun Wang.
Front Oncol, 2020 Jan 11; 9. PMID: 31921686    Free PMC article.
Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms.
Petros Fessas, Lucia A Possamai, +5 authors, David J Pinato.
Immunology, 2019 Oct 28; 159(2). PMID: 31646612    Free PMC article.
Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report.
Deni Rkman, Robert Likić, +2 authors, Marija Gamulin.
Croat Med J, 2020 Jan 03; 60(6). PMID: 31894921    Free PMC article.
Imaging of tumour response to immunotherapy.
Clarisse Dromain, Catherine Beigelman, +2 authors, Antonia Digklia.
Eur Radiol Exp, 2020 Jan 05; 4(1). PMID: 31900689    Free PMC article.
Systematic Review.
One man's trash-another man's treasure: fecal transplantation.
Nancy Gupta, Stephen B Hanauer.
Hepatobiliary Surg Nutr, 2020 Jan 14; 8(6). PMID: 31929989    Free PMC article.
Giant cell myocarditis with central diabetes insipidus: A case report.
Shogo Yamaguchi, Akinori Sawamura, +12 authors, Toyoaki Murohara.
J Cardiol Cases, 2020 Jan 15; 21(1). PMID: 31933698    Free PMC article.
Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy.
Michael A Morse, Howard Hochster, Al Benson.
Oncologist, 2019 Aug 07; 25(1). PMID: 31383813    Free PMC article.
Current Status of Immunotherapy for Lung Cancer and Future Perspectives.
Ho Cheol Kim, Chang Min Choi.
Tuberc Respir Dis (Seoul), 2020 Jan 07; 83(1). PMID: 31905428    Free PMC article.
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors.
Aine O'Reilly, Peta Hughes, +15 authors, Olga Husson.
Support Care Cancer, 2019 May 16; 28(2). PMID: 31089820    Free PMC article.
Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review.
Shaheen Khan, David E Gerber.
Semin Cancer Biol, 2019 Jul 23; 64. PMID: 31330185    Free PMC article.
Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review.
Takumi Onoyama, Yohei Takeda, +6 authors, Hajime Isomoto.
World J Gastroenterol, 2020 Jan 29; 26(3). PMID: 31988594    Free PMC article.
Systematic Review.
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.
Karmela Kim Chan, Cynthia Magro, +10 authors, Anne R Bass.
Oncologist, 2019 Oct 17;. PMID: 31615951
Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx.
Marcus A Carden, Manila Gaddh, +9 authors, Imre Bodó.
Blood Adv, 2020 Feb 07; 4(3). PMID: 32027742    Free PMC article.
A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer.
Ashley E Ross, Paula J Hurley, +9 authors, Emmanuel S Antonarakis.
Prostate Cancer Prostatic Dis, 2019 Oct 16; 23(1). PMID: 31611635    Free PMC article.
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019).
M Majem, E García-Martínez, +7 authors, J A Lopez-Martin.
Clin Transl Oncol, 2020 Jan 30; 22(2). PMID: 31993963
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.
Karmela Kim Chan, Cynthia Magro, +10 authors, Anne R Bass.
Oncologist, 2020 Feb 12; 25(2). PMID: 32043775    Free PMC article.
Fatal Adverse Events Associated With Programmed Cell Death Ligand 1 Inhibitors: A Systematic Review and Meta-Analysis.
Xuewen Wang, Shijie Wu, +4 authors, Xiong Chen.
Front Pharmacol, 2020 Feb 23; 11. PMID: 32076409    Free PMC article.
Systematic Review.
Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment.
Kyung Hwan Kim, Joon Young Hur, +9 authors, Eui-Cheol Shin.
Oncoimmunology, 2020 Feb 23; 9(1). PMID: 32076579    Free PMC article.
Organ-Specific Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Monotherapy Versus Combination Therapy in Cancer: A Meta-Analysis of Randomized Controlled Trials.
Lijun Da, Yuanjun Teng, +4 authors, Feixue Song.
Front Pharmacol, 2020 Feb 23; 10. PMID: 32082164    Free PMC article.
Systematic Review.
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease.
Hamzah Abu-Sbeih, David M Faleck, +26 authors, Yinghong Wang.
J Clin Oncol, 2019 Dec 05; 38(6). PMID: 31800340    Free PMC article.
Transdermal cold atmospheric plasma-mediated immune checkpoint blockade therapy.
Guojun Chen, Zhitong Chen, +6 authors, Zhen Gu.
Proc Natl Acad Sci U S A, 2020 Feb 08; 117(7). PMID: 32029590    Free PMC article.
A dynamical motif comprising the interactions between antigens and CD8 T cells may underlie the outcomes of viral infections.
Subhasish Baral, Rustom Antia, Narendra M Dixit.
Proc Natl Acad Sci U S A, 2019 Aug 16; 116(35). PMID: 31413198    Free PMC article.
Direct comparison of target-reactivity and cross-reactivity induced by CAR- and BiTE-redirected T cells for the development of antibody-based T-cell therapy.
Masaki Maruta, Toshiki Ochi, +6 authors, Masaki Yasukawa.
Sci Rep, 2019 Sep 19; 9(1). PMID: 31527633    Free PMC article.
Management of immune checkpoint inhibitor-related adverse events: A review of case reports.
Xiaoyan Si, Peng Song, +12 authors, Li Zhang.
Thorac Cancer, 2020 Jan 24; 11(3). PMID: 31970923    Free PMC article.
Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related hematological adverse events.
Junling Zhuang, Jianhua Du, +10 authors, Li Zhang.
Thorac Cancer, 2020 Feb 06; 11(3). PMID: 32017466    Free PMC article.
Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma.
Sarah Abou Alaiwi, Wanling Xie, +14 authors, Lauren C Harshman.
J Immunother Cancer, 2020 Feb 19; 8(1). PMID: 32066646    Free PMC article.
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.
Frank B Cortazar, Zoe A Kibbelaar, +28 authors, David E Leaf.
J Am Soc Nephrol, 2020 Jan 04; 31(2). PMID: 31896554    Free PMC article.
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.
Daniel Y Wang, Joe-Elie Salem, +24 authors, Douglas B Johnson.
JAMA Oncol, 2018 Sep 23; 4(12). PMID: 30242316    Free PMC article.
Highly Cited. Systematic Review.
Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification.
Zhenhuan Zhao, Jiling Ren, +4 authors, Shu Man Fu.
Ann Rheum Dis, 2018 Sep 27; 78(3). PMID: 30254034    Free PMC article.
Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab.
R T Casey, O Giger, +12 authors, B G Challis.
Semin Oncol, 2018 Sep 29; 45(3). PMID: 30262398    Free PMC article.
The challenges of checkpoint inhibition in the treatment of multiple myeloma.
Barry Paul, Shuqi Kang, Zhihong Zheng, Yubin Kang.
Cell Immunol, 2018 Oct 22; 334. PMID: 30342750    Free PMC article.
Immune dysregulation in cancer patients developing immune-related adverse events.
Shaheen Khan, Saad A Khan, +8 authors, David E Gerber.
Br J Cancer, 2018 Nov 01; 120(1). PMID: 30377338    Free PMC article.
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study.
Naval Daver, Guillermo Garcia-Manero, +24 authors, Hagop Kantarjian.
Cancer Discov, 2018 Nov 10; 9(3). PMID: 30409776    Free PMC article.
Highly Cited.
The Reciprocity between Radiotherapy and Cancer Immunotherapy.
Yifan Wang, Zhi-Gang Liu, +6 authors, Wen Jiang.
Clin Cancer Res, 2018 Nov 11; 25(6). PMID: 30413527    Free PMC article.
A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti-PD-1 immune checkpoint antibody in a lung cancer patient.
Takayuki Jodai, Chieko Yoshida, +9 authors, Yusuke Tomita.
Immun Inflamm Dis, 2018 Nov 22; 7(1). PMID: 30461210    Free PMC article.
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer.
Margaret L Axelrod, Rebecca S Cook, Douglas B Johnson, Justin M Balko.
Clin Cancer Res, 2018 Nov 23; 25(8). PMID: 30463850    Free PMC article.
CNS inflammatory disorder after concurrent radiotherapy-temozolomide and nivolumab in a glioblastoma patient.
Anna Luisa Di Stefano, Julien Savatovsky, +7 authors, Dimitri Psimaras.
Neuro Oncol, 2018 Nov 27; 21(1). PMID: 30476174    Free PMC article.
Immune checkpoint inhibitors: recent progress and potential biomarkers.
Pramod Darvin, Salman M Toor, Varun Sasidharan Nair, Eyad Elkord.
Exp Mol Med, 2018 Dec 14; 50(12). PMID: 30546008    Free PMC article.
Highly Cited. Review.
Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity.
Julio C Valencia, Nkolika Egbukichi, Rebecca A Erwin-Cohen.
J Interferon Cytokine Res, 2018 Dec 19; 39(1). PMID: 30562133    Free PMC article.
A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy.
Alice Horisberger, Stefano La Rosa, +4 authors, Michel Obeid.
J Immunother Cancer, 2018 Dec 28; 6(1). PMID: 30587227    Free PMC article.
Biomarkers for Immunotherapy Toxicity: Are Cytokines the Answer?
Douglas B Johnson, Justin M Balko.
Clin Cancer Res, 2018 Dec 28; 25(5). PMID: 30587548    Free PMC article.
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience.
Omar Mamlouk, Umut Selamet, +16 authors, Ala Abudayyeh.
J Immunother Cancer, 2019 Jan 08; 7(1). PMID: 30612580    Free PMC article.
Highly Cited.
Complete response of metastatic melanoma in a patient with Crohn's disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies.
Christopher C Frohne, Ernesto M Llano, +2 authors, Jason J Luke.
J Immunother Cancer, 2019 Jan 08; 7(1). PMID: 30612589    Free PMC article.
Targeting Costimulatory Pathways in Systemic Sclerosis.
Gonçalo Boleto, Yannick Allanore, Jérôme Avouac.
Front Immunol, 2019 Jan 09; 9. PMID: 30619351    Free PMC article.
N2 year in review and message from the editor to our reviewers.
Josep Dalmau, Dennis L Kolson, Friedemann Paul, Scott S Zamvil.
Neurol Neuroimmunol Neuroinflamm, 2019 Jan 15; 6(1). PMID: 30637299    Free PMC article.
Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors.
Alexandre Thibault Jacques Maria, Léo Partouche, +7 authors, Philippe Guilpain.
Front Immunol, 2019 Jan 29; 9. PMID: 30687318    Free PMC article.
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy.
Tori N Yamamoto, Ping-Hsien Lee, +15 authors, Christopher A Klebanoff.
J Clin Invest, 2019 Jan 30; 129(4). PMID: 30694219    Free PMC article.
Highly Cited.
FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab.
Matthew Scarpelli, Christopher Zahm, +3 authors, Glenn Liu.
J Immunother Cancer, 2019 Feb 01; 7(1). PMID: 30700328    Free PMC article.
T cell checkpoint regulators in the heart.
Nir Grabie, Andrew H Lichtman, Robert Padera.
Cardiovasc Res, 2019 Feb 06; 115(5). PMID: 30721928    Free PMC article.
Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury.
Hamzah Abu-Sbeih, Tenglong Tang, +6 authors, Yinghong Wang.
J Immunother Cancer, 2019 Feb 08; 7(1). PMID: 30728076    Free PMC article.
CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy.
January Salas-Mckee, Weimin Kong, +4 authors, Joseph A Fraietta.
Hum Vaccin Immunother, 2019 Feb 09; 15(5). PMID: 30735463    Free PMC article.
Risk of Pneumonitis and Pneumonia Associated With Immune Checkpoint Inhibitors for Solid Tumors: A Systematic Review and Meta-Analysis.
Qiang Su, Emily C Zhu, +4 authors, Zu-Hua Gao.
Front Immunol, 2019 Feb 20; 10. PMID: 30778352    Free PMC article.
Systematic Review.
Balancing the Checkpoint: Managing Colitis Associated with Dual Checkpoint Inhibitors and High-Dose Aspirin.
Muhammad B Hammami, Ryan Gill, +4 authors, Michael G Kattah.
Dig Dis Sci, 2019 Feb 20; 64(3). PMID: 30778872
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma.
Beckey Trinh, Guacimara Ortega Sanchez, Petra Herzig, Heinz Läubli.
J Immunother Cancer, 2019 Feb 23; 7(1). PMID: 30791949    Free PMC article.
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors.
Magid Awadalla, Doll Lauren Alexandra Golden, +34 authors, Tomas G Neilan.
J Immunother Cancer, 2019 Feb 24; 7(1). PMID: 30795818    Free PMC article.
Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.
Yu Fujita, Roberto Tinoco, +2 authors, Ze'ev A Ronai.
Trends Mol Med, 2019 Mar 23; 25(5). PMID: 30898473    Free PMC article.
Cutaneous Toxicity After Chemoradiotherapy and PD-L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the Eye.
Tom van den Ende, Stef P Menting, +2 authors, Hanneke W M van Laarhoven.
Oncologist, 2019 Mar 25; 24(4). PMID: 30902915    Free PMC article.
Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review.
Meghan E Sise, Harish Seethapathy, Kerry L Reynolds.
Oncologist, 2019 Mar 25; 24(6). PMID: 30902916    Free PMC article.
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System.
Emanuel Raschi, Alessandra Mazzarella, +6 authors, Fabrizio De Ponti.
Target Oncol, 2019 Mar 31; 14(2). PMID: 30927173
Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report.
Osamu Honjo, Terufumi Kubo, +5 authors, Toshihiko Torigoe.
J Immunother Cancer, 2019 Apr 05; 7(1). PMID: 30944043    Free PMC article.
Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights from Real-World Practice.
Ravi B Parikh, Matthew D Galsky, +7 authors, Ronac Mamtani.
Oncologist, 2019 Apr 05; 24(6). PMID: 30944183    Free PMC article.
Targeted antibody and cytokine cancer immunotherapies through collagen affinity.
Jun Ishihara, Ako Ishihara, +15 authors, Jeffrey A Hubbell.
Sci Transl Med, 2019 Apr 12; 11(487). PMID: 30971453    Free PMC article.
Highly Cited.
Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies.
Dongxu Wang, Jianzhen Lin, +7 authors, Haitao Zhao.
J Hematol Oncol, 2019 Apr 25; 12(1). PMID: 31014381    Free PMC article.
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis.
Yucai Wang, Shouhao Zhou, +16 authors, Michael L Wang.
JAMA Oncol, 2019 Apr 26; 5(7). PMID: 31021376    Free PMC article.
Highly Cited. Systematic Review.
Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports.
Roberta Noseda, Raffaela Bertoli, Laura Müller, Alessandro Ceschi.
J Immunother Cancer, 2019 May 03; 7(1). PMID: 31046841    Free PMC article.
Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment.
Hamzah Abu-Sbeih, Cynthia Nguyen Tran, +5 authors, Yinghong Wang.
J Immunother Cancer, 2019 May 06; 7(1). PMID: 31053161    Free PMC article.
Nivolumab-Associated Acute Demyelinating Encephalitis: A Case Report and Literature Review.
Zubair Zafar, Carrie Vogler, Tamer Hudali, Mukul Bhattarai.
Clin Med Res, 2019 Jun 05; 17(1-2). PMID: 31160476    Free PMC article.
Immunotherapy with check-point inhibitors (CPI) in adult malignancies: a protocol for the systematic review of the quality of economic analyses.
Ying Wang, Pierre Camateros, +2 authors, Peter Ellis.
Syst Rev, 2019 Jun 13; 8(1). PMID: 31186068    Free PMC article.
Systematic Review.
Mechanisms of immune-related adverse events associated with immune checkpoint blockade: using germline genetics to develop a personalized approach.
Zia Khan, Christian Hammer, +2 authors, Matthew L Albert.
Genome Med, 2019 Jun 22; 11(1). PMID: 31221204    Free PMC article.
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition.
Abdul Rafeh Naqash, Ebenezer Appah, +6 authors, Paul R Walker.
J Immunother Cancer, 2019 Jul 07; 7(1). PMID: 31277704    Free PMC article.
A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis.
Douglas B Johnson, Wyatt J McDonnell, +30 authors, Justin M Balko.
Nat Med, 2019 Jul 25; 25(8). PMID: 31332390    Free PMC article.
Highly Cited.
Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma.
Fangkun Liu, Jing Huang, +2 authors, Zhixiong Liu.
Aging (Albany NY), 2019 Aug 05; 11(15). PMID: 31377744    Free PMC article.
How I treat cancer: treatment of rheumatological side effects of immunotherapy.
Karolina Benesova, Hanns-Martin Lorenz, Jan Leipe, Karin Jordan.
ESMO Open, 2019 Aug 20; 4(Suppl 4). PMID: 31423343    Free PMC article.
Clinical insights on outcomes of corticosteroid administration in immune checkpoint inhibitor-induced pneumonitis by retrospective case series analysis.
Changhee Park, Bhumsuk Keam, +10 authors, Yung-Jue Bang.
ESMO Open, 2019 Dec 06; 4(6). PMID: 31803501    Free PMC article.
Systemic Vasculitis Associated With Immune Check Point Inhibition: Analysis and Review.
Teresa M Crout, Day S Lennep, Shweta Kishore, Vikas Majithia.
Curr Rheumatol Rep, 2019 May 23; 21(6). PMID: 31115712
Sirt1-Overexpressing Mesenchymal Stem Cells Drive the Anti-tumor Effect through Their Pro-inflammatory Capacity.
Fei Ye, Jinghua Jiang, +7 authors, Lixin Wei.
Mol Ther, 2020 Feb 07; 28(3). PMID: 32027844    Free PMC article.
Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α.
Liku B Tezera, Magdalena K Bielecka, +16 authors, Paul T Elkington.
Elife, 2020 Feb 25; 9. PMID: 32091388    Free PMC article.
Severe Epididymo-Orchitis and Encephalitis Complicating Anti-PD-1 Therapy.
Henry T Quach, Charles J Robbins, +5 authors, Douglas B Johnson.
Oncologist, 2019 Apr 03; 24(7). PMID: 30936376    Free PMC article.
Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer.
Christopher S Nabel, Mariano Severgnini, +12 authors, Lauren C Harshman.
Oncologist, 2019 May 16; 24(8). PMID: 31088979    Free PMC article.
Cost-Effectiveness Analysis of Biomarker-Guided Treatment for Metastatic Gastric Cancer in the Second-Line Setting.
Brianna Lauren, Sassan Ostvar, +9 authors, Chin Hur.
J Oncol, 2020 Mar 10; 2020. PMID: 32148492    Free PMC article.
Coalition Forces of Immunologists and Oncologists for Defeating Cancer.
Eui-Cheol Shin.
Immune Netw, 2020 Mar 12; 20(1). PMID: 32158589    Free PMC article.
Peripheral blood immune cell-based biomarkers in anti-PD-1/PD-L1 therapy.
Kyung Hwan Kim, Chang Gon Kim, Eui-Cheol Shin.
Immune Netw, 2020 Mar 12; 20(1). PMID: 32158596    Free PMC article.
Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives.
Sun Min Lim, Min Hee Hong, Hye Ryun Kim.
Immune Netw, 2020 Mar 12; 20(1). PMID: 32158598    Free PMC article.
Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors.
Juwhan Choi, Sung Yong Lee.
Immune Netw, 2020 Mar 12; 20(1). PMID: 32158597    Free PMC article.
Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer.
Matteo Bellone, Arianna Brevi, Samuel Huber.
Microbiol Mol Biol Rev, 2020 Mar 07; 84(2). PMID: 32132244    Free PMC article.
Screening for Potential Biomarkers in Peripheral Blood From Miners Exposed to Radon Radiation.
Lu Sun, Yan Pan, +5 authors, Jianxiang Liu.
Dose Response, 2020 Mar 14; 18(1). PMID: 32165872    Free PMC article.
AKI in Patients Receiving Immune Checkpoint Inhibitors.
Mark A Perazella, Ben Sprangers.
Clin J Am Soc Nephrol, 2019 May 03; 14(7). PMID: 31048326    Free PMC article.
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study.
Norio Okada, Shintaro Iwama, +30 authors, Hiroshi Arima.
Br J Cancer, 2020 Feb 06; 122(6). PMID: 32009131    Free PMC article.
Checkpoint Inhibitors.
Lucie Heinzerling, Enrico N de Toni, +2 authors, Lisa Zimmer.
Dtsch Arztebl Int, 2019 Apr 04; 116(8). PMID: 30940340    Free PMC article.
Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy.
Leyre Zubiri, Ian M Allen, +16 authors, Kerry L Reynolds.
Oncologist, 2020 Mar 13; 25(3). PMID: 32162817    Free PMC article.
Gastrointestinal and Hepatic Complications of Immunotherapy: Current Management and Future Perspectives.
Michael Dougan.
Curr Gastroenterol Rep, 2020 Mar 19; 22(4). PMID: 32185493
Harnessing radiation to improve immunotherapy: better with particles?
Marco Durante, Silvia Formenti.
Br J Radiol, 2019 Jul 19; 93(1107). PMID: 31317768    Free PMC article.
A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab.
Daniel J Olson, Padma Rajagopal, +3 authors, Thomas F Gajewski.
J Immunother Cancer, 2020 Mar 15; 8(1). PMID: 32169870    Free PMC article.
Toxicities of Immune Checkpoint Inhibitors: Itis-Ending Adverse Reactions and More.
Moataz Ellithi, Radowan Elnair, Guy Vin Chang, Mohamed A Abdallah.
Cureus, 2020 Mar 20; 12(2). PMID: 32190487    Free PMC article.
Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study.
Chiara Pozzessere, Hasna Bouchaab, +7 authors, Catherine Beigelman-Aubry.
ERJ Open Res, 2020 Mar 24; 6(1). PMID: 32201690    Free PMC article.
Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution.
Sofia España, Alejandra Pérez Montes de Oca, +6 authors, Olatz Etxaniz.
Transl Lung Cancer Res, 2020 Mar 25; 9(1). PMID: 32206558    Free PMC article.
Retrospective analysis of treatment-naive Slovenian patients with metastatic melanoma treated with pembrolizumab - real-world experience.
Nezka Hribernik, Marko Boc, +4 authors, Martina Rebersek.
Radiol Oncol, 2020 Jan 20; 54(1). PMID: 31955148    Free PMC article.
Immune Checkpoint Inhibitors and Immune-Related Adverse Events in Patients With Advanced Melanoma: A Systematic Review and Network Meta-analysis.
Ching-Yuan Chang, Haesuk Park, +5 authors, Wei-Hsuan Lo-Ciganic.
JAMA Netw Open, 2020 Mar 27; 3(3). PMID: 32211869    Free PMC article.
Systematic Review.
Nanotherapeutics for Immuno-Oncology: A Crossroad for New Paradigms.
Wantong Song, Manisit Das, Xuesi Chen.
Trends Cancer, 2020 Mar 27; 6(4). PMID: 32209444    Free PMC article.
Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release.
Xuan Liu, Jianyun Wen, +5 authors, Xiaotao Jiang.
Ther Adv Med Oncol, 2020 Mar 28; 12. PMID: 32215059    Free PMC article.
Progressive multifocal leukoencephalopathy treated with nivolumab.
Ethan Hoang, Nancy L Bartlett, +2 authors, David B Clifford.
J Neurovirol, 2019 Mar 14; 25(2). PMID: 30864100    Free PMC article.
Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects.
Ke-Yu Li, Jia-Long Yuan, +5 authors, Lei Zheng.
Chronic Dis Transl Med, 2020 Apr 01; 6(1). PMID: 32226930    Free PMC article.
Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment.
Gabriele Sulli, Michael Tun Yin Lam, Satchidananda Panda.
Trends Cancer, 2019 Aug 20; 5(8). PMID: 31421905    Free PMC article.
Highly Cited. Review.
Immunogenicity of Protein Pharmaceuticals.
Robert Dingman, Sathy V Balu-Iyer.
J Pharm Sci, 2019 Jan 02; 108(5). PMID: 30599169    Free PMC article.
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity.
Alexandra Schnell, Lloyd Bod, Asaf Madi, Vijay K Kuchroo.
Cell Res, 2020 Jan 25; 30(4). PMID: 31974523    Free PMC article.
Development of immune checkpoint therapy for cancer.
Jill M Fritz, Michael J Lenardo.
J Exp Med, 2019 May 10; 216(6). PMID: 31068379    Free PMC article.
Highly Cited. Review.
Natural Compounds with Potential to Modulate Cancer Therapies and Self-Reactive Immune Cells.
Rhiane Moody, Kirsty Wilson, Anthony Jaworowski, Magdalena Plebanski.
Cancers (Basel), 2020 Mar 19; 12(3). PMID: 32183059    Free PMC article.
Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy?
Zhenyang Zhang, Jiangbo Lin, Mingqiang Kang.
J Thorac Dis, 2020 Apr 11; 12(3). PMID: 32274192    Free PMC article.
CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy.
Alberto L Horenstein, Cristiano Bracci, Fabio Morandi, Fabio Malavasi.
Front Immunol, 2019 May 10; 10. PMID: 31068926    Free PMC article.
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study.
Douglas B Johnson, Ali Manouchehri, +6 authors, Joe-Elie Salem.
J Immunother Cancer, 2019 May 24; 7(1). PMID: 31118078    Free PMC article.
Highly Cited.
Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma.
Mamta Parikh, Poornima Bajwa.
Semin Nephrol, 2020 Mar 05; 40(1). PMID: 32130969    Free PMC article.
Role of medical imaging for immune checkpoint blockade therapy: From response assessment to prognosis prediction.
Hong Wei, Hanyu Jiang, Bin Song.
Cancer Med, 2019 Aug 07; 8(12). PMID: 31385454    Free PMC article.
Mechanisms of checkpoint inhibition-induced adverse events.
P Urwyler, I Earnshaw, +9 authors, S Papa.
Clin Exp Immunol, 2020 Jan 29; 200(2). PMID: 31989585    Free PMC article.
Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes.
Z Quandt, A Young, M Anderson.
Clin Exp Immunol, 2020 Feb 07; 200(2). PMID: 32027018    Free PMC article.
It Is Time to Talk About Fertility and Immunotherapy.
Narjust Duma, Matteo Lambertini.
Oncologist, 2020 Feb 25; 25(4). PMID: 32091651    Free PMC article.
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
Julie M Shabto, Dylan J Martini, +13 authors, Mehmet A Bilen.
Cancer Med, 2020 Feb 27; 9(8). PMID: 32100417    Free PMC article.
Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effect.
J Boegeholz, C S Brueggen, +5 authors, C C Widmer.
BMC Cancer, 2020 Apr 16; 20(1). PMID: 32290812    Free PMC article.
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer.
Charles Dolladille, Stéphane Ederhy, +11 authors, Joachim Alexandre.
JAMA Oncol, 2020 Apr 17; 6(6). PMID: 32297899    Free PMC article.
Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database.
Quentin Scanvion, Johana Béné, +16 authors, Guillaume Lefèvre.
Oncoimmunology, 2020 Apr 22; 9(1). PMID: 32313716    Free PMC article.
Probiotics Lactobacillus reuteri Abrogates Immune Checkpoint Blockade-Associated Colitis by Inhibiting Group 3 Innate Lymphoid Cells.
Tingting Wang, Naisheng Zheng, +4 authors, Lisong Shen.
Front Immunol, 2019 Jun 20; 10. PMID: 31214189    Free PMC article.
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Koji Haratani, Hidetoshi Hayashi, Kazuhiko Nakagawa.
BMC Med, 2020 Apr 22; 18(1). PMID: 32312270    Free PMC article.
Epitherapy and immune checkpoint blockade: using epigenetic reinvigoration of exhausted and dysfunctional T cells to reimburse immunotherapy response.
Isabella McGoverne, Jenny Dunn, +3 authors, Sudha Rao.
BMC Immunol, 2020 Apr 23; 21(1). PMID: 32316916    Free PMC article.
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study.
Nieves Martinez Chanza, Wanling Xie, +17 authors, Lauren C Harshman.
J Immunother Cancer, 2020 Mar 29; 8(1). PMID: 32217762    Free PMC article.
Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors.
Pier Vitale Nuzzo, Gregory R Pond, +9 authors, Guru Sonpavde.
J Immunother Cancer, 2020 Apr 03; 8(1). PMID: 32234849    Free PMC article.
Ushering in Integrated T Cell Repertoire Profiling in Cancer.
Ning Jiang, Alexandra A Schonnesen, Ke-Yue Ma.
Trends Cancer, 2019 Feb 14; 5(2). PMID: 30755308    Free PMC article.
Immunotherapy in Older Adults with Cancer.
Richard Curtis Godby, Douglas B Johnson, Grant R Williams.
Curr Oncol Rep, 2019 May 09; 21(7). PMID: 31065907    Free PMC article.
IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: a case report.
Takeshi Terashima, Eri Iwami, +5 authors, Keisuke Eguchi.
BMC Pulm Med, 2020 Apr 27; 20(1). PMID: 32334571    Free PMC article.
Development of oncolytic virotherapy: from genetic modification to combination therapy.
Qiaoshuai Lan, Shuai Xia, +4 authors, Lu Lu.
Front Med, 2020 Mar 09; 14(2). PMID: 32146606    Free PMC article.
Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies.
T Sakakida, T Ishikawa, +19 authors, K Takayama.
Clin Transl Oncol, 2019 Oct 03; 22(6). PMID: 31576495
Pretreatment nutritional status and response to checkpoint inhibitors in lung cancer.
Chung-Shien Lee, Craig E Devoe, +2 authors, Nagashree Seetharamu.
Lung Cancer Manag, 2020 Apr 30; 9(2). PMID: 32346405    Free PMC article.
Modulation of Vaccine-Induced HIV-1-Specific Immune Responses by Co-Electroporation of PD-L1 Encoding DNA.
Pierre Tannig, Antonia Sophia Peter, +5 authors, Vladimir Temchura.
Vaccines (Basel), 2020 Jan 18; 8(1). PMID: 31947643    Free PMC article.
Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
Marco Russano, Fabrizio Citarella, +2 authors, Daniele Santini.
J Thorac Oncol, 2020 Apr 14; 15(7). PMID: 32283315    Free PMC article.
Cancer patients' experiences with immune checkpoint modulators: A qualitative study.
Kari Ala-Leppilampi, Natalie A Baker, +11 authors, Aaron R Hansen.
Cancer Med, 2020 Mar 03; 9(9). PMID: 32119767    Free PMC article.
Prognostic significance of the radiologic features of pneumonitis induced by anti-PD-1 therapy.
Satoshi Watanabe, Takeshi Ota, +17 authors, Toshiaki Kikuchi.
Cancer Med, 2020 Mar 10; 9(9). PMID: 32150668    Free PMC article.
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events.
Yousef R Badran, Justine V Cohen, +3 authors, Michael Dougan.
J Immunother Cancer, 2019 Aug 24; 7(1). PMID: 31439050    Free PMC article.
Diagnosis, monitoring, and management of adverse events from immune checkpoint inhibitor therapy.
O F Khan, J Monzon.
Curr Oncol, 2020 May 06; 27(Suppl 2). PMID: 32368173    Free PMC article.
The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case Report.
Sean J Judge, Jingran Ji, +11 authors, May Cho.
Front Oncol, 2020 May 07; 10. PMID: 32373540    Free PMC article.
Bronchial inflammatory granulation after endobronchial ultrasound-guided transbronchial needle aspiration and immunotherapy.
Huoqiang Wang, Fuqiang Shao, +2 authors, Lei Jiang.
Eur J Nucl Med Mol Imaging, 2019 Jan 23; 46(5). PMID: 30666340
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis.
Lili Zhang, Magid Awadalla, +41 authors, Tomas G Neilan.
Eur Heart J, 2020 Mar 01; 41(18). PMID: 32112560    Free PMC article.
Treatment of immune checkpoint inhibitor-induced inflammatory arthritis.
Susanna Jeurling, Laura C Cappelli.
Curr Opin Rheumatol, 2020 Mar 14; 32(3). PMID: 32168068    Free PMC article.
Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma.
Aleksi Suo, Yin Chan, +7 authors, Tina Cheng.
Oncologist, 2020 Feb 13; 25(5). PMID: 32048768    Free PMC article.
MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors.
Dominik Marschner, Martina Falk, +17 authors, Natalie Köhler.
JCI Insight, 2020 Mar 04; 5(6). PMID: 32125286    Free PMC article.
Durability of response in metastatic melanoma patients after combined treatment with radiation therapy and ipilimumab.
Quaovi H Sodji, Paulina M Gutkin, +3 authors, Susan J Knox.
Melanoma Manag, 2020 May 14; 7(1). PMID: 32399174    Free PMC article.
Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities.
Kristen E Pauken, Michael Dougan, +2 authors, Arlene H Sharpe.
Trends Immunol, 2019 May 06; 40(6). PMID: 31053497    Free PMC article.
Highly Cited. Review.
Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients.
Anne Schaefer, Christos Sachpekidis, +5 authors, Theodoros G Soldatos.
Cancers (Basel), 2020 Apr 25; 12(4). PMID: 32325840    Free PMC article.
Contribution of Macrophages and T Cells in Skeletal Metastasis.
Veronica Mendoza-Reinoso, Laurie K McCauley, Pierrick G J Fournier.
Cancers (Basel), 2020 Apr 25; 12(4). PMID: 32326073    Free PMC article.
Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade.
Allison Betof Warner, Jessica S Palmer, +9 authors, Paul B Chapman.
J Clin Oncol, 2020 Feb 14; 38(15). PMID: 32053428    Free PMC article.
IgA vasculitis and polymyalgia rheumatica induced by durvalumab.
Ivette Casafont-Solé, Melania Martínez-Morillo, +3 authors, Teresa Moran.
Transl Lung Cancer Res, 2020 May 19; 9(2). PMID: 32420087    Free PMC article.
Oncologic Emergencies: Immune-Based Cancer Therapies and Complications.
Brit Long, Elizabeth Brém, Alex Koyfman.
West J Emerg Med, 2020 May 19; 21(3). PMID: 32421502    Free PMC article.
Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database.
Alessandro Ceschi, Roberta Noseda, Karine Palin, Katia Verhamme.
Front Pharmacol, 2020 May 20; 11. PMID: 32425791    Free PMC article.
A guide to cancer immunotherapy: from T cell basic science to clinical practice.
Alex D Waldman, Jill M Fritz, Michael J Lenardo.
Nat Rev Immunol, 2020 May 21; 20(11). PMID: 32433532    Free PMC article.
Normalization Cancer Immunotherapy for Melanoma.
Matthew D Vesely, Lieping Chen.
J Invest Dermatol, 2020 Feb 25; 140(6). PMID: 32092349    Free PMC article.
Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy.
Michael T Serzan, Princy N Kumar, Michael B Atkins.
J Immunother Cancer, 2020 May 22; 8(1). PMID: 32434789    Free PMC article.
COVID-19 and immune checkpoint inhibitors: initial considerations.
Ryan J Sullivan, Douglas B Johnson, +4 authors, Kerry L Reynolds.
J Immunother Cancer, 2020 May 22; 8(1). PMID: 32434790    Free PMC article.
Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders.
Michelle Coureau, Anne-Pascale Meert, Thierry Berghmans, Bogdan Grigoriu.
Front Med (Lausanne), 2020 May 28; 7. PMID: 32457912    Free PMC article.
Pneumocystis Pneumonia: Checkpoint Inhibition to the Rescue?
Julian Better, Ulrich Matt.
Am J Respir Cell Mol Biol, 2020 Feb 29; 62(6). PMID: 32109143    Free PMC article.
The Role of Pharmacists in Managing Adverse Events Related to Immune Checkpoint Inhibitor Therapy.
Patrick Medina, Kate D Jeffers, Van A Trinh, R Donald Harvey.
J Pharm Pract, 2019 Nov 07; 33(3). PMID: 31694455    Free PMC article.
Opportunistic infections complicating immunotherapy for non-small cell lung cancer.
Ziwei Liu, Tao Liu, +8 authors, Li Zhang.
Thorac Cancer, 2020 Apr 21; 11(6). PMID: 32311221    Free PMC article.
Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors.
Konstantinos Melissaropoulos, Kalliopi Klavdianou, +3 authors, Dimitrios Daoussis.
Int J Mol Sci, 2020 May 15; 21(9). PMID: 32403289    Free PMC article.
Focus on immune-related adverse events (irAEs) in immunotherapy of hepatobiliary malignancies.
Lei Zhang, Haitao Zhao.
Hepatobiliary Surg Nutr, 2020 Jun 09; 9(3). PMID: 32509826    Free PMC article.
Non-small-cell Lung Cancer with Severe Skin Manifestations Related to Radiation Recall Dermatitis after Atezolizumab Treatment.
Kei Nakashima, Koichi Saruwatari, +14 authors, Takuro Sakagami.
Intern Med, 2020 Feb 14; 59(9). PMID: 32051381    Free PMC article.
Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer.
Zia Khan, Flavia Di Nucci, +15 authors, Matthew L Albert.
Proc Natl Acad Sci U S A, 2020 May 21; 117(22). PMID: 32430334    Free PMC article.
A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors.
Joshua Tobias, Claire Battin, +13 authors, Ursula Wiedermann.
Front Immunol, 2020 Jun 13; 11. PMID: 32528470    Free PMC article.
Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease.
Catherine Baker, Matthew S Hayden.
F1000Res, 2020 Oct 21; 9. PMID: 32528662    Free PMC article.
Supramolecular Self-Assembled Nanostructures for Cancer Immunotherapy.
Zichao Huang, Wantong Song, Xuesi Chen.
Front Chem, 2020 Jun 13; 8. PMID: 32528926    Free PMC article.
High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients.
Dedong Cao, Huilin Xu, +2 authors, Wei Ge.
Oncoimmunology, 2019 Aug 21; 8(9). PMID: 31428527    Free PMC article.
The relationships between cancer and autoimmune rheumatic diseases.
Laura C Cappelli, Ami A Shah.
Best Pract Res Clin Rheumatol, 2020 Feb 08; 34(1). PMID: 32029389    Free PMC article.
A case report of fulminant cytokine release syndrome complicated by dermatomyositis after the combination therapy with immune checkpoint inhibitors.
Junichiro Ohira, Michi Kawamoto, Yoshio Sugino, Nobuo Kohara.
Medicine (Baltimore), 2020 Apr 14; 99(15). PMID: 32282733    Free PMC article.
Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors.
Bernadett Szabados, Yasmin Abu-Ghanem, +3 authors, Thomas Powles.
Eur Urol, 2020 Jun 15; 78(2). PMID: 32534910    Free PMC article.
Elevated levels of IL-17A and IL-35 in plasma and bronchoalveolar lavage fluid are associated with checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer.
Yi Na Wang, Dan Feng Lou, +4 authors, Hong Chao Chen.
Oncol Lett, 2020 Jun 23; 20(1). PMID: 32565986    Free PMC article.
Reporting of Immune Checkpoint Inhibitor Therapy-Associated Diabetes, 2015-2019.
Jiaqing Liu, Huaqiang Zhou, +4 authors, Li Zhang.
Diabetes Care, 2020 May 13; 43(7). PMID: 32393586    Free PMC article.
[Combination of Radiation Therapy and Immunotherapy for Non-small Cell Lung Cancer: Peer Exchange on Frontier Academic Topics].
Radiotherapy-Immunotherapy Discussion Group, Xinghao Ai, +11 authors, Zhengfei Zhu.
Zhongguo Fei Ai Za Zhi, 2020 Jun 11; 23(6). PMID: 32517461    Free PMC article.
Real time visualization of cancer cell death, survival and proliferation using fluorochrome-transfected cells in an IncuCyte® imaging system.
Thomas M Lanigan, Stephanie M Rasmussen, +4 authors, Jeffrey H Ruth.
J Biol Methods, 2020 Jun 25; 7(2). PMID: 32577423    Free PMC article.
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database.
Rosanna Ruggiero, Federica Fraenza, +8 authors, Annalisa Capuano.
Front Pharmacol, 2020 Jun 26; 11. PMID: 32581796    Free PMC article.
Detecting and Filtering Immune-Related Adverse Events Signal Based on Text Mining and Observational Health Data Sciences and Informatics Common Data Model: Framework Development Study.
Yue Yu, Kathryn Ruddy, +7 authors, Guoqian Jiang.
JMIR Med Inform, 2020 Jun 13; 8(6). PMID: 32530430    Free PMC article.
Immune checkpoint inhibitor-associated celiac disease.
Yousef R Badran, Angela Shih, +9 authors, Michael Dougan.
J Immunother Cancer, 2020 Jun 26; 8(1). PMID: 32581063    Free PMC article.
Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors.
Keitaro Shimozaki, Yasutaka Sukawa, +13 authors, Takanori Kanai.
Cancer Manag Res, 2020 Jul 02; 12. PMID: 32606951    Free PMC article.
Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes.
Alejandro Meraz-Muñoz, Eitan Amir, +6 authors, Abhijat Kitchlu.
J Immunother Cancer, 2020 Jul 01; 8(1). PMID: 32601079    Free PMC article.
Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
Yoshitaka Yamaguchi, Hikaru Nagasawa, Yuji Katagiri, Manabu Wada.
J Med Case Rep, 2020 Jul 06; 14(1). PMID: 32620173    Free PMC article.
Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy.
Sawsan Rashdan, John D Minna, David E Gerber.
Lancet Respir Med, 2018 Jun 02; 6(6). PMID: 29856320    Free PMC article.
A Tale of Immune-Related Adverse Events With Sequential Trials of Checkpoint Inhibitors in a Patient With Metastatic Renal Cell Carcinoma.
Vinit Singh, Yvonne Chu, Varsha Gupta, Charlie Weige Zhao.
Cureus, 2020 Jul 09; 12(6). PMID: 32637277    Free PMC article.
AIEgen-coupled upconversion nanoparticles eradicate solid tumors through dual-mode ROS activation.
Duo Mao, Fang Hu, +9 authors, Bin Liu.
Sci Adv, 2020 Jul 09; 6(26). PMID: 32637621    Free PMC article.
Balancing Cancer Immunotherapy Efficacy and Toxicity.
Douglas B Johnson, Baruch D Jakubovic, Vincent Sibaud, Meghan E Sise.
J Allergy Clin Immunol Pract, 2020 Jul 01; 8(9). PMID: 32599218    Free PMC article.
Adverse events associated with immune checkpoint inhibitors: a new era in autoimmune diabetes.
Halis Kaan Akturk, Aaron W Michels.
Curr Opin Endocrinol Diabetes Obes, 2020 Jul 04; 27(4). PMID: 32618630    Free PMC article.
The Changing Landscape of Autoimmune Hemolytic Anemia.
Wilma Barcellini, Bruno Fattizzo.
Front Immunol, 2020 Jul 14; 11. PMID: 32655543    Free PMC article.
Glycogen Synthase Kinase 3β in Cancer Biology and Treatment.
Takahiro Domoto, Masahiro Uehara, Dilireba Bolidong, Toshinari Minamoto.
Cells, 2020 Jun 07; 9(6). PMID: 32503133    Free PMC article.
Toward Systems Biomarkers of Response to Immune Checkpoint Blockers.
Óscar Lapuente-Santana, Federica Eduati.
Front Oncol, 2020 Jul 17; 10. PMID: 32670886    Free PMC article.
Infections associated with the new 'nibs and mabs' and cellular therapies.
Marcela V Maus, Michail S Lionakis.
Curr Opin Infect Dis, 2020 Jul 14; 33(4). PMID: 32657964    Free PMC article.
Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective study.
Dimitrios Daoussis, Konstantinos Melissaropoulos, +7 authors, Haralabos Kalofonos.
Mediterr J Rheumatol, 2020 Jul 18; 31(2). PMID: 32676566    Free PMC article.
Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review.
Sara Colomer-Lahiguera, Denise Bryant-Lukosius, +7 authors, Manuela Eicher.
J Patient Rep Outcomes, 2020 Jul 18; 4(1). PMID: 32676785    Free PMC article.
Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand.
James Randall Patrinely, Arissa C Young, +10 authors, Douglas B Johnson.
Eur J Cancer, 2020 Jul 01; 135. PMID: 32599411    Free PMC article.
Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis.
Qiang Zhang, Hua Zhong, +4 authors, Fang Cao.
Front Bioeng Biotechnol, 2020 Jul 23; 8. PMID: 32695752    Free PMC article.
Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?
Lucia Musacchio, Serena Maria Boccia, +9 authors, Violante Di Donato.
J Clin Med, 2020 Jun 07; 9(6). PMID: 32503218    Free PMC article.
Combination Therapy and Nanoparticulate Systems: Smart Approaches for the Effective Treatment of Breast Cancer.
Shivaprasad Gadag, Shristi Sinha, +2 authors, Usha Y Nayak.
Pharmaceutics, 2020 Jun 12; 12(6). PMID: 32521684    Free PMC article.
Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis.
Shilpa Grover, Michael Dougan, +18 authors, Osama E Rahma.
Cancer, 2020 Jun 23; 126(16). PMID: 32567084    Free PMC article.
A Review of Immune-Mediated Adverse Events in Melanoma.
Lucy Boyce Kennedy, April K S Salama.
Oncol Ther, 2020 Jul 24; 7(2). PMID: 32699983    Free PMC article.
Immune checkpoint inhibitors in patients with pretreated HodgkinÊs lymphoma: a Korean single-center, retrospective study.
Joon Young Hur, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim.
Blood Res, 2020 Jul 01; 55(2). PMID: 32595170    Free PMC article.
Cancer immunotherapy using checkpoint blockade.
Antoni Ribas, Jedd D Wolchok.
Science, 2018 Mar 24; 359(6382). PMID: 29567705    Free PMC article.
Highly Cited. Review.
Rapid onset type 1 diabetes with anti-PD-1 directed therapy.
Karen Yun, Gregory Daniels, +2 authors, Sandip Pravin Patel.
Oncotarget, 2020 Aug 01; 11(28). PMID: 32733645    Free PMC article.
Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use.
Rebecca N Jerome, Meghan Morrison Joly, +6 authors, Jill M Pulley.
Drug Saf, 2020 Mar 01; 43(6). PMID: 32112228    Free PMC article.
Acute myelomonocytic leukemia during pembrolizumab treatment for non-small cell lung cancer: A case report.
Hong-Beum Kim, Sang-Gon Park, +2 authors, Yong Sub Na.
World J Clin Cases, 2020 Aug 04; 8(13). PMID: 32742992    Free PMC article.
Remarkable antitumor effect of nivolumab in a patient with metastatic renal cell carcinoma previously treated with a peptide-based vaccine.
Ryoma Kurahashi, Takanobu Motoshima, +8 authors, Tomomi Kamba.
IJU Case Rep, 2020 Aug 04; 3(2). PMID: 32743467    Free PMC article.
Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.
Lei Li, Xi Chen, +3 authors, Qing Zhou.
Biosci Rep, 2020 Jul 15; 40(7). PMID: 32662515    Free PMC article.
Targeting Immunometabolism Mediated by CD73 Pathway in EGFR-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance.
Anna Passarelli, Michele Aieta, Alessandro Sgambato, Cesare Gridelli.
Front Immunol, 2020 Aug 08; 11. PMID: 32760402    Free PMC article.
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy.
Adrienne M Luoma, Shengbao Suo, +13 authors, Kai W Wucherpfennig.
Cell, 2020 Jul 01; 182(3). PMID: 32603654    Free PMC article.
Nivolumab-Induced Autoimmune-Like Cholestatic Hepatitis in a Liver Transplant Recipient.
Chimaobi Anugwom, Thomas Leventhal.
ACG Case Rep J, 2020 Aug 09; 7(7). PMID: 32766358    Free PMC article.
Comparative risk of serious and fatal treatment-related adverse events caused by 19 immune checkpoint inhibitors used in cancer treatment: a network meta-analysis.
Tingting Liu, Bo Jin, +4 authors, Guang Li.
Ther Adv Med Oncol, 2020 Aug 11; 12. PMID: 32774474    Free PMC article.
Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events.
Sandra M Herrmann, Mark A Perazella.
Kidney Int Rep, 2020 Aug 11; 5(8). PMID: 32775813    Free PMC article.
Immune Check Point Inhibitor-Associated Endothelialitis.
Shane A Bobart, Itunu Owoyemi, +2 authors, Sandra M Herrmann.
Kidney Int Rep, 2020 Aug 11; 5(8). PMID: 32775844    Free PMC article.
Immune checkpoint signaling and cancer immunotherapy.
Xing He, Chenqi Xu.
Cell Res, 2020 May 30; 30(8). PMID: 32467592    Free PMC article.
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations.
Luca Piscitani, Vittorio Sirolli, +2 authors, Mario Bonomini.
Int J Mol Sci, 2020 Jul 16; 21(14). PMID: 32664269    Free PMC article.
Targeted therapy for hepatocellular carcinoma.
Ao Huang, Xin-Rong Yang, +2 authors, Jian Zhou.
Signal Transduct Target Ther, 2020 Aug 13; 5(1). PMID: 32782275    Free PMC article.
Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study.
Naoto Okada, Rie Matsuoka, +6 authors, Keisuke Ishizawa.
Sci Rep, 2020 Aug 15; 10(1). PMID: 32792640    Free PMC article.
Large-Scale Analysis Reveals the Specific Clinical and Immune Features of DGCR5 in Glioma.
Xuechao Wu, Peng Hou, +2 authors, Xiaojie Lu.
Onco Targets Ther, 2020 Aug 18; 13. PMID: 32801772    Free PMC article.
COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management.
Marco Russano, Fabrizio Citarella, +6 authors, Daniele Santini.
Expert Opin Biol Ther, 2020 Jun 27; 20(9). PMID: 32588674    Free PMC article.
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance.
Emanuel Raschi, Milo Gatti, +3 authors, Fabrizio De Ponti.
Target Oncol, 2020 Jul 30; 15(4). PMID: 32725437    Free PMC article.
Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors.
Kartik Anand, Geetanjali Sahu, +5 authors, Swaminathan P Iyer.
ESMO Open, 2020 Aug 21; 5(4). PMID: 32817069    Free PMC article.
Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service.
Osama Abu-Shawer, Prabhsimranjot Singh, +11 authors, Osama Rahma.
J Immunother Cancer, 2020 Aug 21; 8(2). PMID: 32817360    Free PMC article.
Inflammatory Manifestations of Systemic Diseases in the Central Nervous System.
David A Lapides, Mark M McDonald.
Curr Treat Options Neurol, 2020 Aug 25; 22(9). PMID: 32834714    Free PMC article.
Cardiovascular Complications of Novel Anti-Cancer Immunotherapy: Old Problems from New Agents?
Woo Baek Chung, Jong Chan Youn, Ho Joong Youn.
Korean Circ J, 2020 Jul 30; 50(9). PMID: 32725983    Free PMC article.
Nivolumab plus gemcitabine, dexamethasone, and cisplatin chemotherapy induce durable complete remission in relapsed/refractory primary mediastinal B-cell lymphoma: a case report and literature review.
Gang Huang, Ju Huang, +2 authors, Yuan Liu.
J Int Med Res, 2020 Aug 14; 48(8). PMID: 32783492    Free PMC article.
Early Onset Immune-Related Adverse Event to Identify Pseudo-Progression in a Patient With Ovarian Cancer Treated With Nivolumab: A Case Report and Review of the Literature.
Hui Li, Xin Zhou, +6 authors, Jun Chen.
Front Med (Lausanne), 2020 Aug 28; 7. PMID: 32850889    Free PMC article.
Scientifically based combination therapies with immuno-oncology checkpoint inhibitors.
Hui Yi Chew, Riccardo Dolcetti, Fiona Simpson.
Br J Clin Pharmacol, 2020 May 07; 86(9). PMID: 32372470    Free PMC article.
CD47 prevents the elimination of diseased fibroblasts in scleroderma.
Tristan Lerbs, Lu Cui, +7 authors, Gerlinde Wernig.
JCI Insight, 2020 Aug 21; 5(16). PMID: 32814713    Free PMC article.
Liver dysfunction is associated with poor prognosis in patients after immune checkpoint inhibitor therapy.
Keisuke Yokohama, Akira Asai, +9 authors, Kazuhide Higuchi.
Sci Rep, 2020 Sep 04; 10(1). PMID: 32879383    Free PMC article.
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad.
Augusto Bleve, Barbara Durante, Antonio Sica, Francesca Maria Consonni.
Int J Mol Sci, 2020 Aug 23; 21(16). PMID: 32823961    Free PMC article.
PET Imaging of the Natural Killer Cell Activation Receptor NKp30.
Travis M Shaffer, Amin Aalipour, Christian M Schürch, Sanjiv S Gambhir.
J Nucl Med, 2020 Jun 14; 61(9). PMID: 32532927    Free PMC article.
The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19.
Lauren A Callender, Michelle Curran, +3 authors, Catherine J Betts.
Front Immunol, 2020 Sep 10; 11. PMID: 32903476    Free PMC article.
Nivolumab and ipilimumab immunotherapy for hemodialysis patients with advanced renal cell carcinoma.
Y Kobayashi, H Arai, M Honda.
Curr Oncol, 2020 Sep 10; 27(4). PMID: 32905370    Free PMC article.
Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments.
Martin Krenn, Anna Grisold, +4 authors, Fritz Zimprich.
Front Mol Neurosci, 2020 Sep 15; 13. PMID: 32922263    Free PMC article.
Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis.
Boris Shulgin, Yuri Kosinsky, +8 authors, Gabriel Helmlinger.
Oncoimmunology, 2020 Sep 17; 9(1). PMID: 32934874    Free PMC article.
Safety and efficacy of nivolumab as a second line therapy in metastatic renal cell carcinoma: a retrospective chart review.
Marija Gamulin, Eric Nham, +2 authors, Robert Likić.
Croat Med J, 2020 Sep 04; 61(4). PMID: 32881430    Free PMC article.
The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients.
Xiaoyang Zhai, Jian Zhang, +4 authors, Hui Zhu.
Cancer Biol Med, 2020 Sep 19; 17(3). PMID: 32944393    Free PMC article.
Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis.
Arsen Osipov, Su Jin Lim, +6 authors, Mark Yarchoan.
Clin Cancer Res, 2020 Jun 27; 26(18). PMID: 32586938    Free PMC article.
Critical Care Management of Toxicities Associated With Targeted Agents and Immunotherapies for Cancer.
Cristina Gutierrez, Colleen McEvoy, +4 authors, Stephen M Pastores.
Crit Care Med, 2019 Nov 15; 48(1). PMID: 31725440    Free PMC article.
Integration of stereotactic radiosurgery or whole brain radiation therapy with immunotherapy for treatment of brain metastases.
Zhou Su, Lin Zhou, Jianxin Xue, You Lu.
Chin J Cancer Res, 2020 Sep 24; 32(4). PMID: 32963458    Free PMC article.
Natural products and their derivatives: Promising modulators of tumor immunotherapy.
Li-Juan Deng, Ming Qi, +3 authors, Jia-Xu Chen.
J Leukoc Biol, 2020 Jul 18; 108(2). PMID: 32678943    Free PMC article.
Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression.
Liang Wen, Xiuwen Zou, +2 authors, Tingbo Liang.
Front Immunol, 2020 Sep 26; 11. PMID: 32973816    Free PMC article.
Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data.
Theodoros G Soldatos, Antonia Dimitrakopoulou-Strauss, +2 authors, Christos Sachpekidis.
Diagnostics (Basel), 2018 Nov 06; 8(4). PMID: 30384507    Free PMC article.
Do toxicity patterns vary between programmed death-1 and programmed death ligand-1 inhibitors?
Dwight H Owen, Gregory A Otterson.
J Thorac Dis, 2019 Jan 12; 10(Suppl 33). PMID: 30631557    Free PMC article.
Isolated adrenocorticotropic hormone deficiency potentially induced by nivolumab following pseudo-progression in clear cell renal cell carcinoma: A case report.
Nobuki Furubayashi, Takahito Negishi, +4 authors, Motonobu Nakamura.
Mol Clin Oncol, 2019 Jan 27; 10(2). PMID: 30680212    Free PMC article.
The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients.
Koichi Saruwatari, Ryo Sato, +8 authors, Takuro Sakagami.
Cancers (Basel), 2019 Jan 27; 11(2). PMID: 30682845    Free PMC article.
Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.
Meng H Tan, Ravi Iyengar, +5 authors, Roma Gianchandani.
Clin Diabetes Endocrinol, 2019 Jan 30; 5. PMID: 30693099    Free PMC article.
Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?
Virginie Lemiale, Anne-Pascale Meert, +5 authors, Groupe de Recherche en Reanimation Respiratoire du patient d’Onco-Hématologie (Grrr-OH).
Ann Intensive Care, 2019 Feb 02; 9(1). PMID: 30707321    Free PMC article.
Cardiac Complications in Immune Checkpoint Inhibition Therapy.
Kazuko Tajiri, Masaki Ieda.
Front Cardiovasc Med, 2019 Feb 08; 6. PMID: 30729114    Free PMC article.
Pembrolizumab-related renal toxicities: diagnosis first, treatment later.
Ben Sprangers.
Clin Kidney J, 2019 Feb 13; 12(1). PMID: 30746131    Free PMC article.
Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy.
Vineet Govinda Gupta, Ranga Rao Rangaraju, +2 authors, Ruchika Khetrapal.
South Asian J Cancer, 2019 Feb 16; 8(1). PMID: 30766859    Free PMC article.
The evolving role of immuno-oncology for the treatment of head and neck cancer.
Arianna L Strome, Xiaoyu Zhang, Scott E Strome.
Laryngoscope Investig Otolaryngol, 2019 Mar 05; 4(1). PMID: 30828620    Free PMC article.
Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: a Minireview of Current Clinical Guidelines.
Saralinh Trinh, Alex Le, Sajida Gowani, Ninh M La-Beck.
Asia Pac J Oncol Nurs, 2019 Apr 02; 6(2). PMID: 30931360    Free PMC article.
Highly Cited. Review.
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research.
Liting You, Ruizhan Tong, +3 authors, You Lu.
Mol Ther Methods Clin Dev, 2019 Apr 17; 13. PMID: 30989086    Free PMC article.
Efficacy and safety of programmed cell death-1/programmed cell death ligand-1 inhibitors in advanced urothelial malignancy: A systematic review and meta-analysis.
Smita Pattanaik, Sumit Dey, +4 authors, Ravimohan Suryanarayan Mavuduru.
Indian J Urol, 2019 Apr 20; 35(2). PMID: 31000914    Free PMC article.
Surviving Cancer without a Broken Heart.
Oren Caspi, Doron Aronson.
Rambam Maimonides Med J, 2019 Apr 20; 10(2). PMID: 31002639    Free PMC article.
Severe pulmonary toxicity from immune checkpoint inhibitor treated successfully with intravenous immunoglobulin: Case report and review of the literature.
Camille R Petri, Rushad Patell, +2 authors, Robert W Hallowell.
Respir Med Case Rep, 2019 Apr 23; 27. PMID: 31008047    Free PMC article.
Sequential Blockade of PD-1 and PD-L1 Causes Fulminant Cardiotoxicity-From Case Report to Mouse Model Validation.
Shin-Yi Liu, Wen-Chien Huang, +5 authors, Yu-Jen Chen.
Cancers (Basel), 2019 Apr 27; 11(4). PMID: 31022941    Free PMC article.
Immune checkpoint inhibitors in malignancy.
Luke Ardolino, Anthony Joshua.
Aust Prescr, 2019 May 03; 42(2). PMID: 31048940    Free PMC article.
Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies.
Ryo Sato, Kosuke Imamura, +13 authors, Takuro Sakagami.
J Clin Med, 2019 May 31; 8(6). PMID: 31146442    Free PMC article.
Cardiotoxicity of Immune Checkpoint Inhibitors.
Lili Zhang, Maeve Jones-O'Connor, +6 authors, Tomas G Neilan.
Curr Treat Options Cardiovasc Med, 2019 Jun 09; 21(7). PMID: 31175469
Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors.
Anne Rogiers, Annelies Boekhout, +3 authors, Bart Neyns.
J Oncol, 2019 Jun 12; 2019. PMID: 31182961    Free PMC article.
MicroRNAs aid the assessment of programmed death ligand 1 expression in patients with non-small cell lung cancer.
Anna Grenda, Marcin Nicoś, +8 authors, Janusz Milanowski.
Oncol Lett, 2019 Jun 13; 17(6). PMID: 31186735    Free PMC article.
Alleviation of exhaustion-induced immunosuppression and sepsis by immune checkpoint blockers sequentially administered with antibiotics-analysis of a new mathematical model.
Avi Gillis, Michael Beil, +3 authors, Zvia Agur.
Intensive Care Med Exp, 2019 Jun 13; 7(1). PMID: 31187301    Free PMC article.
Immune Checkpoint Inhibition in Classical Hodgkin Lymphoma: From Early Achievements towards New Perspectives.
Diego De Goycoechea, Gregoire Stalder, Filipe Martins, Michel A Duchosal.
J Oncol, 2019 Jun 18; 2019. PMID: 31205470    Free PMC article.
Coverage Evaluation of CTCAE for Capturing the Immune-related Adverse Events Leveraging Text Mining Technologies.
Yue Yu, Kathryn J Ruddy, +4 authors, Guoqian Jiang.
AMIA Jt Summits Transl Sci Proc, 2019 Jul 02; 2019. PMID: 31259034    Free PMC article.
Correlation between thyroid transcription factor-1 expression, immune-related thyroid dysfunction, and efficacy of anti-programmed cell death protein-1 treatment in non-small cell lung cancer.
Junji Koyama, Atsushi Horiike, +11 authors, Makoto Nishio.
J Thorac Dis, 2019 Jul 10; 11(5). PMID: 31285885    Free PMC article.
A pooled meta-analysis of PD-1/L1 inhibitors incorporation therapy for advanced non-small cell lung cancer.
Ning Wan, Bo Ji, +4 authors, Wenjie Huang.
Onco Targets Ther, 2019 Jul 16; 12. PMID: 31303759    Free PMC article.
Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian Populations.
Jiqiao Yang, Xiujing He, +2 authors, Hubing Shi.
Front Pharmacol, 2019 Jul 18; 10. PMID: 31312140    Free PMC article.
Disseminated blastomycosis in a patient on pembrolizumab for metastatic melanoma.
Ian Ferguson, Meghan Heberton, +2 authors, Lynn Cornelius.
JAAD Case Rep, 2019 Jul 18; 5(7). PMID: 31312706    Free PMC article.
Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives.
Weiqi Xu, Ken Liu, +4 authors, Jiansong Ji.
Ther Adv Med Oncol, 2019 Aug 07; 11. PMID: 31384311    Free PMC article.
The neurotoxic effects of immune checkpoint inhibitor therapy for melanoma.
Lavinia Spain, Rachel Wong.
Melanoma Manag, 2019 Aug 14; 6(2). PMID: 31406561    Free PMC article.
Clinical features of immune-related thyroid dysfunction and its association with outcomes in patients with advanced malignancies treated by PD-1 blockade.
Tomoki Sakakida, Takeshi Ishikawa, +16 authors, Koichi Takayama.
Oncol Lett, 2019 Aug 20; 18(2). PMID: 31423288    Free PMC article.
Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma.
Hoda Z Pourhassan, David Tryon, +2 authors, John Wong.
Exp Hematol Oncol, 2019 Sep 14; 8. PMID: 31516766    Free PMC article.
Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis.
Xiaodi Guo, Wendong Li, +2 authors, Qiang Su.
Eur J Clin Pharmacol, 2020 Jun 09; 76(10). PMID: 32507925    Free PMC article.
Systematic Review.
Treatment-related adverse events as surrogate to response rate to immune checkpoint blockade.
Yanyun Shen, Yunfeng Chen, Duoqin Wang, Zhidong Zhu.
Medicine (Baltimore), 2020 Sep 15; 99(37). PMID: 32925773    Free PMC article.
Systematic Review.
LAG-3: from molecular functions to clinical applications.
Takumi Maruhashi, Daisuke Sugiura, Il-Mi Okazaki, Taku Okazaki.
J Immunother Cancer, 2020 Sep 16; 8(2). PMID: 32929051    Free PMC article.
Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case series.
Puja Arora, Laura Talamo, +5 authors, Elizabeth M Gaughan.
Cardiooncology, 2020 Sep 29; 6. PMID: 32983574    Free PMC article.
Mimi Wong, Nirjhar Nandi, Ashim Sinha.
AACE Clin Case Rep, 2020 Sep 29; 6(1). PMID: 32984519    Free PMC article.
Use of glucocorticoids in the management of immunotherapy-related adverse effects.
Hanping Wang, Jiaxin Zhou, +4 authors, Li Zhang.
Thorac Cancer, 2020 Sep 08; 11(10). PMID: 32893490    Free PMC article.
Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care.
Brianna Hoffner, Krista M Rubin.
J Adv Pract Oncol, 2019 Mar 01; 10(Suppl 1). PMID: 33014514    Free PMC article.
PD-1/PD-L1 Inhibitors for Non-Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management.
Marianne J Davies.
J Adv Pract Oncol, 2019 Mar 01; 10(Suppl 1). PMID: 33014515    Free PMC article.
Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2.
Shuang Dong, Chenggang Luo, +17 authors, Sheng Hu.
Front Oncol, 2020 Oct 06; 10. PMID: 33014801    Free PMC article.
Immune-Related Adverse Events and Corticosteroid Use for Cancer-Related Symptoms Are Associated With Efficacy in Patients With Non-small Cell Lung Cancer Receiving Anti-PD-(L)1 Blockade Agents.
Mariona Riudavets, Joaquin Mosquera, +9 authors, Margarita Majem.
Front Oncol, 2020 Oct 06; 10. PMID: 33014837    Free PMC article.
Enhancing cancer immunotherapy with nanomedicine.
Darrell J Irvine, Eric L Dane.
Nat Rev Immunol, 2020 Feb 02; 20(5). PMID: 32005979    Free PMC article.
Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab.
Yutaka Natori, Eisaku Sasaki, +5 authors, Shigehira Saji.
J Immunother Cancer, 2020 Oct 03; 8(2). PMID: 33004543    Free PMC article.
89Zr-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs.
Elly L van der Veen, Danique Giesen, +3 authors, Marjolijn N Lub-de Hooge.
J Immunother Cancer, 2020 Oct 07; 8(2). PMID: 33020241    Free PMC article.
Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm.
Nicki Panoskaltsis, Neil E McCarthy, +9 authors, Stella C Knight.
Cancer Immunol Immunother, 2020 Oct 10; 70(4). PMID: 33033851    Free PMC article.
Pneumonitis Induced by Immune Checkpoint Inhibitors: From Clinical Data to Translational Investigation.
Shicong Zhu, Yang Fu, +2 authors, Jun Wang.
Front Oncol, 2020 Oct 13; 10. PMID: 33042827    Free PMC article.
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy.
Ying Jing, Jin Liu, +10 authors, Leng Han.
Nat Commun, 2020 Oct 04; 11(1). PMID: 33009409    Free PMC article.
COVID-19 and Cancer: Current Challenges and Perspectives.
Ziad Bakouny, Jessica E Hawley, +4 authors, Corrie A Painter.
Cancer Cell, 2020 Oct 14; 38(5). PMID: 33049215    Free PMC article.
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer.
Mingjia Li, Daniel Spakowicz, +13 authors, Dwight H Owen.
Cancer Immunol Immunother, 2020 Jul 31; 69(11). PMID: 32728772    Free PMC article.
HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial.
Yan Song, Ning Li, +12 authors, Jing Huang.
J Immunother Cancer, 2020 Oct 17; 8(2). PMID: 33060149    Free PMC article.
Management of Immune Checkpoint Inhibitor Toxicities.
Quentin Durrechou, Charlotte Domblides, +5 authors, Amaury Daste.
Cancer Manag Res, 2020 Oct 17; 12. PMID: 33061607    Free PMC article.
Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy.
Simone Nüssing, Joseph A Trapani, Ian A Parish.
Front Immunol, 2020 Oct 20; 11. PMID: 33072137    Free PMC article.
Uncoupling Therapeutic Efficacy from Immune-Related Adverse Events in Immune Checkpoint Blockade.
Weilei Hu, Guosheng Wang, +2 authors, Ming You.
iScience, 2020 Oct 22; 23(10). PMID: 33083746    Free PMC article.
Integrative analysis of key candidate genes and signaling pathways in autoimmune thyroid dysfunction related to anti-CTLA-4 therapy by bioinformatics.
Ying Zhang, Francesca Garofano, +4 authors, Ingo G H Schmidt-Wolf.
Invest New Drugs, 2020 Jun 06; 38(6). PMID: 32500465    Free PMC article.
Novel Strategies to Combat CMV-Related Cardiovascular Disease.
Elena Vasilieva, Sara Gianella, Michael L Freeman.
Pathog Immun, 2020 Oct 23; 5(1). PMID: 33089035    Free PMC article.
Renal Tubular Acidosis and Immune Checkpoint Inhibitor Therapy: An Immune-Related Adverse Event of PD-1 Inhibitor-A Report of 3 Cases.
Sandra M Herrmann, Mariam P Alexander, Michael F Romero, Ladan Zand.
Kidney Med, 2020 Oct 23; 2(5). PMID: 33089143    Free PMC article.
MRI Findings of Immune Checkpoint Inhibitor-Induced Hypophysitis: Possible Association with Fibrosis.
R Kurokawa, Y Ota, +10 authors, O Abe.
AJNR Am J Neuroradiol, 2020 Aug 09; 41(9). PMID: 32763900    Free PMC article.
Higher Checkpoint Inhibitor Arthritis Disease Activity may be Associated With Cancer Progression: Results From an Observational Registry.
Karmela Kim Chan, Aidan Tirpack, +6 authors, Anne R Bass.
ACR Open Rheumatol, 2020 Oct 04; 2(10). PMID: 33010198    Free PMC article.
Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma.
Matthew D Tucker, Brian I Rini.
Cancers (Basel), 2020 Sep 24; 12(9). PMID: 32961934    Free PMC article.
Combined Methylome and Transcriptome Analyses Reveals Potential Therapeutic Targets for EGFR Wild Type Lung Cancers with Low PD-L1 Expression.
Weilei Hu, Guosheng Wang, Lonny B Yarmus, Yuan Wan.
Cancers (Basel), 2020 Sep 10; 12(9). PMID: 32899191    Free PMC article.
Pharmacogenomics for immunotherapy and immune-related cardiotoxicity.
Jessica A Castrillon, Charis Eng, Feixiong Cheng.
Hum Mol Genet, 2020 Jul 06; 29(R2). PMID: 32620943    Free PMC article.
Toxicity of Immune Checkpoint Inhibitors: Considerations for the Surgeon.
Beth A Helmink, Christina L Roland, Colleen M Kiernan, Jennifer A Wargo.
Ann Surg Oncol, 2020 Jan 23; 27(5). PMID: 31965370    Free PMC article.
Perspectives From an Onconephrology Interest Group: Conference Report.
Abhijat Kitchlu, Christopher T Chan, +3 authors, Paul Tam.
Can J Kidney Health Dis, 2020 Oct 30; 7. PMID: 33117547    Free PMC article.
Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy.
Feliciano Barrón, Roberto Sánchez, +7 authors, Oscar Arrieta.
Front Oncol, 2020 Oct 30; 10. PMID: 33117699    Free PMC article.
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant.
Chang Yang, Bai-Rong Xia, +3 authors, Wei-Lin Jin.
Front Immunol, 2020 Oct 31; 11. PMID: 33123161    Free PMC article.
Carbon Ion Radiobiology.
Walter Tinganelli, Marco Durante.
Cancers (Basel), 2020 Oct 22; 12(10). PMID: 33080914    Free PMC article.
Checkpoint Inhibitor-Associated Arthritis: A Systematic Review of Case Reports and Case Series.
Nilasha Ghosh, Michael D Tiongson, +4 authors, Anne R Bass.
J Clin Rheumatol, 2020 Apr 30; 27(8). PMID: 32345841    Free PMC article.
Systematic Review.
Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance.
Vanessa Gauttier, Sabrina Pengam, +40 authors, Nicolas Poirier.
J Clin Invest, 2020 Oct 20; 130(11). PMID: 33074246    Free PMC article.
Biomarkers in immunotherapy: literature review and future directions.
Rebecca Pharaon, Maria A Koczywas, +2 authors, Erminia Massarelli.
J Thorac Dis, 2020 Nov 05; 12(9). PMID: 33145089    Free PMC article.
Cardiotoxicity of Contemporary Anticancer Immunotherapy.
Natalie Dal'bo, Rushin Patel, +4 authors, Sarju Ganatra.
Curr Treat Options Cardiovasc Med, 2020 Nov 10; 22(12). PMID: 33162729    Free PMC article.
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
Rossana Franzin, Giuseppe Stefano Netti, +5 authors, Elena Ranieri.
Front Immunol, 2020 Nov 10; 11. PMID: 33162990    Free PMC article.
Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report.
Maria Anna Siciliano, Stefano Dastoli, +4 authors, Vito Barbieri.
Front Oncol, 2020 Nov 10; 10. PMID: 33163407    Free PMC article.
[The use of immune checkpoint inhibitors in routine oncology].
Julian Schardt.
Z Rheumatol, 2020 Sep 17; 79(8). PMID: 32936368    Free PMC article.
Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions.
David Bauché, Smita Mauze, +11 authors, Drake Laface.
J Immunother Cancer, 2020 Nov 01; 8(2). PMID: 33127658    Free PMC article.
Type 1 Diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric Cancer: A Case Report.
Shoko Marshall, Aki Kizuki, +5 authors, Hiroshi Sakura.
Case Rep Oncol, 2020 Nov 12; 13(3). PMID: 33173483    Free PMC article.
Thyroid Dysfunctions Due to Immune Checkpoint Inhibitors: A Review.
Rawaa El Sabbagh, Nadim S Azar, Assaad A Eid, Sami T Azar.
Int J Gen Med, 2020 Nov 13; 13. PMID: 33177863    Free PMC article.
A large randomized clinical trial is necessary to establish the role of camrelizumab in hepatocellular carcinoma.
Nishal Ravindran, Paul J Thuluvath.
Ann Transl Med, 2020 Nov 13; 8(19). PMID: 33178785    Free PMC article.
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy.
Bin Zhang, Ping Cheng.
Mol Cancer, 2020 Nov 12; 19(1). PMID: 33172438    Free PMC article.
Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.
Susan Spillane, Shrujal Baxi, +4 authors, Elad Sharon.
Oncologist, 2020 Oct 24; 25(11). PMID: 33094874    Free PMC article.
Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma.
Xiaoshuai Ji, Feng Ding, +5 authors, Tao Xin.
Front Oncol, 2020 Nov 17; 10. PMID: 33194678    Free PMC article.
Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors.
Eleonora De Martin, Jean-Marie Michot, +2 authors, Didier Samuel.
JHEP Rep, 2020 Nov 19; 2(6). PMID: 33205034    Free PMC article.
CYP1B1 as a therapeutic target in cardio-oncology.
Alexa N Carrera, Marianne K O Grant, Beshay N Zordoky.
Clin Sci (Lond), 2020 Nov 14; 134(21). PMID: 33185690    Free PMC article.
Severe mesenteric ischemia with multiple organ failure in a patient previously treated with a humanized monoclonal antibody against programmed death receptor-1 (pembrolizumab), a case of pembrolizumab associated catastrophic antiphospholipid syndrome?
E M W Mintjens-Jager, M E Vos, +3 authors, M van Meurs.
SAGE Open Med Case Rep, 2020 Nov 24; 8. PMID: 33224503    Free PMC article.
Efficacy and immune-related adverse event associations in avelumab-treated patients.
Karen Kelly, Juliane Manitz, +8 authors, James L Gulley.
J Immunother Cancer, 2020 Nov 22; 8(2). PMID: 33219092    Free PMC article.
Salvage camrelizumab plus apatinib for relapsed esophageal neuroendocrine carcinoma after esophagectomy: a case report and review of the literature.
Lei Liu, Yuanyuan Liu, +2 authors, Wenbin Wu.
Cancer Biol Ther, 2020 Oct 24; 21(11). PMID: 33092443    Free PMC article.
Bilateral Posterior Uveitis and Retinal Detachment During Immunotherapy: A Case Report and Literature Review.
Ling Peng, Qi-Qi Mao, +8 authors, Hai Jiang.
Front Oncol, 2020 Nov 27; 10. PMID: 33240807    Free PMC article.
Transcriptional Control of Regulatory T Cells in Cancer: Toward Therapeutic Targeting?
Pierre Stéphan, Raphaëlle Lautraite, Allison Voisin, Yenkel Grinberg-Bleyer.
Cancers (Basel), 2020 Nov 05; 12(11). PMID: 33143070    Free PMC article.
Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature.
Ciro Manzo, Marco Isetta, Maria Natale, Alberto Castagna.
Medicines (Basel), 2020 Nov 07; 7(11). PMID: 33153016    Free PMC article.
Multidisciplinary Clinical Approach to Cancer Patients with Immune-Related Adverse Events Induced by Checkpoint Inhibitors.
Maria-Carlota Londoño, Maria Reig, RETOINMUNO Multidisciplinary Group.
Cancers (Basel), 2020 Nov 25; 12(11). PMID: 33228219    Free PMC article.
Pre-Existing Cardiovascular Conditions as Clinical Predictors of Myocarditis Reporting with Immune Checkpoint Inhibitors: A VigiBase Study.
Roberta Noseda, Lorenzo Ruinelli, Linda C van der Gaag, Alessandro Ceschi.
Cancers (Basel), 2020 Nov 27; 12(11). PMID: 33238481    Free PMC article.
Co-inhibitory Receptor Signaling in T-Cell-Mediated Autoimmune Glomerulonephritis.
Kei Nagai.
Front Med (Lausanne), 2020 Dec 01; 7. PMID: 33251233    Free PMC article.
Immune tumor board: integral part in the multidisciplinary management of cancer patients treated with cancer immunotherapy.
Heinz Läubli, Stefan Dirnhofer, Alfred Zippelius.
Virchows Arch, 2018 Aug 26; 474(4). PMID: 30143868
An introduction to the clinical practice of theranostics in oncology.
J Harvey Turner.
Br J Radiol, 2018 Sep 05; 91(1091). PMID: 30179054    Free PMC article.
Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer.
Emmett V Schmidt.
Semin Immunopathol, 2018 Oct 31; 41(1). PMID: 30374524    Free PMC article.
Enhancing the Anticancer Efficacy of Immunotherapy through Combination with Histone Modification Inhibitors.
Wanyu Sun, Shuting Lv, +2 authors, Lihui Wang.
Genes (Basel), 2018 Dec 19; 9(12). PMID: 30558227    Free PMC article.
Therapeutic Targets for Bone and Soft-Tissue Sarcomas.
Shinji Miwa, Norio Yamamoto, +3 authors, Hiroyuki Tsuchiya.
Int J Mol Sci, 2019 Jan 10; 20(1). PMID: 30621224    Free PMC article.
Checkpoint inhibitors: What gastroenterologists need to know.
Monjur Ahmed.
World J Gastroenterol, 2019 Jan 10; 24(48). PMID: 30622372    Free PMC article.
Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report.
Johan Pluvy, Solenn Brosseau, +6 authors, Valérie Gounant.
BMC Pulm Med, 2019 Jan 13; 19(1). PMID: 30634951    Free PMC article.
Design and Synthesis of A PD-1 Binding Peptide and Evaluation of Its Anti-Tumor Activity.
Abdul Baset Abbas, Bingjing Lin, +3 authors, Hanmei Xu.
Int J Mol Sci, 2019 Feb 01; 20(3). PMID: 30699956    Free PMC article.
Targeting Immune Checkpoints in Lung Cancer: Current Landscape and Future Prospects.
Long Long, Chen Zhao, +3 authors, Honglei Chen.
Clin Drug Investig, 2019 Feb 20; 39(4). PMID: 30778885
[Ventricular extrasystoles and wide complex tachycardias].
Artur Berkovitz, Thomas Deneke, +15 authors, Kai Sonne.
Herzschrittmacherther Elektrophysiol, 2019 Mar 09; 30(1). PMID: 30848338
Glial Cell Expression of PD-L1.
Priyanka Chauhan, James R Lokensgard.
Int J Mol Sci, 2019 Apr 17; 20(7). PMID: 30987269    Free PMC article.
PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models.
Leah A Mitchell, Kader Yagiz, +14 authors, Amy H Lin.
Oncotarget, 2019 May 02; 10(23). PMID: 31040917    Free PMC article.
Autoimmune Endocrine Dysfunctions Associated with Cancer Immunotherapies.
Silvia Martina Ferrari, Poupak Fallahi, +8 authors, Alessandro Antonelli.
Int J Mol Sci, 2019 May 30; 20(10). PMID: 31137683    Free PMC article.
Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report.
Michael A Cardis, Hong Jiang, +2 authors, Isaac Brownell.
BMC Cancer, 2019 Jun 06; 19(1). PMID: 31164102    Free PMC article.
Anti-PD-1 and anti-PD-L1 drugs treatment-related adverse events for patients with cancer: Protocol for an overview of systematic reviews with meta-analyses.
Jing Li, Ming Liu, +4 authors, JunHai Jia.
Medicine (Baltimore), 2019 Jul 07; 98(27). PMID: 31277179    Free PMC article.
Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events.
Esmée P Hoefsmit, Elisa A Rozeman, John B A G Haanen, Christian U Blank.
ESMO Open, 2019 Aug 20; 4(4). PMID: 31423333    Free PMC article.
Evaluation of the usefulness of protocol-based pharmacist-facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer.
Hiroaki Ikesue, Kaori Kusuda, +9 authors, Tohru Hashida.
J Clin Pharm Ther, 2020 Jun 11; 45(6). PMID: 32519774    Free PMC article.
Type 1 diabetes induced by immune checkpoint inhibitors.
Rui Zhang, Xiao-Ling Cai, +2 authors, Li-Nong Ji.
Chin Med J (Engl), 2020 Aug 26; 133(21). PMID: 32842016    Free PMC article.
Management of the Adverse Effects of Immune Checkpoint Inhibitors.
Manuel Morgado, Ana Plácido, Sandra Morgado, Fátima Roque.
Vaccines (Basel), 2020 Oct 07; 8(4). PMID: 33019641    Free PMC article.
CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function.
Nicholas F Kuhn, Andrea V Lopez, +3 authors, Renier J Brentjens.
Nat Commun, 2020 Dec 04; 11(1). PMID: 33268774    Free PMC article.
Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation.
Marina Chulkina, Ellen J Beswick, Irina V Pinchuk.
Int J Mol Sci, 2020 Dec 05; 21(23). PMID: 33271941    Free PMC article.
Immunotherapy in patients with autoimmune disease.
Sagar Rakshit, Julian R Molina.
J Thorac Dis, 2020 Dec 08; 12(11). PMID: 33282408    Free PMC article.
Recent updates on Sintilimab in solid tumor immunotherapy.
Xuhong Liu, Yong Yi.
Biomark Res, 2020 Dec 10; 8(1). PMID: 33292551    Free PMC article.
Retreatment with immune checkpoint inhibitors in solid tumors: a systematic review.
Kaili Yang, Jiarui Li, +2 authors, Chunmei Bai.
Ther Adv Med Oncol, 2020 Dec 10; 12. PMID: 33294036    Free PMC article.
Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors.
Maansi Joshi, Stephen M Ansell.
J Immunol Res, 2020 Dec 10; 2020. PMID: 33294467    Free PMC article.
Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy.
Xing Huang, Tianyu Tang, +5 authors, Tingbo Liang.
NPJ Precis Oncol, 2020 Dec 11; 4(1). PMID: 33299118    Free PMC article.
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy.
Yuefei Zhu, Xiangrong Yu, +2 authors, Zhiqing Pang.
Acta Pharm Sin B, 2020 Dec 12; 10(11). PMID: 33304779    Free PMC article.
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges.
John D Martin, Horacio Cabral, Triantafyllos Stylianopoulos, Rakesh K Jain.
Nat Rev Clin Oncol, 2020 Feb 09; 17(4). PMID: 32034288    Free PMC article.
Immunotherapy Use in Patients With Lung Cancer and Comorbidities.
Mitchell S von Itzstein, Amrit S Gonugunta, +2 authors, David E Gerber.
Cancer J, 2020 Dec 11; 26(6). PMID: 33298724    Free PMC article.
The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors.
Xiao-Hui Jia, Lu-Ying Geng, +7 authors, Hui Guo.
J Exp Clin Cancer Res, 2020 Dec 16; 39(1). PMID: 33317597    Free PMC article.
Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis.
Nso Nso, Daniel Antwi-Amoabeng, +8 authors, Nageshwara Gullapalli.
World J Cardiol, 2020 Dec 15; 12(11). PMID: 33312443    Free PMC article.
A retrospective analysis of eosinophilia as a predictive marker of response and toxicity to cancer immunotherapy.
Tharani Krishnan, Yoko Tomita, Rachel Roberts-Thomson.
Future Sci OA, 2020 Dec 15; 6(10). PMID: 33312694    Free PMC article.
Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with Pembrolizumab.
Jun Sugisaka, Yukihiro Toi, +16 authors, Shunichi Sugawara.
JMA J, 2020 Dec 17; 3(1). PMID: 33324776    Free PMC article.
Lung Cancer Immunotherapy in Transplant Patients and in Patients With Autoimmune Diseases.
Tomasz Kubiatowski, Marcin Nicoś, Paweł Krawczyk.
Front Oncol, 2020 Dec 18; 10. PMID: 33330040    Free PMC article.
Interim [18F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma.
Christos Sachpekidis, Annette Kopp-Schneider, +4 authors, Antonia Dimitrakopoulou-Strauss.
Eur J Nucl Med Mol Imaging, 2020 Dec 19; 48(6). PMID: 33336264    Free PMC article.
The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.
Costas D Arvanitis, Gino B Ferraro, Rakesh K Jain.
Nat Rev Cancer, 2019 Oct 12; 20(1). PMID: 31601988    Free PMC article.
Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis.
Sibo Tian, Jeffrey M Switchenko, +9 authors, Kristin A Higgins.
Int J Radiat Oncol Biol Phys, 2020 Jan 27; 108(1). PMID: 31982496    Free PMC article.
Strategies for improving the management of immune-related adverse events.
Aung Naing, Joud Hajjar, +4 authors, Patrick Hwu.
J Immunother Cancer, 2020 Dec 15; 8(2). PMID: 33310772    Free PMC article.
The Advanced Practice Provider Perspective: Treating Patients With Immuno-Oncology Combination Therapy Across Tumor Types.
Brianna Hoffner, Renae Vaughn, Maureen Reed, Melinda S Weber.
J Adv Pract Oncol, 2019 May 01; 10(4). PMID: 33343985    Free PMC article.
Programmed cell death 1 (PD-1)/PD-ligand 1(PD-L1) inhibitors-related pneumonitis in patients with advanced non-small cell lung cancer.
Yuxin Sun, Chi Shao, +6 authors, Zuojun Xu.
Asia Pac J Clin Oncol, 2020 Aug 07; 16(6). PMID: 32757454    Free PMC article.
Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer.
Karan Mediratta, Sara El-Sahli, Vanessa D'Costa, Lisheng Wang.
Cancers (Basel), 2020 Dec 02; 12(12). PMID: 33256070    Free PMC article.
Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist.
Bruno Fattizzo, Juri Alessandro Giannotta, Fabio Serpenti, Wilma Barcellini.
J Clin Med, 2020 Dec 03; 9(12). PMID: 33261016    Free PMC article.
Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity.
Noelia Silva-Pilipich, Eva Martisova, +5 authors, Lucia Vanrell.
Biomedicines, 2020 Dec 06; 8(12). PMID: 33276580    Free PMC article.
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial.
Noemí Puig, Luis A Corchete-Sánchez, +15 authors, Enrique M Ocio.
Cancers (Basel), 2020 Dec 09; 12(12). PMID: 33287189    Free PMC article.
Current Trends in Cancer Immunotherapy.
Ivan Y Filin, Valeriya V Solovyeva, +2 authors, Albert A Rizvanov.
Biomedicines, 2020 Dec 23; 8(12). PMID: 33348704    Free PMC article.
Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated Myocarditis.
Zsofia D Drobni, Amna Zafar, +12 authors, Tomas G Neilan.
J Am Heart Assoc, 2020 Nov 17; 9(23). PMID: 33190570    Free PMC article.
Central Nervous System Demyelination Associated With Immune Checkpoint Inhibitors: Review of the Literature.
Marcos C B Oliveira, Marcelo H de Brito, Mateus M Simabukuro.
Front Neurol, 2020 Dec 29; 11. PMID: 33362680    Free PMC article.
Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer.
Megan M Tu, Terry L Ng, +3 authors, Dan Theodorescu.
Bladder Cancer, 2019 Aug 16; 5(2). PMID: 33365377    Free PMC article.
Systematic Review.
Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy.
Omar M El Kawkgi, Dingfeng Li, Anupam Kotwal, Robert A Wermers.
Mayo Clin Proc Innov Qual Outcomes, 2020 Dec 29; 4(6). PMID: 33367219    Free PMC article.
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm.
Antonella Argentiero, Antonio Giovanni Solimando, +7 authors, Michele Guida.
Front Oncol, 2021 Jan 01; 10. PMID: 33381454    Free PMC article.
Circulating leukocyte-platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents.
Carlos Zamora, Mariona Riudavets, +11 authors, Silvia Vidal.
Cancer Immunol Immunother, 2021 Jan 04; 70(6). PMID: 33388994
Immune-Related Neurological Toxicities of PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis.
Yuan Tian, Aiqin Gao, +5 authors, Yuping Sun.
Front Immunol, 2021 Jan 05; 11. PMID: 33391266    Free PMC article.
Systematic Review.
Nephrotoxicity in patients with solid tumors treated with anti-PD-1/PD-L1 monoclonal antibodies: a systematic review and meta-analysis.
Han Li, Jinsheng Xu, +3 authors, Jingjing Jin.
Invest New Drugs, 2021 Jan 08; 39(3). PMID: 33409896    Free PMC article.
Systematic Review.
Multiple sclerosis outcomes after cancer immunotherapy.
Catherine R Garcia, Rani Jayswal, +2 authors, John L Villano.
Clin Transl Oncol, 2019 Feb 23; 21(10). PMID: 30788836    Free PMC article.
Leveraging TCR Affinity in Adoptive Immunotherapy against Shared Tumor/Self-Antigens.
Aaron M Miller, Milad Bahmanof, +2 authors, Stephen P Schoenberger.
Cancer Immunol Res, 2018 Nov 30; 7(1). PMID: 30482746    Free PMC article.
Gastrointestinal toxicities of immune checkpoint inhibitors: a multicenter retrospective analysis.
Christine Shieh, Divya Chalikonda, +2 authors, C Andrew Kistler.
Ann Gastroenterol, 2021 Jan 09; 34(1). PMID: 33414621    Free PMC article.
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors.
Flora Pirozzi, Remo Poto, +9 authors, Valentina Mercurio.
Curr Oncol Rep, 2021 Jan 09; 23(2). PMID: 33415405    Free PMC article.
Immune checkpoint inhibitors-related myocarditis in patients with cancer: an analysis of international spontaneous reporting systems.
Rulan Ma, Quanziang Wang, +2 authors, Yong Zhang.
BMC Cancer, 2021 Jan 09; 21(1). PMID: 33413213    Free PMC article.
The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysis.
Huilin Xu, Ximing Xu, +2 authors, Dedong Cao.
Ther Adv Med Oncol, 2021 Jan 12; 12. PMID: 33425028    Free PMC article.
Immune-Related Adverse Events in the Older Adult with Cancer Receiving Immune Checkpoint Inhibitor Therapy.
Matthew D Biniakewitz, Mary Kate Kasler, Kristen L Fessele.
Asia Pac J Oncol Nurs, 2021 Jan 12; 8(1). PMID: 33426185    Free PMC article.
A Systematic Review of Immune Checkpoint Inhibitor-Associated Glomerular Disease.
Abhijat Kitchlu, Kenar D Jhaveri, +5 authors, Rimda Wanchoo.
Kidney Int Rep, 2021 Jan 12; 6(1). PMID: 33426386    Free PMC article.
Homeostasis Research Model Based on Yin-Yang Theory: Five Examples.
Di Wang, Miao Qu.
Chin J Integr Med, 2021 Jan 13; 27(6). PMID: 33433846
Immune checkpoint inhibitor-induced musculoskeletal manifestations.
Foteini Angelopoulou, Dimitrios Bogdanos, +2 authors, Dimitrios Daoussis.
Rheumatol Int, 2020 Aug 04; 41(1). PMID: 32743706
Treatment-related adverse events and response rate to immune checkpoint inhibition.
Yanmin Li, Zhengping Wang, +2 authors, Chenchen Feng.
J Int Med Res, 2019 Nov 30; 48(3). PMID: 31777292    Free PMC article.
Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer.
Marion Allouchery, Thomas Lombard, +8 authors, French Network of Regional Pharmacovigilance Centers.
J Immunother Cancer, 2021 Jan 12; 8(2). PMID: 33428586    Free PMC article.
Immune manifestations with checkpoint inhibitors in a single Brazilian center: experience and literature review.
Rafael A Schmerling, Antonio C Buzaid, +10 authors, Morton Scheinberg.
Future Sci OA, 2021 Jan 14; 7(1). PMID: 33437507    Free PMC article.
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
Marie Kostine, Axel Finckh, +20 authors, Thierry Schaeverbeke.
Ann Rheum Dis, 2020 Apr 25; 80(1). PMID: 32327425    Free PMC article.
Immunotherapy-related pneumonitis and bacterial pneumonia after the successful treatment of metastatic malignant melanoma with pembrolizumab: A case report.
Qin Ma, Lei Yang, Feng Gu.
Medicine (Baltimore), 2021 Jan 13; 100(1). PMID: 33429766    Free PMC article.
Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events.
Ryosuke Matsukane, Hiroyuki Watanabe, +11 authors, Nobuaki Egashira.
Sci Rep, 2021 Jan 16; 11(1). PMID: 33446685    Free PMC article.
Neurotoxicities associated with immune checkpoint inhibitor therapy.
Sophie L Duong, Frank J Barbiero, Richard J Nowak, Joachim M Baehring.
J Neurooncol, 2021 Jan 18; 152(2). PMID: 33454891
C3, C3AR1, HLA-DRA, and HLA-E as potential prognostic biomarkers for renal clear cell carcinoma.
Guangdi Chu, Wei Jiao, +3 authors, Haitao Niu.
Transl Androl Urol, 2021 Jan 19; 9(6). PMID: 33457236    Free PMC article.
Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age?
Jiajie Hou, Michael Karin, Beicheng Sun.
Nat Rev Clin Oncol, 2021 Jan 21; 18(5). PMID: 33469195    Free PMC article.
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview.
Diederick J van Doorn, Robert Bart Takkenberg, Heinz-Josef Klümpen.
Pharmaceuticals (Basel), 2020 Dec 31; 14(1). PMID: 33374927    Free PMC article.
NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer.
Yuehong Cui, Qian Li, +9 authors, Tianshu Liu.
Front Oncol, 2021 Jan 23; 10. PMID: 33479597    Free PMC article.
Recent advances and discoveries in the mechanisms and functions of CAR T cells.
Rebecca C Larson, Marcela V Maus.
Nat Rev Cancer, 2021 Jan 24; 21(3). PMID: 33483715    Free PMC article.
Impact of Sequencing Radiation Therapy and Immune Checkpoint Inhibitors in the Treatment of Melanoma Brain Metastases.
Daniel A Pomeranz Krummel, Tahseen H Nasti, +16 authors, Soma Sengupta.
Int J Radiat Oncol Biol Phys, 2020 Feb 15; 108(1). PMID: 32057994    Free PMC article.
Next-Generation Immunotherapies to Improve Anticancer Immunity.
Yaoyao Shi, Katarzyna Tomczak, +3 authors, Cara Haymaker.
Front Pharmacol, 2021 Jan 29; 11. PMID: 33505304    Free PMC article.
Cytomegalovirus infection as an underestimated trigger for checkpoint inhibitor-related pneumonitis in lung cancer: a retrospective study.
X Lin, T Lu, +10 authors, C Zhou.
Clin Transl Oncol, 2020 Jul 03; 23(2). PMID: 32613413
Clinical characteristics and management of immune checkpoint inhibitor-related pneumonitis: A single-institution retrospective study.
Hanping Wang, Yanwei Zhao, +8 authors, Li Zhang.
Cancer Med, 2020 Nov 20; 10(1). PMID: 33211395    Free PMC article.
Immunometabolic Status of COVID-19 Cancer Patients.
A Sica, M P Colombo, +3 authors, V Torri.
Physiol Rev, 2020 Jul 30; 100(4). PMID: 32721181    Free PMC article.
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer.
Yuyan Jiang, Jiaguo Huang, Cheng Xu, Kanyi Pu.
Nat Commun, 2021 Feb 04; 12(1). PMID: 33531498    Free PMC article.
Artificial Intelligence for Histology-Based Detection of Microsatellite Instability and Prediction of Response to Immunotherapy in Colorectal Cancer.
Lindsey A Hildebrand, Colin J Pierce, +2 authors, Asaf Maoz.
Cancers (Basel), 2021 Jan 27; 13(3). PMID: 33494280    Free PMC article.
Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma.
Taigo Kato, Kazuma Kiyotani, +12 authors, Motohide Uemura.
Oncoimmunology, 2021 Feb 05; 10(1). PMID: 33537170    Free PMC article.
Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications.
Sang T Kim, Ajay Sheshadri, +22 authors, Naval Daver.
Front Immunol, 2021 Feb 09; 11. PMID: 33552049    Free PMC article.
Variable Expression of Programmed Cell Death Protein 1-Ligand 1 in Kidneys Independent of Immune Checkpoint Inhibition.
Samy Hakroush, Sarah Birgit Kopp, +4 authors, Björn Tampe.
Front Immunol, 2021 Feb 09; 11. PMID: 33552089    Free PMC article.
Incidence risk of PD-1/PD-L1-related pneumonia and diarrhea in non-small cell lung cancer (NSCLC) patients: a systematic review and meta-analysis of randomized controlled trials.
Zhi-Qiang Tong, Dong-Yuan Wu, Duo Liu, Mei Dong.
Eur J Clin Pharmacol, 2021 Feb 11; 77(8). PMID: 33564898
Systematic Review.
Pembrolizumab-Induced Severe Neuropathy in a Patient with Metastatic Urothelial Carcinoma after Achieving Complete Response: Guillain-Barré Syndrome-Like Onset.
Shuntaro Aoki, Masato Yasui, +3 authors, Junichi Ohta.
Case Rep Oncol, 2021 Feb 11; 13(3). PMID: 33564288    Free PMC article.
Endocrine immune-related adverse events: a double-edged sword?
Michelle Rengarajan, Justin F Gainor.
Transl Lung Cancer Res, 2021 Feb 12; 10(1). PMID: 33569289    Free PMC article.
Clinical types of checkpoint inhibitor-related pneumonitis in lung cancer patients: a multicenter experience.
Xinqing Lin, Haiyi Deng, +15 authors, Chengzhi Zhou.
Transl Lung Cancer Res, 2021 Feb 12; 10(1). PMID: 33569323    Free PMC article.
Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors.
Li Zhong, Qing Wu, +2 authors, Xianhe Xie.
Cancer Immunol Immunother, 2021 Feb 13; 70(9). PMID: 33576872
Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors.
Peter A Bielecki, Morgan E Lorkowski, +7 authors, Efstathios Karathanasis.
Nanoscale Horiz, 2021 Jan 06; 6(2). PMID: 33400743    Free PMC article.
Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?
Elham Sajjadi, Konstantinos Venetis, Cristian Scatena, Nicola Fusco.
Ecancermedicalscience, 2021 Feb 13; 14. PMID: 33574895    Free PMC article.
Recombinant oncolytic adenovirus expressing a soluble PVR elicits long-term antitumor immune surveillance.
Hailin Zhang, Yonghui Zhang, +5 authors, Jiwu Wei.
Mol Ther Oncolytics, 2021 Feb 13; 20. PMID: 33575467    Free PMC article.
Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling.
Nicolas Page, Sylvain Lemeille, +6 authors, Doron Merkler.
Nat Commun, 2021 Feb 14; 12(1). PMID: 33579927    Free PMC article.
Considerations when treating high-grade pediatric glioma patients with immunotherapy.
Erin Crotty, Kira Downey, +6 authors, Hideho Okada.
Expert Rev Neurother, 2020 Nov 24; 21(2). PMID: 33225764    Free PMC article.
Advances on immune-related adverse events associated with immune checkpoint inhibitors.
Yong Fan, Yan Geng, Lin Shen, Zhuoli Zhang.
Front Med, 2020 Aug 12; 15(1). PMID: 32779094
Modulation of regulatory T cell function and stability by co-inhibitory receptors.
Liliana E Lucca, Margarita Dominguez-Villar.
Nat Rev Immunol, 2020 Apr 10; 20(11). PMID: 32269380
Efficacy and Safety of PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus PD-1/PD-L1 Inhibitors in Advanced Non-Small Cell Lung Cancer: A Network Analysis of Randomized Controlled Trials.
Xiang Li, Shi Yan, +7 authors, Nan Wu.
Front Oncol, 2021 Feb 16; 10. PMID: 33585195    Free PMC article.
Systematic Review.
Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities.
Leona Yamamoto, Nicola Amodio, Annamaria Gulla, Kenneth Carl Anderson.
Front Oncol, 2021 Feb 16; 10. PMID: 33585226    Free PMC article.
Pre-existing interstitial lung disease does not affect prognosis in non-small cell lung cancer patients with PD-L1 expression ≥50% on first-line pembrolizumab.
Ou Yamaguchi, Kyoichi Kaira, +8 authors, Hiroshi Kagamu.
Thorac Cancer, 2020 Nov 14; 12(3). PMID: 33185333    Free PMC article.
A digital single-molecule nanopillar SERS platform for predicting and monitoring immune toxicities in immunotherapy.
Junrong Li, Alain Wuethrich, +5 authors, Matt Trau.
Nat Commun, 2021 Feb 19; 12(1). PMID: 33597530    Free PMC article.
Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy.
Anh Nguyen, Anujan Ramesh, +6 authors, Ashish A Kulkarni.
Sci Adv, 2020 Oct 04; 6(40). PMID: 33008894    Free PMC article.
Expert Insights on Triple-Negative Breast Cancer: Preparing for the Next Wave of Treatments.
Heather R Greene, Lee S Schwartzberg.
J Adv Pract Oncol, 2021 Feb 19; 11(3). PMID: 33598323    Free PMC article.
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer.
Dristhi Ragoonanan, Sajad J Khazal, +39 authors, Kris M Mahadeo.
Nat Rev Clin Oncol, 2021 Feb 21; 18(7). PMID: 33608690
Comorbidity and frailty assessment in renal cell carcinoma patients.
Jean Courcier, Alexandre De La Taille, Nathalie Lassau, Alexandre Ingels.
World J Urol, 2021 Feb 23; 39(8). PMID: 33616708
Immune Checkpoint Inhibitors: Cardiotoxicity in Pre-clinical Models and Clinical Studies.
Shirley Xu, Umesh C Sharma, Cheyanna Tuttle, Saraswati Pokharel.
Front Cardiovasc Med, 2021 Feb 23; 8. PMID: 33614750    Free PMC article.
Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events.
Andrew Nashed, Shijun Zhang, +11 authors, Lang Li.
Cancer Immunol Immunother, 2021 Feb 25; 70(10). PMID: 33625533
Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade.
Jason Beattie, Hira Rizvi, +10 authors, Matthew D Hellmann.
J Immunother Cancer, 2021 Feb 12; 9(2). PMID: 33568350    Free PMC article.
Varied functions of immune checkpoints during cancer metastasis.
Ali Safarzadeh, Mohsen Alizadeh, +7 authors, Nicola Silvestris.
Cancer Immunol Immunother, 2020 Sep 10; 70(3). PMID: 32902664    Free PMC article.
Application of Bionanomaterials in Tumor Immune Microenvironment Therapy.
Jiawei Wang, Yan Bao, Yandan Yao.
J Immunol Res, 2021 Feb 26; 2021. PMID: 33628850    Free PMC article.
Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements.
Ke-Tao Jin, Wen-Lin Du, +3 authors, Xiao-Zhou Mou.
Cancers (Basel), 2021 Feb 07; 13(4). PMID: 33546172    Free PMC article.
Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens.
Romain Darrigrand, Alison Pierson, +9 authors, Sébastien Apcher.
Commun Biol, 2021 Mar 03; 4(1). PMID: 33649389    Free PMC article.
Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS.
Chenxin Chen, Ting Chen, +9 authors, Jia He.
Front Pharmacol, 2021 Mar 02; 12. PMID: 33643048    Free PMC article.
Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events-A Comprehensive Review.
Josefien W Hommes, Rik J Verheijden, Karijn P M Suijkerbuijk, Dörte Hamann.
Front Oncol, 2021 Mar 02; 10. PMID: 33643899    Free PMC article.
Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologist.
Alexandra L Lewis, Jamie Chaft, Monica Girotra, Gregory W Fischer.
Br J Anaesth, 2020 Feb 03; 124(3). PMID: 32007241    Free PMC article.
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
Rudolf A de Boer, Jean-Sébastien Hulot, +38 authors, Johannes Backs.
Eur J Heart Fail, 2020 Oct 24; 22(12). PMID: 33094495    Free PMC article.
COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints.
Christopher C Goodnow.
Immunol Cell Biol, 2020 Oct 29; 99(2). PMID: 33113212    Free PMC article.
A Gene Mutation Signature Predicting Immunotherapy Benefits in Patients With NSCLC.
Dong Pan, Angela Y Hu, Scott J Antonia, Chuan-Yuan Li.
J Thorac Oncol, 2020 Dec 12; 16(3). PMID: 33307194    Free PMC article.
Immunotherapy causing pneumonitis in a patient with non-small cell lung cancer (NSCLC).
Rui Li, Gina Lee, Ahmed El-Sherief.
BMJ Case Rep, 2019 Mar 07; 12(3). PMID: 30837232    Free PMC article.
Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy.
Liwei Jiang, Yi-Jun Wang, +21 authors, Reza Abdi.
Cell, 2020 Nov 27; 183(5). PMID: 33242418    Free PMC article.
Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy.
Nina M Muñoz, Malea Williams, +15 authors, Rahul A Sheth.
J Immunother Cancer, 2021 Feb 17; 9(2). PMID: 33589526    Free PMC article.
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy.
Tianyu Tang, Xing Huang, +3 authors, Tingbo Liang.
Signal Transduct Target Ther, 2021 Feb 21; 6(1). PMID: 33608497    Free PMC article.
Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.
Javid Moslehi, Andrew H Lichtman, +2 authors, Richard N Kitsis.
J Clin Invest, 2021 Mar 02; 131(5). PMID: 33645548    Free PMC article.
Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis.
Margaret Gatti-Mays, James L Gulley.
J Immunother Cancer, 2021 Feb 20; 9(2). PMID: 33602697    Free PMC article.
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Agnese Paderi, Roberta Giorgione, +7 authors, Lorenzo Antonuzzo.
Cancers (Basel), 2021 Mar 07; 13(4). PMID: 33670634    Free PMC article.
Real Impact of Novel Immunotherapy Drugs in Cancer. The Experience of 10 Last Years.
Andreas Koulouris, Christos Tsagkaris, Michail Nikolaou.
Toxins (Basel), 2021 Mar 07; 13(2). PMID: 33672017    Free PMC article.
TNF in the era of immune checkpoint inhibitors: friend or foe?
Allen Y Chen, Jedd D Wolchok, Anne R Bass.
Nat Rev Rheumatol, 2021 Mar 10; 17(4). PMID: 33686279    Free PMC article.
Efficacy and safety of Infliximab for steroid-resistant immune-related adverse events: A retrospective study.
Yukio Kadokawa, Mari Takagi, +12 authors, Fumio Imamura.
Mol Clin Oncol, 2021 Mar 09; 14(4). PMID: 33680456    Free PMC article.
Racial disparities in immune-related adverse events of immune checkpoint inhibitors and association with survival based on clinical and biochemical responses.
Monica Peravali, Cristiane Gomes-Lima, +6 authors, Irina Veytsman.
World J Clin Oncol, 2021 Mar 09; 12(2). PMID: 33680877    Free PMC article.
Myasthenia gravis and concurrent myositis following PD-L1 checkpoint inhibitor for non-small cell lung cancer.
Chun Seng Phua, Ari Murad, +2 authors, Cecilia Cappelen-Smith.
BMJ Neurol Open, 2021 Mar 09; 2(1). PMID: 33681778    Free PMC article.
Abdominal immune-related adverse events: detection on ultrasonography, CT, MRI and 18F-Fluorodeoxyglucose positron emission tomography.
Mark A Anderson, Vikram Kurra, +3 authors, Susanna I Lee.
Br J Radiol, 2020 Oct 29; 94(1118). PMID: 33112648    Free PMC article.
Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease.
Rebecca C Arend, Amy Jackson-Fisher, +2 authors, Bradley J Monk.
Cancer Biol Ther, 2021 Jan 12; 22(2). PMID: 33427569    Free PMC article.
Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application.
Feifei Pu, Fengxia Chen, +2 authors, Zengwu Shao.
Onco Targets Ther, 2021 Mar 11; 14. PMID: 33688199    Free PMC article.
Emerging Immunotherapies in the Treatment of Brain Metastases.
Edwin Nieblas-Bedolla, Naema Nayyar, +2 authors, Priscilla K Brastianos.
Oncologist, 2020 Oct 27; 26(3). PMID: 33103803    Free PMC article.
Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors.
Ciro Manzo, Marco Isetta.
Reumatologia, 2021 Mar 13; 59(1). PMID: 33707798    Free PMC article.
Asymptomatic Immune Checkpoint Inhibitor-associated Myocarditis.
Junya Tanabe, Nobuhide Watanabe, +3 authors, Kazuaki Tanabe.
Intern Med, 2020 Oct 09; 60(4). PMID: 33028770    Free PMC article.
Identification of characteristic subepithelial surface granulomatosis in immune-related adverse event-associated enterocolitis.
Terufumi Kubo, Yoshihiko Hirohashi, +16 authors, Toshihiko Torigoe.
Cancer Sci, 2021 Jan 19; 112(3). PMID: 33459466    Free PMC article.
Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors.
Alberto Picca, Giulia Berzero, +16 authors, Dimitri Psimaras.
Neurol Neuroimmunol Neuroinflamm, 2021 Feb 28; 8(3). PMID: 33637598    Free PMC article.
Systematic Review.
Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?
Heidar J Albandar, Jacob Fuqua, +3 authors, Patrick C Ma.
Cancers (Basel), 2021 Mar 07; 13(5). PMID: 33673446    Free PMC article.
The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity.
Yun-Shiuan Olivia Hsu, Kun-Lin Lu, +8 authors, Chun-Bing Chen.
Front Immunol, 2021 Mar 16; 12. PMID: 33717075    Free PMC article.
Perspectives on Oncolytic Salmonella in Cancer Immunotherapy-A Promising Strategy.
Ding Wang, Xiaodong Wei, +2 authors, Ling Zhang.
Front Immunol, 2021 Mar 16; 12. PMID: 33717106    Free PMC article.
Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using 68Ga-FAPI PET/CT.
Daniel Finke, Markus B Heckmann, +4 authors, Lorenz H Lehmann.
Front Cardiovasc Med, 2021 Mar 16; 8. PMID: 33718446    Free PMC article.
Nivolumab-Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from Immunotherapy.
Mansour Gergi, Kara K Landry, +3 authors, Diego Adrianzen Herrera.
Oncologist, 2020 Oct 06; 25(12). PMID: 33017484    Free PMC article.
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors.
Johanna Winter, Max M Lenders, +10 authors, Nikolaus B Wagner.
Cancer Immunol Immunother, 2020 Oct 29; 70(4). PMID: 33113003
Considerations for treatment duration in responders to immune checkpoint inhibitors.
Thomas U Marron, Aideen E Ryan, +21 authors, Jennifer L Guerriero.
J Immunother Cancer, 2021 Mar 04; 9(3). PMID: 33653801    Free PMC article.
Electrocardiographic features of immune checkpoint inhibitor associated myocarditis.
Daniel A Zlotoff, Malek Z O Hassan, +37 authors, Tomas G Neilan.
J Immunother Cancer, 2021 Mar 04; 9(3). PMID: 33653803    Free PMC article.
Lipid Metabolism and Immune Checkpoints.
Qianjin Liao, Yujuan Zhou, Longzheng Xia, Deliang Cao.
Adv Exp Med Biol, 2021 Mar 20; 1316. PMID: 33740251
Next generation of immune checkpoint inhibitors and beyond.
Julian A Marin-Acevedo, ErinMarie O Kimbrough, Yanyan Lou.
J Hematol Oncol, 2021 Mar 21; 14(1). PMID: 33741032    Free PMC article.
Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitis.
James A Hutchinson, Katharina Kronenberg, +21 authors, Sebastian Haferkamp.
Nat Commun, 2021 Mar 06; 12(1). PMID: 33664251    Free PMC article.
Morphology of tumor and nontumor tissue in liver resection specimens for hepatocellular carcinoma following nivolumab therapy.
Camila C Simoes, Swan N Thung, +3 authors, Stephen C Ward.
Mod Pathol, 2020 Sep 30; 34(4). PMID: 32989224
The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation.
Natalie Köhler, Dietrich Alexander Ruess, Rebecca Kesselring, Robert Zeiser.
Front Immunol, 2021 Mar 23; 12. PMID: 33746972    Free PMC article.
A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies.
Tyler J Nielsen, Brian Z Ring, +2 authors, Brock L Schweitzer.
Heliyon, 2021 Mar 23; 7(3). PMID: 33748492    Free PMC article.
Cancer Therapy-Associated Thrombosis.
Steven P Grover, Yohei M Hisada, +2 authors, Nigel Mackman.
Arterioscler Thromb Vasc Biol, 2021 Feb 12; 41(4). PMID: 33567864    Free PMC article.
Combined immunotherapy and targeted treatment for primary alveolar soft part sarcoma of the lung: case report and literature review.
Hui Su, Chao Yu, Xuezhen Ma, Qingcui Song.
Invest New Drugs, 2021 Mar 26; 39(5). PMID: 33765213
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.
E E A P Mulder, K de Joode, +19 authors, A A M van der Veldt.
BMC Cancer, 2021 Mar 27; 21(1). PMID: 33765967    Free PMC article.
Expert Perspective: Immune Checkpoint Inhibitors and Rheumatologic Complications.
Laura C Cappelli, Clifton O Bingham.
Arthritis Rheumatol, 2020 Nov 14; 73(4). PMID: 33186490    Free PMC article.
Elective Colectomy in a Patient with Active Ulcerative Colitis and Metastatic Melanoma Enabling Successful Treatment with Immune Checkpoint Inhibitors.
Ana Luisa Perdigoto, Thuy Tran, +8 authors, Harriet M Kluger.
Clin Oncol Case Rep, 2021 Mar 30; 3(5). PMID: 33778814    Free PMC article.
Case of slowly progressive type 1 diabetes mellitus with drastically reduced insulin secretory capacity after immune checkpoint inhibitor treatment for advanced renal cell carcinoma.
Hiroki Yamaguchi, Yumika Miyoshi, +6 authors, Tetsuyuki Yasuda.
Diabetol Int, 2021 Apr 01; 12(2). PMID: 33786278    Free PMC article.
Knowledge gap about immune checkpoint inhibitors among rheumatologists and medical students: a survey.
Guilherme Ferreira Maciel da Silva, Joaquim Ivo Vasques Dantas Landim, +4 authors, Francisco Airton Castro Rocha.
Rheumatol Int, 2020 Aug 09; 41(5). PMID: 32767082
A case of panuveitis and retinal vasculitis associated with pembrolizumab therapy for metastatic lung cancer.
Kyung Woo Kim, Sentaro Kusuhara, +3 authors, Makoto Nakamura.
Am J Ophthalmol Case Rep, 2021 Apr 03; 22. PMID: 33796799    Free PMC article.
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.
G Curigliano, D Lenihan, +27 authors, ESMO Guidelines Committee. Electronic address:
Ann Oncol, 2020 Jan 22; 31(2). PMID: 31959335    Free PMC article.
Immune Check Point Inhibitors and Immune-Related Adverse Events in Small Cell Lung Cancer.
Wanting Hou, Xiaohan Zhou, Cheng Yi, Hong Zhu.
Front Oncol, 2021 Apr 06; 11. PMID: 33816235    Free PMC article.
Current status and future perspectives of immunotherapy in bladder cancer treatment.
Zhangsong Wu, Jinjian Liu, Ruixiang Dai, Song Wu.
Sci China Life Sci, 2020 Sep 15; 64(4). PMID: 32926318
Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
Florian Moik, Wei-Shin Evelyn Chan, +8 authors, Cihan Ay.
Blood, 2020 Oct 18; 137(12). PMID: 33067632    Free PMC article.
Frequency of pre-treatment may not increase the immune-related adverse events of RCC patients treated with nivolumab.
Kosuke Mizutani, Toshiki Ito, +6 authors, Takuya Koie.
Medicine (Baltimore), 2021 Apr 01; 100(13). PMID: 33787647    Free PMC article.
Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy.
Yosuke Ishitsuka, Yuma Hanaoka, Atsushi Tanemura, Manabu Fujimoto.
Cancers (Basel), 2021 Apr 04; 13(5). PMID: 33800195    Free PMC article.
Advanced Nanotechnology for Enhancing Immune Checkpoint Blockade Therapy.
Chiara Cremolini, Emanuela Vitale, Raffaella Rastaldo, Claudia Giachino.
Nanomaterials (Basel), 2021 Apr 04; 11(3). PMID: 33800368    Free PMC article.
Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era.
Sara Cherri, Silvia Noventa, +5 authors, Alberto Zaniboni.
Cancers (Basel), 2021 Apr 04; 13(5). PMID: 33801385    Free PMC article.
Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer.
Florus C de Jong, Vera C Rutten, Tahlita C M Zuiverloon, Dan Theodorescu.
Int J Mol Sci, 2021 Apr 04; 22(6). PMID: 33802033    Free PMC article.
The Entire Intestinal Tract Surveillance Using Capsule Endoscopy after Immune Checkpoint Inhibitor Administration: A Prospective Observational Study.
Keitaro Shimozaki, Kenro Hirata, +11 authors, Takanori Kanai.
Diagnostics (Basel), 2021 Apr 04; 11(3). PMID: 33803735    Free PMC article.
Quantitative Dynamic 18F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors.
Christos Sachpekidis, Jessica C Hassel, +2 authors, Antonia Dimitrakopoulou-Strauss.
Cancers (Basel), 2021 Apr 04; 13(5). PMID: 33804417    Free PMC article.
Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.
Yuzhe Sun, Edward Davis.
Nanomaterials (Basel), 2021 Apr 04; 11(3). PMID: 33809633    Free PMC article.
Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockade.
Kim M Kraus, Julius C Fischer, +4 authors, Stephanie E Combs.
Sci Rep, 2021 Apr 09; 11(1). PMID: 33828117    Free PMC article.
Reconsidering Dexamethasone for Antiemesis when Combining Chemotherapy and Immunotherapy.
Tobias Janowitz, Sam Kleeman, Robert H Vonderheide.
Oncologist, 2021 Jan 20; 26(4). PMID: 33465258    Free PMC article.
CD6 is a target for cancer immunotherapy.
Jeffrey H Ruth, Mikel Gurrea-Rubio, +15 authors, David A Fox.
JCI Insight, 2021 Jan 27; 6(5). PMID: 33497367    Free PMC article.
Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases.
Joseph Meserve, Antonio Facciorusso, +3 authors, Siddharth Singh.
Aliment Pharmacol Ther, 2020 Dec 15; 53(3). PMID: 33314269    Free PMC article.
Systematic Review.
A Multi-Omics Analysis of Metastatic Melanoma Identifies a Germinal Center-Like Tumor Microenvironment in HLA-DR-Positive Tumor Areas.
Laura Gadeyne, Yannick Van Herck, +14 authors, Francesca Maria Bosisio.
Front Oncol, 2021 Apr 13; 11. PMID: 33842341    Free PMC article.
Immuno-oncology: a narrative review of gastrointestinal and hepatic toxicities.
Stergios Boussios, Matin Sheriff, +7 authors, Nicholas Pavlidis.
Ann Transl Med, 2021 Apr 13; 9(5). PMID: 33842644    Free PMC article.
The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer.
Lili Zhang, Kerry L Reynolds, +2 authors, Tomas G Neilan.
JACC CardioOncol, 2021 Apr 13; 3(1). PMID: 33842895    Free PMC article.
Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors.
Michael S Sander, Igor Stukalin, +7 authors, Tina Cheng.
Cancer Med, 2021 Mar 17; 10(8). PMID: 33724676    Free PMC article.
Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it.
I Trestini, A Caldart, +6 authors, S Pilotto.
ESMO Open, 2021 Mar 28; 6(2). PMID: 33773420    Free PMC article.
Advances in immunotherapy for hepatocellular carcinoma.
Bruno Sangro, Pablo Sarobe, Sandra Hervás-Stubbs, Ignacio Melero.
Nat Rev Gastroenterol Hepatol, 2021 Apr 15; 18(8). PMID: 33850328    Free PMC article.
TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8+ T cells in conjunction with CEACAM1.
Camille M Lake, Kelsey Voss, +4 authors, Andrew L Snow.
Cell Death Dis, 2021 Apr 16; 12(4). PMID: 33854046    Free PMC article.
High ELF4 expression in human cancers is associated with worse disease outcomes and increased resistance to anticancer drugs.
Doris Kafita, Victor Daka, +7 authors, Sody Munsaka.
PLoS One, 2021 Apr 10; 16(4). PMID: 33836003    Free PMC article.
TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative review.
Alessandro Rizzo, Veronica Mollica, +8 authors, Francesco Massari.
Transl Androl Urol, 2021 Apr 15; 10(3). PMID: 33850788    Free PMC article.
Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review.
Laure Thouvenin, Timothée Olivier, +2 authors, Alex Friedlaender.
Ther Adv Drug Saf, 2021 Apr 16; 12. PMID: 33854755    Free PMC article.
Bacteria-Based Cancer Immunotherapy.
Xuehui Huang, Jingmei Pan, +4 authors, Shaobing Zhou.
Adv Sci (Weinh), 2021 Apr 16; 8(7). PMID: 33854892    Free PMC article.
Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review.
Butuo Li, Chao Jiang, +5 authors, Linlin Wang.
Front Immunol, 2021 Apr 17; 12. PMID: 33859637    Free PMC article.
Systematic Review.
Endocrine toxicities of immune checkpoint inhibitors.
Jordan J Wright, Alvin C Powers, Douglas B Johnson.
Nat Rev Endocrinol, 2021 Apr 21; 17(7). PMID: 33875857    Free PMC article.
The Role of Anti-PD-1/PD-L1 in the Treatment of Skin Cancer.
James Randall Patrinely, Anna K Dewan, Douglas B Johnson.
BioDrugs, 2020 May 25; 34(4). PMID: 32447657    Free PMC article.
Stoichiometry of multi-specific immune checkpoint RNA Abs for T cell activation and tumor inhibition using ultra-stable RNA nanoparticles.
Dan Shu, Long Zhang, +2 authors, Peixuan Guo.
Mol Ther Nucleic Acids, 2021 Apr 20; 24. PMID: 33868786    Free PMC article.
Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA.
Mark Kalinich, William Murphy, +10 authors, Yevgeniy R Semenov.
J Immunother Cancer, 2021 Apr 02; 9(3). PMID: 33789879    Free PMC article.
Immunotherapy and fatigue: what we know and what we don't know.
Muhammad Azeem Khan, Vaia Florou, Umang Swami.
Oncotarget, 2021 Apr 24; 12(8). PMID: 33889294    Free PMC article.
Cytomegalovirus pneumonia complicating immune checkpoint inhibitors-induced pneumonitis: A case report.
Omar Badran, Anton Ouryvaev, Veronika Baturov, Ayelet Shai.
Mol Clin Oncol, 2021 Apr 28; 14(6). PMID: 33903826    Free PMC article.
TNFR2: Role in Cancer Immunology and Immunotherapy.
Yang Yang, Md Sahidul Islam, Yuanjia Hu, Xin Chen.
Immunotargets Ther, 2021 Apr 29; 10. PMID: 33907692    Free PMC article.
Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis.
Sophia H Verspohl, Tobias Holderried, +2 authors, Valentin S Schäfer.
Ther Adv Musculoskelet Dis, 2021 Apr 30; 13. PMID: 33912248    Free PMC article.
Association of Immune Related Adverse Events With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Cancers: A Systemic Review and Meta-analysis.
Yong Fan, Wenhui Xie, +5 authors, Zhuoli Zhang.
Front Oncol, 2021 Apr 30; 11. PMID: 33912454    Free PMC article.
Systematic Review.
Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events.
Busra Isik, Mariam P Alexander, +7 authors, Sandra M Herrmann.
Kidney Int Rep, 2021 Apr 30; 6(4). PMID: 33912752    Free PMC article.
Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitors.
Despina Michailidou, Ali Raza Khaki, +3 authors, Petros Grivas.
Sci Rep, 2021 Apr 29; 11(1). PMID: 33907229    Free PMC article.
Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update.
Shuja Sheikh, Usman Alvi, Betty Soliven, Kourosh Rezania.
J Clin Med, 2021 May 01; 10(7). PMID: 33917535    Free PMC article.
Immune Checkpoints in Pediatric Solid Tumors: Targetable Pathways for Advanced Therapeutic Purposes.
Claudia Cocco, Fabio Morandi, Irma Airoldi.
Cells, 2021 May 01; 10(4). PMID: 33920505    Free PMC article.
Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era.
Chiara Burgaletto, Oronzo Brunetti, +4 authors, Antonella Argentiero.
Cancers (Basel), 2021 May 01; 13(8). PMID: 33921021    Free PMC article.
Pembrolizumab-induced myasthenia gravis-like disorder, ocular myositis, and hepatitis: a case report.
Chia-Yi Tian, Yang-Hao Ou, Shih-Liang Chang, Chih-Ming Lin.
J Med Case Rep, 2021 May 01; 15(1). PMID: 33926558    Free PMC article.
Late Effects after Chimeric Antigen Receptor T cell Therapy for Lymphoid Malignancies.
Rajshekhar Chakraborty, Brian T Hill, Aneela Majeed, Navneet S Majhail.
Transplant Cell Ther, 2021 May 01; 27(3). PMID: 33928266    Free PMC article.
Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors.
Po-Hsin Lee, Tsung-Ying Yang, +6 authors, Gee-Chen Chang.
Sci Rep, 2021 May 02; 11(1). PMID: 33931705    Free PMC article.
Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma.
Teresa Schmidt, Sied Kebir, +14 authors, Martin Glas.
Front Oncol, 2021 May 04; 11. PMID: 33937037    Free PMC article.
Radiomics of 18F Fluorodeoxyglucose PET/CT Images Predicts Severe Immune-related Adverse Events in Patients with NSCLC.
Wei Mu, Ilke Tunali, +2 authors, Robert James Gillies.
Radiol Artif Intell, 2020 Jan 29; 2(1). PMID: 33937811    Free PMC article.
The Role of Programmed Death-1 in Type 1 Diabetes.
Christopher G Tucker, Alexander J Dwyer, Brian T Fife, Tijana Martinov.
Curr Diab Rep, 2021 May 07; 21(6). PMID: 33956235    Free PMC article.
Immune-related adverse events of checkpoint inhibitors.
Manuel Ramos-Casals, Julie R Brahmer, +7 authors, Maria E Suárez-Almazor.
Nat Rev Dis Primers, 2020 May 10; 6(1). PMID: 32382051
Inflammatory markers in autoimmunity induced by checkpoint inhibitors.
Beate Husain, Michael Constantin Kirchberger, +5 authors, Lucie Heinzerling.
J Cancer Res Clin Oncol, 2021 Apr 11; 147(6). PMID: 33837821    Free PMC article.
A Rare Case of Pembrolizumab-Induced Dermatomyositis in a Patient with Cancer of Unknown Primary Origin.
Kensaku Takatsuki, Toyoshi Yanagihara, +5 authors, Takashige Maeyama.
Am J Case Rep, 2021 Apr 28; 22. PMID: 33903584    Free PMC article.
Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer.
Salomon M Manz, Marco Losa, Ralph Fritsch, Michael Scharl.
Therap Adv Gastroenterol, 2021 May 06; 14. PMID: 33948110    Free PMC article.
How do cancer cells replenish their fuel supply?
Abdallah K Alameddine, Frederick T Conlin, +2 authors, Khaled O Alameddine.
Cancer Rep (Hoboken), 2018 Jun 01; 1(1). PMID: 32729259    Free PMC article.
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
Jacqueline T Brown, Yuan Liu, +14 authors, Mehmet Asim Bilen.
Oncologist, 2021 Feb 27; 26(5). PMID: 33634507    Free PMC article.
Clinical recommendations for perioperative immunotherapy-induced adverse events in patients with non-small cell lung cancer.
Jun Ni, Miao Huang, +48 authors, Ming-Lei Zhuo.
Thorac Cancer, 2021 Apr 01; 12(9). PMID: 33787090    Free PMC article.
Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?
Katerina Chatzidionysiou, Matina Liapi, +2 authors, Anca Catrina.
Clin Rheumatol, 2020 Sep 30; 40(5). PMID: 32989505    Free PMC article.
Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function.
Łukasz Mielczarek, Anna Brodziak, +3 authors, Anna M Czarnecka.
Cancer Chemother Pharmacol, 2021 Mar 27; 87(6). PMID: 33768301    Free PMC article.
Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors.
Jee Hee Yoon, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang.
Endocrinol Metab (Seoul), 2021 Apr 07; 36(2). PMID: 33820396    Free PMC article.
Immune Checkpoint Inhibitor Associated Hepatotoxicity in Primary Liver Cancer Versus Other Cancers: A Systematic Review and Meta-Analysis.
Jianyang Fu, Wang-Zhong Li, +4 authors, Changqing Xie.
Front Oncol, 2021 May 11; 11. PMID: 33968750    Free PMC article.
Systematic Review.
Role of cardiovascular magnetic resonance in early detection and treatment of cardiac dysfunction in oncology patients.
Srilakshmi Vallabhaneni, Kathleen W Zhang, +4 authors, Daniel J Lenihan.
Int J Cardiovasc Imaging, 2021 May 14; 37(10). PMID: 33982196
Sequential Systemic Treatment in Advanced Hepatocellular Carcinoma Is Able to Prolong Median Survival to More than 3 Years in a Selected Real-World Cohort.
Johann von Felden, Kathrin Karkmann, +6 authors, Kornelius Schulze.
Visc Med, 2021 May 14; 37(2). PMID: 33981749    Free PMC article.
Adverse events induced by immune checkpoint inhibitors.
Ana Luisa Perdigoto, Harriet Kluger, Kevan C Herold.
Curr Opin Immunol, 2021 Mar 01; 69. PMID: 33640598    Free PMC article.
Triple-negative breast cancer: new treatment strategies in the era of precision medicine.
Song-Yang Wu, Hai Wang, Zhi-Ming Shao, Yi-Zhou Jiang.
Sci China Life Sci, 2020 Aug 18; 64(3). PMID: 32803712
Biological drug and drug delivery-mediated immunotherapy.
Qingqing Xiao, Xiaotong Li, +4 authors, Wei He.
Acta Pharm Sin B, 2021 May 18; 11(4). PMID: 33996408    Free PMC article.
CT, MRI and PET/CT features of abdominal manifestations of cutaneous melanoma: a review of current concepts in the era of tumor-specific therapies.
Maxime Barat, Sarah Guegan-Bart, +6 authors, Philippe Soyer.
Abdom Radiol (NY), 2020 Nov 03; 46(5). PMID: 33135115
Intratumoural administration and tumour tissue targeting of cancer immunotherapies.
Ignacio Melero, Eduardo Castanon, +2 authors, Aurelien Marabelle.
Nat Rev Clin Oncol, 2021 May 20; 18(9). PMID: 34006998    Free PMC article.
Antibiotics and steroids, the double enemies of anticancer immunotherapy: a review of the literature.
Fausto Meriggi, Alberto Zaniboni.
Cancer Immunol Immunother, 2020 Nov 10; 70(6). PMID: 33165628
A case of nivolumab-induced cervical lymphadenopathy in a patient with gastric cancer.
Koichi Taira, Akie Kimura, +9 authors, Yasuhiro Fujiwara.
J Gastrointest Oncol, 2021 May 21; 12(2). PMID: 34012675    Free PMC article.
Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study.
Fei Xu, Zhu Zeng, +10 authors, Yihong Shen.
Transl Lung Cancer Res, 2021 May 21; 10(4). PMID: 34012795    Free PMC article.
Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen.
Anna Pous, Cristina Izquierdo, +6 authors, Teresa Moran.
Transl Lung Cancer Res, 2021 May 21; 10(4). PMID: 34012801    Free PMC article.
In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma.
Isabella Lurje, Wiebke Werner, +3 authors, Linda Hammerich.
Front Immunol, 2021 May 25; 12. PMID: 34025657    Free PMC article.
[Clinical Recommendations for Perioperative Immunotherapy-induced Adverse Events in Patients with Non-small Cell Lung Cancer].
Jun Ni, Miao Huang, +48 authors, Minglei Zhuo.
Zhongguo Fei Ai Za Zhi, 2021 Apr 06; 24(3). PMID: 33819964    Free PMC article.
Increased Incidence of Venous Thromboembolism with Cancer Immunotherapy.
Joanna Roopkumar, Shadi Swaidani, +14 authors, Alok A Khorana.
Med (N Y), 2021 May 27; 2(4). PMID: 34036293    Free PMC article.
Case Report: THSD7A-Positive Membranous Nephropathy Caused by Tislelizumab in a Lung Cancer Patient.
Minjiang Chen, Lei Zhang, +3 authors, Mengzhao Wang.
Front Immunol, 2021 May 28; 12. PMID: 34040602    Free PMC article.
Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies.
Alan H Baik, Olalekan O Oluwole, +4 authors, Javid J Moslehi.
Circ Res, 2021 May 04; 128(11). PMID: 33934609    Free PMC article.
Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review.
Tao Ouyang, Yanyan Cao, +7 authors, Chuansheng Zheng.
Front Oncol, 2021 May 29; 11. PMID: 34046338    Free PMC article.
Systematic Review.
Risk of non-infectious uveitis or myasthenia gravis in patients on checkpoint inhibitors in a large healthcare claims database.
Tian Xia, Alexander J Brucker, Brendan McGeehan, Brian L VanderBeek.
Br J Ophthalmol, 2020 Oct 23; 106(1). PMID: 33087313    Free PMC article.
Nanotechnology synergized immunoengineering for cancer.
Deepak S Chauhan, Anupam Dhasmana, +6 authors, Murali M Yallapu.
Eur J Pharm Biopharm, 2021 Mar 29; 163. PMID: 33774162    Free PMC article.
Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
Xiao Han, Hongjun Li, +2 authors, Zhen Gu.
Acc Chem Res, 2020 Oct 20; 53(11). PMID: 33073988    Free PMC article.
Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in Cancer.
Margaux Saillard, Mara Cenerenti, Pedro Romero, Camilla Jandus.
Vaccines (Basel), 2021 Jun 03; 9(5). PMID: 34064410    Free PMC article.
Comparative Transcriptomics of Immune Checkpoint Inhibitor Myocarditis Identifies Guanylate Binding Protein 5 and 6 Dysregulation.
Daniel Finke, Markus B Heckmann, +11 authors, Lorenz H Lehmann.
Cancers (Basel), 2021 Jun 03; 13(10). PMID: 34065419    Free PMC article.
Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes.
Charline Lafayolle de la Bruyère, Pierre-Jean Souquet, +9 authors, Julien Péron.
Cancers (Basel), 2021 Jun 03; 13(10). PMID: 34068892    Free PMC article.
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women.
Valentino Martelli, Maria Maddalena Latocca, +8 authors, Matteo Lambertini.
Breast Cancer (Dove Med Press), 2021 Jun 04; 13. PMID: 34079366    Free PMC article.
Combined with interventional therapy, immunotherapy can create a new outlook for tumor treatment.
Tonglei Fang, Junyuan Xiao, +3 authors, Yingsheng Cheng.
Quant Imaging Med Surg, 2021 Jun 04; 11(6). PMID: 34079746    Free PMC article.
Nanotechnology for Cancer Imaging: Advances, Challenges, and Clinical Opportunities.
Christina H Liu, Piotr Grodzinski.
Radiol Imaging Cancer, 2021 May 29; 3(3). PMID: 34047667    Free PMC article.
Organ-Specific Immune-Related Adverse Events for PD-1 Antibodies in Lung Cancer Treatment.
Xiaohu Zheng, Haiming Wei.
Front Oncol, 2021 Jun 08; 11. PMID: 34094910    Free PMC article.
Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functions.
Anna S Tocheva, Michael Peled, +9 authors, Adam Mor.
J Biol Chem, 2020 Oct 21; 295(52). PMID: 33077516    Free PMC article.
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer.
Andrew C Johns, Lai Wei, +14 authors, Carolyn J Presley.
J Geriatr Oncol, 2021 Feb 26; 12(5). PMID: 33627226    Free PMC article.
Run for your life: an integrated virtual tissue platform for incorporating exercise oncology into immunotherapy.
Josua Aponte Serrano, Amit Hagar.
Cancer Immunol Immunother, 2021 Jan 09; 70(7). PMID: 33416943
Association of immune-related adverse events induced by nivolumab with a battery of autoantibodies.
Iñigo Les, Mireia Martínez, +7 authors, Severina Domínguez.
Ann Med, 2021 Jun 02; 53(1). PMID: 34060971    Free PMC article.
Genetic variation associated with thyroid autoimmunity shapes the systemic immune response to PD-1 checkpoint blockade.
Zia Khan, Christian Hammer, +9 authors, G Scott Chandler.
Nat Commun, 2021 Jun 09; 12(1). PMID: 34099659    Free PMC article.
Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis.
Maen Abdelrahim, Omar Mamlouk, +9 authors, Ala Abudayyeh.
Oncoimmunology, 2021 Jun 10; 10(1). PMID: 34104543    Free PMC article.
Assessment of the Clinical Trials Safety Profile of PD-1/PD-L1 Inhibitors Among Patients With Cancer: An Updated Systematic Review and Meta-Analysis.
Yuan Tian, Alan Huang, +4 authors, Yuping Sun.
Front Oncol, 2021 Jun 11; 11. PMID: 34109117    Free PMC article.
Systematic Review.
Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies.
Kenneth K W To, Winnie Fong, William C S Cho.
Front Oncol, 2021 Jun 12; 11. PMID: 34113560    Free PMC article.
Stromal Cells Underlining the Paths From Autoimmunity, Inflammation to Cancer With Roles Beyond Structural and Nutritional Support.
Amanda M Honan, Zhibin Chen.
Front Cell Dev Biol, 2021 Jun 12; 9. PMID: 34113615    Free PMC article.
Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors.
Dan Zhao, Haiqing Li, +11 authors, Ravi Salgia.
Cancers (Basel), 2021 Jun 03; 13(11). PMID: 34071259    Free PMC article.
Psychological Distress of Metastatic Melanoma Patients during Treatment with Immune Checkpoint Inhibitors: Results of a Prospective Study.
Lisa Wiens, Norbert Schäffeler, +2 authors, Andrea Forschner.
Cancers (Basel), 2021 Jun 03; 13(11). PMID: 34072206    Free PMC article.
Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.
Sebastian Zahnreich, Heinz Schmidberger.
Cancers (Basel), 2021 Jun 03; 13(11). PMID: 34073340    Free PMC article.
Immune checkpoint inhibitors-related encephalitis in melanoma and non-melanoma cancer patients: a single center experience.
A Taliansky, O Furman, +7 authors, A Itay.
Support Care Cancer, 2021 Jun 14; 29(12). PMID: 34120259    Free PMC article.
Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management.
Qin Zhang, Liansha Tang, +2 authors, Weimin Li.
Front Immunol, 2021 Jun 15; 12. PMID: 34122422    Free PMC article.
Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators.
Hwa Kyung Byun, Jee Suk Chang, +7 authors, Sang Joon Shin.
Front Oncol, 2021 Jun 15; 11. PMID: 34123816    Free PMC article.
Immune checkpoint inhibitor associated ocular hypertension (from presumed trabeculitis).
Julia Canestraro, Anna Do, +4 authors, Jasmine H Francis.
Am J Ophthalmol Case Rep, 2021 Jun 15; 23. PMID: 34124410    Free PMC article.
Identification of a 15-pseudogene based prognostic signature for predicting survival and antitumor immune response in breast cancer.
Liqiang Tan, Xiaofang He, Guoping Shen.
Aging (Albany NY), 2020 Dec 31; 13(10). PMID: 33378744    Free PMC article.
Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients.
Alexandre Gérard, Jerome Doyen, +10 authors, Barbara Seitz-Polski.
J Immunother Cancer, 2021 Jun 06; 9(6). PMID: 34088741    Free PMC article.
Toxicities of Immunotherapy for Small Cell Lung Cancer.
Yang Fu, Yue Zheng, Pei-Pei Wang, Zhen-Yu Ding.
Front Oncol, 2021 Jun 18; 11. PMID: 34136376    Free PMC article.
Atezolizumab-induced anaphylactic shock in a patient with hepatocellular carcinoma undergoing immunotherapy: A case report.
Li-Fang Bian, Chao Zheng, Xiao-Lan Shi.
World J Clin Cases, 2021 Jun 19; 9(16). PMID: 34141773    Free PMC article.
Efficacy of artificial liver support system in severe immune-associated hepatitis caused by camrelizumab: A case report and review of the literature.
You-Wen Tan, Li Chen, Xing-Bei Zhou.
World J Clin Cases, 2021 Jun 19; 9(17). PMID: 34141809    Free PMC article.
Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: Case report and literature review.
Burcin Özdirik, Fabian Jost-Brinkmann, +5 authors, Tobias Müller.
Medicine (Baltimore), 2021 Jun 16; 100(24). PMID: 34128898    Free PMC article.
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Abdul Rafeh Naqash, Biagio Ricciuti, +15 authors, Paul R Walker.
Cancer Immunol Immunother, 2020 Mar 07; 69(7). PMID: 32140762
Recent Advancements in Nanomedicine for 'Cold' Tumor Immunotherapy.
Qinjun Chen, Tao Sun, Chen Jiang.
Nanomicro Lett, 2021 Jun 18; 13(1). PMID: 34138315    Free PMC article.
Effect of Systemic Corticosteroid Therapy on the Efficacy and Safety of Nivolumab in the Treatment of Non-Small-Cell Lung Cancer.
Kengo Umehara, Kaori Yama, +6 authors, Hideki Sato.
Cancer Control, 2021 Mar 19; 28. PMID: 33733906    Free PMC article.
Intelligent stimuli-responsive nano immunomodulators for cancer immunotherapy.
Yanhua Li, Xia Zhang, +3 authors, Bo Tang.
Chem Sci, 2021 Jun 25; 12(9). PMID: 34164080    Free PMC article.
Immunotherapy-Induced Acute Tubulointerstitial Nephritis.
Kevin Parza, Kevin Dao, +3 authors, Maryam Gondal.
Cureus, 2021 Jun 25; 13(5). PMID: 34164249    Free PMC article.
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment.
Alessandro Granito, Luigi Muratori, +5 authors, Paolo Muratori.
World J Gastroenterol, 2021 Jun 26; 27(22). PMID: 34168403    Free PMC article.
Immune Checkpoint Inhibitors-Related Thyroid Dysfunction: Epidemiology, Clinical Presentation, Possible Pathogenesis, and Management.
Ling Zhan, Hong-Fang Feng, +4 authors, Sheng-Rong Sun.
Front Endocrinol (Lausanne), 2021 Jun 29; 12. PMID: 34177799    Free PMC article.
Systematic Review.
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report.
Alessandra Ferro, Angela Filoni, +5 authors, Laura Bonanno.
Front Med (Lausanne), 2021 Jun 29; 8. PMID: 34179028    Free PMC article.
Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child.
Masato Ogishi, Rui Yang, +52 authors, Jean-Laurent Casanova.
Nat Med, 2021 Jun 30; 27(9). PMID: 34183838    Free PMC article.
Insulin-mediated immune dysfunction in the development of preeclampsia.
Gustav van Niekerk, Claudia Christowitz, Anna-Mart Engelbrecht.
J Mol Med (Berl), 2021 Mar 27; 99(7). PMID: 33768298
Drug-induced immune-mediated thrombocytopenia secondary to durvalumab use.
Sean C Dougherty, Alia C Lynch, Richard D Hall.
Clin Case Rep, 2021 Jul 01; 9(6). PMID: 34188921    Free PMC article.
Pericardial disease in patients treated with immune checkpoint inhibitors.
Jingyi Gong, Zsofia Dora Drobni, +13 authors, Tomas G Neilan.
J Immunother Cancer, 2021 Jun 20; 9(6). PMID: 34145031    Free PMC article.
Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction.
Haixia Qin, Brittany Vlaminck, +3 authors, Svetomir N Markovic.
Mayo Clin Proc Innov Qual Outcomes, 2021 Jul 02; 5(3). PMID: 34195558    Free PMC article.
Rheumatic Immune-Related Adverse Events-A Consequence of Immune Checkpoint Inhibitor Therapy.
Anca Bobircă, Florin Bobircă, +6 authors, Anca Emanuela Mușetescu.
Biology (Basel), 2021 Jul 03; 10(6). PMID: 34203101    Free PMC article.
Activation of the DDR Pathway Leads to the Down-Regulation of the TGFβ Pathway and a Better Response to ICIs in Patients With Metastatic Urothelial Carcinoma.
Chaozheng Zhou, Anqi Lin, +6 authors, Peng Luo.
Front Immunol, 2021 Jul 06; 12. PMID: 34220801    Free PMC article.
Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment.
Natasha Mupeta Kaweme, Fuling Zhou.
Front Immunol, 2021 Jul 06; 12. PMID: 34220833    Free PMC article.
Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience.
Diana Oleas, Mónica Bolufer, +8 authors, María José Soler.
Clin Kidney J, 2020 Feb 10; 14(5). PMID: 34221369    Free PMC article.
A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report.
Jianzheng Wang, Qingli Li, +7 authors, Xiaobing Chen.
Front Oncol, 2021 Jul 06; 11. PMID: 34221988    Free PMC article.
Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysis.
Daria Maria Filippini, Milo Gatti, +5 authors, Lisa Licitra.
Int J Cancer, 2021 Apr 13; 149(3). PMID: 33844854    Free PMC article.
Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new challenge for internists and general practitioners.
Marek Z Wojtukiewicz, Magdalena M Rek, +7 authors, Kenneth V Honn.
Cancer Metastasis Rev, 2021 Jul 09; 40(3). PMID: 34236546    Free PMC article.
Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach.
Fabien Grimaud, Guillaume Penaranda, +9 authors, Amélie Rognon.
Ther Clin Risk Manag, 2021 Jul 09; 17. PMID: 34234443    Free PMC article.
Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation.
Chris M Li, Zhibin Chen.
Front Cell Dev Biol, 2021 Jul 09; 9. PMID: 34235145    Free PMC article.
Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem.
Kikkie Poels, Suzanne I M Neppelenbroek, +3 authors, Tom T P Seijkens.
J Immunother Cancer, 2021 Jun 26; 9(6). PMID: 34168005    Free PMC article.
MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.
Elena Shklovskaya, Helen Rizos.
Int J Mol Sci, 2021 Jul 03; 22(13). PMID: 34201655    Free PMC article.
The Comprehensive "Omics" Approach from Metabolomics to Advanced Omics for Development of Immune Checkpoint Inhibitors: Potential Strategies for Next Generation of Cancer Immunotherapy.
Sang Jun Yoon, Chae Bin Lee, +2 authors, Soo Kyung Bae.
Int J Mol Sci, 2021 Jul 03; 22(13). PMID: 34203237    Free PMC article.
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Fan Huang, Christophe Gonçalves, +30 authors, Sonia V Del Rincón.
J Clin Invest, 2021 Mar 11; 131(8). PMID: 33690225    Free PMC article.
Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma.
Zhencong Chen, Mengnan Zhao, +11 authors, Lijie Tan.
EBioMedicine, 2021 Jul 01; 69. PMID: 34192657    Free PMC article.
The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors.
Saby George, Elizabeth J Bell, +7 authors, Frank X Liu.
Oncologist, 2021 May 07; 26(7). PMID: 33955118    Free PMC article.
[Cardiotoxicity of Anti-PD-L1 Antibody and the Effect of Levothyroxine 
in Attenuating the Related Mortality in Mice].
Zhenyin Chen, Min Wang, +3 authors, Guangbiao Zhou.
Zhongguo Fei Ai Za Zhi, 2021 Jun 23; 24(6). PMID: 34157799    Free PMC article.
The cancer patient and cardiology.
José Luis Zamorano, Christer Gottfridsson, +16 authors, Giorgio Minotti.
Eur J Heart Fail, 2020 Aug 19; 22(12). PMID: 32809231    Free PMC article.
Programmed Death Ligand 1-Expressing Classical Dendritic Cells MitigateHelicobacter-Induced Gastritis.
Du-Min Go, Seung Hyun Lee, +9 authors, Dae-Yong Kim.
Cell Mol Gastroenterol Hepatol, 2021 Apr 25; 12(2). PMID: 33894424    Free PMC article.
Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models.
Yao-Xin Lin, Yi Wang, +10 authors, Jinjun Shi.
Sci Transl Med, 2021 Jun 25; 13(599). PMID: 34162754    Free PMC article.
Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer.
Lea Daniello, Mariam Elshiaty, +15 authors, Petros Christopoulos.
Front Oncol, 2021 Jul 17; 11. PMID: 34268127    Free PMC article.
Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database.
Zhuo Ma, Jie Pei, +7 authors, Zhixia Zhao.
Front Pharmacol, 2021 Jul 20; 12. PMID: 34276364    Free PMC article.
Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation.
Charlotte Domblides, Juliette Rochefort, +5 authors, Marie-Caroline Dieu-Nosjean.
Front Immunol, 2021 Jul 20; 12. PMID: 34276690    Free PMC article.
Paraneoplastic neurological syndrome: an evolving story.
Jiraporn Jitprapaikulsan, Pritikanta Paul, +3 authors, Divyanshu Dubey.
Neurooncol Pract, 2021 Jul 20; 8(4). PMID: 34277016    Free PMC article.
Safety of immune checkpoint inhibitors in patients with cancer and pre-existing autoimmune disease.
Swetha Alexander, Umang Swami, +7 authors, Namrata Singh.
Ann Transl Med, 2021 Jul 20; 9(12). PMID: 34277833    Free PMC article.
The dark side of immunotherapy.
Nwanneka Okwundu, Douglas Grossman, +2 authors, Umang Swami.
Ann Transl Med, 2021 Jul 20; 9(12). PMID: 34277841    Free PMC article.
High-dose corticosteroid use and risk of hospitalization for infection in patients treated with immune checkpoint inhibitors--A nationwide register-based cohort study.
Signe Sørup, Bianka Darvalics, +6 authors, Deirdre Cronin-Fenton.
Cancer Med, 2021 Jun 10; 10(14). PMID: 34105315    Free PMC article.
Regulatory T-cell Transcriptomic Reprogramming Characterizes Adverse Events by Checkpoint Inhibitors in Solid Tumors.
Maria Grigoriou, Aggelos Banos, +13 authors, Panayotis Verginis.
Cancer Immunol Res, 2021 Apr 07; 9(7). PMID: 33820810    Free PMC article.
Immunotherapy-related gastritis: Two case reports and literature review.
Rachel Woodford, Karen Briscoe, Richard Tustin, Ankit Jain.
Clin Med Insights Oncol, 2021 Jul 23; 15. PMID: 34290539    Free PMC article.
Fundamental and Essential Knowledge for Pathologists Engaged in the Research and Practice of Immune Checkpoint Inhibitor-Based Cancer Immunotherapy.
Terufumi Kubo, Tomoyo Shinkawa, +5 authors, Toshihiko Torigoe.
Front Oncol, 2021 Jul 23; 11. PMID: 34290982    Free PMC article.
Serum Troponin T Concentrations Are Frequently Elevated in Advanced Skin Cancer Patients Prior to Immune Checkpoint Inhibitor Therapy: Experience From a Single Tertiary Referral Center.
Jonas K Kurzhals, Tobias Graf, +5 authors, Ewan A Langan.
Front Med (Lausanne), 2021 Jul 23; 8. PMID: 34291066    Free PMC article.
Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis.
Sara Bjursten, Ankur Pandita, +10 authors, Max Levin.
J Immunother Cancer, 2021 Jul 04; 9(7). PMID: 34215689    Free PMC article.
Ocular adverse events in PD-1 and PD-L1 inhibitors.
LeAnne Young, Shanda Finnigan, +4 authors, Elad Sharon.
J Immunother Cancer, 2021 Jul 07; 9(7). PMID: 34226280    Free PMC article.
The knowns & unknowns of pulmonary toxicity following immune checkpoint inhibitor therapies: a narrative review.
Alistair R Miller, Renee Manser.
Transl Lung Cancer Res, 2021 Jul 24; 10(6). PMID: 34295675    Free PMC article.
Exploring the immune-checkpoint inhibitors' efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease.
Francesco Passiglia, Valeria Cetoretta, +2 authors, Silvia Novello.
Transl Lung Cancer Res, 2021 Jul 24; 10(6). PMID: 34295686    Free PMC article.
Diffuse Alveolar Hemorrhage With Avelumab Maintenance Therapy.
Si Li, Nishant Sharma, +6 authors, Pius Ochieng.
Cureus, 2021 Jul 27; 13(6). PMID: 34306873    Free PMC article.
Hypersensitivity and Immune-related Adverse Events in Biologic Therapy.
Jamie L Waldron, Stephen A Schworer, Mildred Kwan.
Clin Rev Allergy Immunol, 2021 Jul 29; 62(3). PMID: 34319562
Prognostic significance of pre-treatment ALBI grade in advanced non-small cell lung cancer receiving immune checkpoint therapy.
Ryosuke Matsukane, Hiroyuki Watanabe, +6 authors, Ichiro Ieiri.
Sci Rep, 2021 Jul 25; 11(1). PMID: 34301991    Free PMC article.
Myocardial Vasculitis Associated With the Immune Checkpoint Inhibitor Pembrolizumab.
Hideo Oishi, Ryota Morimoto, +7 authors, Toyoaki Murohara.
JACC Case Rep, 2021 Jul 29; 2(12). PMID: 34317084    Free PMC article.
Myocardial and Pericardial Toxicity Associated With Immune Checkpoint Inhibitors in Cancer Patients.
Johnny Chahine, Patrick Collier, +2 authors, Allan L Klein.
JACC Case Rep, 2020 Feb 19; 2(2). PMID: 34317203    Free PMC article.
The Risk of Immune-Related Thyroid Dysfunction Induced by PD-1/PD-L1 Inhibitors in Cancer Patients: An Updated Systematic Review and Meta-Analysis.
Yuan Tian, Ran Li, +7 authors, Yuping Sun.
Front Oncol, 2021 Jul 30; 11. PMID: 34322382    Free PMC article.
Systematic Review.
Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to Know.
Luca Russo, Giacomo Avesani, +7 authors, Riccardo Manfredi.
Korean J Radiol, 2021 May 29; 22(8). PMID: 34047505    Free PMC article.
Correlation of Peripheral Blood Parameters and Immune-Related Adverse Events with the Efficacy of Immune Checkpoint Inhibitors.
Rilan Bai, Lingyu Li, +8 authors, Jiuwei Cui.
J Oncol, 2021 Aug 03; 2021. PMID: 34335763    Free PMC article.
Management of Thyrotoxicosis Induced by PD1 or PD-L1 Blockade.
Alessandro Brancatella, Isabella Lupi, +21 authors, Francesco Latrofa.
J Endocr Soc, 2021 Aug 03; 5(9). PMID: 34337277    Free PMC article.
Melanoma Cell Intrinsic GABAA Receptor Enhancement Potentiates Radiation and Immune Checkpoint Inhibitor Response by Promoting Direct and T Cell-Mediated Antitumor Activity.
Daniel A Pomeranz Krummel, Tahseen H Nasti, +18 authors, Soma Sengupta.
Int J Radiat Oncol Biol Phys, 2020 Dec 09; 109(4). PMID: 33289666    Free PMC article.
Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators.
Marco Stellato, Giuseppe Procopio, +9 authors, Daniele Santini.
J Transl Med, 2021 Aug 05; 19(1). PMID: 34344414    Free PMC article.
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma.
Katharina Filipski, Michael Scherer, +12 authors, Patrick N Harter.
J Immunother Cancer, 2021 Jul 21; 9(7). PMID: 34281986    Free PMC article.
Prevalence of dermatological toxicities in patients with melanoma undergoing immunotherapy: Systematic review and meta-analysis.
Náthali Felícia Mineiro Dos Santos Garrett, Ana Cristina Carvalho da Costa, +3 authors, Christiane Inocêncio Vasques.
PLoS One, 2021 Aug 07; 16(8). PMID: 34358260    Free PMC article.
Systematic Review.
A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma.
Su Gao, Hailong Ruan, +7 authors, Xiaoping Zhang.
Front Oncol, 2021 Aug 10; 11. PMID: 34367965    Free PMC article.
Musculoskeletal adverse reactions after immunotherapy for cancer: A case series.
Ioana Creţu, Mihai Bojincă, +7 authors, Ruxandra Ionescu.
Exp Ther Med, 2021 Aug 11; 22(3). PMID: 34373713    Free PMC article.
Abdominal pain as an initial symptom of isolated ACTH deficiency induced by nivolumab in a patient with malignant mesothelioma.
Koichi Hata, Chikara Sakaguchi, Michiko Tsuchiya, Yukio Nagasaka.
BMJ Case Rep, 2021 Jul 23; 14(7). PMID: 34290022    Free PMC article.
Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer.
Kalyan R Chitturi, Jiaqiong Xu, +6 authors, Barry H Trachtenberg.
JACC CardioOncol, 2019 Dec 17; 1(2). PMID: 34396181    Free PMC article.
Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting.
Melissa Y Y Moey, Anna N Tomdio, +6 authors, Blase A Carabello.
JACC CardioOncol, 2021 Aug 17; 2(3). PMID: 34396256    Free PMC article.
Immune Checkpoint Inhibitor Therapy Aggravates T Cell-Driven Plaque Inflammation in Atherosclerosis.
Kikkie Poels, Mandy M T van Leent, +17 authors, Esther Lutgens.
JACC CardioOncol, 2021 Aug 17; 2(4). PMID: 34396271    Free PMC article.
Peptides that immunoactivate the tumor microenvironment.
Natsuki Furukawa, Aleksander S Popel.
Biochim Biophys Acta Rev Cancer, 2020 Dec 05; 1875(1). PMID: 33276025    Free PMC article.
A review of cutting-edge therapies for hepatocellular carcinoma (HCC): Perspectives from patents.
Yan Gao, Liyang Lyu, +2 authors, Yuanjia Hu.
Int J Med Sci, 2021 Aug 18; 18(14). PMID: 34400877    Free PMC article.
Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case report.
Kyosuke Seguchi, Kei Nakashima, +3 authors, Yu Tanaka.
Respir Med Case Rep, 2021 Aug 18; 33. PMID: 34401279    Free PMC article.
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience.
Luca Diamanti, Alberto Picca, +16 authors, Enrico Marchioni.
Neurol Sci, 2021 Aug 24; 43(3). PMID: 34424427
Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review.
Francesco Spagnolo, Andrea Boutros, +5 authors, Matteo Lambertini.
Eur J Clin Invest, 2021 May 23; 51(7). PMID: 34021591    Free PMC article.
Systematic Review.
Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease.
Yusuke Sato, Satoshi Watanabe, +25 authors, Toshiaki Kikuchi.
Transl Lung Cancer Res, 2021 Aug 26; 10(7). PMID: 34430353    Free PMC article.
Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literature.
Víctor Albarrán, Javier Pozas, +6 authors, Pilar Garrido.
Transl Lung Cancer Res, 2021 Aug 26; 10(7). PMID: 34430366    Free PMC article.
Interpretable systems biomarkers predict response to immune-checkpoint inhibitors.
Óscar Lapuente-Santana, Maisa van Genderen, +2 authors, Federica Eduati.
Patterns (N Y), 2021 Aug 26; 2(8). PMID: 34430923    Free PMC article.
Identification of a Costimulatory Molecule Gene Signature to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
Ling Aye, Xiaole Song, +6 authors, Dehui Wang.
Front Cell Dev Biol, 2021 Aug 27; 9. PMID: 34434928    Free PMC article.
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy.
Sasan Ghaffari, Nastaran Khalili, Nima Rezaei.
J Exp Clin Cancer Res, 2021 Aug 28; 40(1). PMID: 34446084    Free PMC article.
Hypothalamic-Pituitary Autoimmunity in Patients Treated with Anti-PD-1 and Anti-PD-L1 Antibodies.
Giuseppe Bellastella, Carla Carbone, +10 authors, Katherine Esposito.
Cancers (Basel), 2021 Aug 28; 13(16). PMID: 34439190    Free PMC article.
Predictive Role of Prior Radiotherapy and Immunotherapy-Related Adverse Effects in Advanced NSCLC Patients Receiving Anti-PD-1/L1 Therapy.
Jeong Uk Lim, Soo Han Kim, +6 authors, Chang Min Choi.
J Clin Med, 2021 Aug 28; 10(16). PMID: 34442015    Free PMC article.
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2.
Lewis Au, Annika Fendler, +32 authors, Samra Turajlic.
Nat Med, 2021 May 28; 27(8). PMID: 34040262    Free PMC article.
Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease.
Alexa R Weingarden, Samuel J S Rubin, John Gubatan.
World J Gastrointest Oncol, 2021 Aug 31; 13(8). PMID: 34457186    Free PMC article.
Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature.
Yolanda Piña, Brittany R Evernden, +6 authors, Edwin Peguero.
SAGE Open Med Case Rep, 2021 Aug 31; 9. PMID: 34457306    Free PMC article.
Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition - Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry.
Jan-Malte Placke, Josefine Rawitzer, +9 authors, Lisa Zimmer.
Front Oncol, 2021 Aug 31; 11. PMID: 34458154    Free PMC article.
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.
Marco Russano, Alessio Cortellini, +47 authors, Daniele Santini.
Cancer Immunol Immunother, 2021 Sep 01; 71(4). PMID: 34462870
Immune checkpoint inhibitor use in patients with end-stage kidney disease: an analysis of reported cases and literature review.
Abhijat Kitchlu, Kenar D Jhaveri, +2 authors, Rimda Wanchoo.
Clin Kidney J, 2021 Sep 04; 14(9). PMID: 34476087    Free PMC article.
Improvement in recurring nivolumab-induced pneumonitis with repetitive administration of infliximab in a patient with head and neck cancer: A case report.
Shohei Ueno, Masato Uenomachi, +7 authors, Eishi Baba.
Mol Clin Oncol, 2021 Sep 04; 15(4). PMID: 34476105    Free PMC article.
Novel insights into the pathogenesis and treatment of NRAS mutant melanoma.
Jeffrey Zhao, Carlos Galvez, +2 authors, Jeffrey A Sosman.
Expert Rev Precis Med Drug Dev, 2021 Sep 07; 6(4). PMID: 34485698    Free PMC article.
Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer.
Wei Xiong, Yunfeng Zhao, He Du, Xuejun Guo.
Front Oncol, 2021 Sep 08; 11. PMID: 34490104    Free PMC article.
Ocular Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Lung Cancer.
Lin Zhou, Xin Wei.
Front Immunol, 2021 Sep 11; 12. PMID: 34504488    Free PMC article.
Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodies.
Morinobu Seki, Shigehisa Kitano, Shigeaki Suzuki.
Cancer Immunol Immunother, 2021 Sep 14; 71(4). PMID: 34515815
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer: Real-World Incidence, Risk Factors, and Management Practices Across Six Health Care Centers in North Carolina.
William T Atchley, Carolina Alvarez, +4 authors, M Patricia Rivera.
Chest, 2021 Feb 24; 160(2). PMID: 33621599    Free PMC article.
Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy.
Amber G Bozward, Vincenzo Ronca, Daniel Osei-Bordom, Ye Htun Oo.
Front Immunol, 2021 Sep 14; 12. PMID: 34512631    Free PMC article.
Spontaneous recovery of immune checkpoint inhibitor-induced thyroiditis with high free T4 level: A case report.
Rie Hagiwara, Daisuke Suzuki, +7 authors, Hodaka Yamada.
Clin Case Rep, 2021 Sep 14; 9(9). PMID: 34512984    Free PMC article.
Immune-mediated inflammatory disease therapeutics: past, present and future.
Iain B McInnes, Ellen M Gravallese.
Nat Rev Immunol, 2021 Sep 15; 21(10). PMID: 34518662    Free PMC article.
Differences between immunotherapy-induced and primary hypophysitis-a multicenter retrospective study.
Felix Amereller, Timo Deutschbein, +7 authors, Sylvère Störmann.
Pituitary, 2021 Sep 15; 25(1). PMID: 34518996    Free PMC article.
Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial.
Belén Sierra-Rodero, Alberto Cruz-Bermúdez, +23 authors, Mariano Provencio.
J Immunother Cancer, 2021 Aug 28; 9(8). PMID: 34446577    Free PMC article.
Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes mellitus: A report of two cases.
Noriko Fujiwara, Mayu Watanabe, +5 authors, Jun Wada.
Clin Case Rep, 2021 Sep 16; 9(9). PMID: 34522382    Free PMC article.
PD-1-stimulated T cell subsets are transcriptionally and functionally distinct.
Shalom Lerrer, Anna S Tocheva, +2 authors, Adam Mor.
iScience, 2021 Sep 16; 24(9). PMID: 34522863    Free PMC article.
CXCR6 is required for antitumor efficacy of intratumoral CD8+ T cell.
Binglin Wang, Yi Wang, +9 authors, Yang Sun.
J Immunother Cancer, 2021 Sep 01; 9(8). PMID: 34462326    Free PMC article.
Dermatologic infections in cancer patients treated with checkpoint inhibitors.
Mytrang H Do, Dulce M Barrios, +6 authors, Mario E Lacouture.
J Am Acad Dermatol, 2021 Mar 22; 85(6). PMID: 33744355    Free PMC article.
Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target.
Wenjing Qian, Mingfang Zhao, Ruoyu Wang, Heming Li.
J Hematol Oncol, 2021 Sep 17; 14(1). PMID: 34526102    Free PMC article.
Avelumab plus axitinib therapy for renal cell carcinoma in a patient with pulmonary alveolar proteinosis: A case report.
Nobuaki Shimizu, Masaru Hasumi, +2 authors, Youtarou Takaku.
Urol Case Rep, 2021 Sep 21; 39. PMID: 34540590    Free PMC article.
Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors.
Zsofia D Drobni, Sean P Murphy, +16 authors, Tomas G Neilan.
Immunother Adv, 2021 Sep 21; 1(1). PMID: 34541581    Free PMC article.
A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors.
Neeraj Chhabra, Joseph Kennedy.
J Med Toxicol, 2021 Apr 08; 17(4). PMID: 33826117    Free PMC article.
Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR.
Nicholas L Bayless, Jeffrey A Bluestone, +8 authors, Theresa L Walunas.
J Immunother Cancer, 2021 Sep 05; 9(9). PMID: 34479924    Free PMC article.
Translational Applications of Hydrogels.
Santiago Correa, Abigail K Grosskopf, +4 authors, Eric A Appel.
Chem Rev, 2021 May 04; 121(18). PMID: 33938724    Free PMC article.
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways.
Lukas Kraehenbuehl, Chien-Huan Weng, +2 authors, Taha Merghoub.
Nat Rev Clin Oncol, 2021 Sep 29; 19(1). PMID: 34580473
Pembrolizumab-caused polyradiculoneuropathy as an immune-related adverse event.
Takashi Kurashige, Mineyo Mito, +5 authors, Tsuyoshi Torii.
Neuropathology, 2021 May 05; 41(4). PMID: 33942396    Free PMC article.
Automated Identification of Patients With Immune-Related Adverse Events From Clinical Notes Using Word Embedding and Machine Learning.
Samir Gupta, Anas Belouali, +2 authors, Subha Madhavan.
JCO Clin Cancer Inform, 2021 May 15; 5. PMID: 33989017    Free PMC article.
An Overview of Cardio-Oncology, a New Frontier to Be Explored.
Kai-Hung Cheng, Yen-Wen Wu, Charles Jia-Yin Hou, Chao-Ming Hung.
Acta Cardiol Sin, 2021 Sep 30; 37(5). PMID: 34584378    Free PMC article.
Atezolizumab-induced bilateral anterior uveitis: A case report.
Tsuyoshi Mito, Shun Takeda, Nozomu Motono, Hiroshi Sasaki.
Am J Ophthalmol Case Rep, 2021 Sep 30; 24. PMID: 34585023    Free PMC article.
Treatment and Survival in Advanced Non-Small Cell Lung Cancer, Urothelial, Ovarian, Gastric and Kidney Cancer: A Nationwide Comprehensive Evaluation.
Signe Sørup, Bianka Darvalics, +9 authors, Deirdre Cronin-Fenton.
Clin Epidemiol, 2021 Oct 01; 13. PMID: 34588817    Free PMC article.
Acquired Coagulopathy With Immune Checkpoint Inhibitors: An Underrecognized Association Between Inflammation and Coagulation.
Jacinth J Joseph, Arun Rajan, +2 authors, Craig M Kessler.
JTO Clin Res Rep, 2020 May 04; 1(3). PMID: 34589945    Free PMC article.
Association Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLC.
Biagio Ricciuti, Abdul Rafeh Naqash, +20 authors, Mark M Awad.
JTO Clin Res Rep, 2020 Jul 15; 1(4). PMID: 34589955    Free PMC article.
Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Antitumor Immunosuppression of EGFR Wild Type Lung Cancers With Low PD-L1 Expression.
Min Wang, Jie Zhu, Fang Zhao, Jiani Xiao.
Front Oncol, 2021 Oct 02; 11. PMID: 34595103    Free PMC article.
Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy.
Victoria S Pelly, Agrin Moeini, +12 authors, Santiago Zelenay.
Cancer Discov, 2021 May 26; 11(10). PMID: 34031121    Free PMC article.
Immune-Related Adverse Events Associated With Outcomes in Patients With NSCLC Treated With Anti-PD-1 Inhibitors: A Systematic Review and Meta-Analysis.
Zhe Zhao, Xinfeng Wang, +4 authors, Xiaoguang Chen.
Front Oncol, 2021 Oct 05; 11. PMID: 34604047    Free PMC article.
Systematic Review.
Antigen presentation by lung epithelial cells directs CD4+ TRM cell function and regulates barrier immunity.
Anukul T Shenoy, Carolina Lyon De Ana, +16 authors, Joseph P Mizgerd.
Nat Commun, 2021 Oct 07; 12(1). PMID: 34611166    Free PMC article.
A Radiomic Approach to Access Tumor Immune Status by CD8+TRMs on Surgically Resected Non-Small-Cell Lung Cancer.
Jie Min, Fei Dong, +5 authors, Ying Chai.
Onco Targets Ther, 2021 Oct 07; 14. PMID: 34611410    Free PMC article.
Immune Checkpoint Inhibitor-Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study.
Li Wang, Xiaolin Li, +3 authors, Jingli Duan.
Front Pharmacol, 2021 Oct 12; 12. PMID: 34630077    Free PMC article.
Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy.
Wenxiang Zhang, Xiangyi Kong, +6 authors, Jing Wang.
Front Oncol, 2021 Oct 12; 11. PMID: 34631507    Free PMC article.
Metabolic Modifications, Inflammation, and Cancer Immunotherapy.
Sihao Zheng, Qibin Song, Pingfeng Zhang.
Front Oncol, 2021 Oct 12; 11. PMID: 34631531    Free PMC article.
Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma.
Zhengjun Lin, Ke Pang, +5 authors, Weijun Peng.
Front Cell Dev Biol, 2021 Oct 12; 9. PMID: 34631703    Free PMC article.
Conjugation of glucosylated polymer chains to checkpoint blockade antibodies augments their efficacy and specificity for glioblastoma.
Tao Yang, Yuki Mochida, +6 authors, Kazunori Kataoka.
Nat Biomed Eng, 2021 Oct 13; 5(11). PMID: 34635819
The benefits and risks of pembrolizumab in combination with chemotherapy as first-line therapy in small-cell lung cancer: a single-arm meta-analysis of noncomparative clinical studies and randomized control trials.
Qiangyun Liu, Yixuan Zhang, +5 authors, Wenxiong Zhang.
World J Surg Oncol, 2021 Oct 15; 19(1). PMID: 34645484    Free PMC article.
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer.
Leyre Zubiri, Gabriel E Molina, +27 authors, Kerry L Reynolds.
J Immunother Cancer, 2021 Sep 22; 9(9). PMID: 34544895    Free PMC article.
PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis.
María Rosario García Campelo, Edurne Arriola, +8 authors, Delvys Rodríguez-Abreu.
J Clin Med, 2021 Oct 14; 10(19). PMID: 34640601    Free PMC article.
Clinical and radiological features of immune checkpoint inhibitor-related pneumonitis in lung cancer and non-lung cancers.
Tomomi W Nobashi, Yuko Nishimoto, +8 authors, Satoshi Noma.
Br J Radiol, 2020 Aug 14; 93(1115). PMID: 32783627    Free PMC article.
Imaging findings of immune checkpoint inhibitor associated pancreatitis.
Jeeban P Das, Michael A Postow, +2 authors, Darragh F Halpenny.
Eur J Radiol, 2020 Sep 10; 131. PMID: 32905952    Free PMC article.
Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus.
Pengcheng Zhou, Jiali Chen, +18 authors, Zhanguo Li.
PLoS Pathog, 2021 Oct 08; 17(10). PMID: 34618873    Free PMC article.
Dynamic Changes of Serum Heart Type-Fatty Acid Binding Protein in Cancer Patients Treated With Immune Checkpoint Inhibitors.
Ming Yuan, Li Zang, +10 authors, Tong Liu.
Front Pharmacol, 2021 Oct 19; 12. PMID: 34658887    Free PMC article.
Paraneoplastic Neuropathies: What's New Since the 2004 Recommended Diagnostic Criteria.
Marco Zoccarato, Wolfgang Grisold, +3 authors, Bruno Giometto.
Front Neurol, 2021 Oct 19; 12. PMID: 34659082    Free PMC article.
Immune Checkpoint Inhibitors and the Heart.
Diana Larisa Mocan-Hognogi, Sebastian Trancǎ, +3 authors, Anca Simona Bojan.
Front Cardiovasc Med, 2021 Oct 19; 8. PMID: 34660728    Free PMC article.
Acute Diffuse Renal Tubulopathy in a Patient With Lung Cancer: A Case Report.
Po-Jung Tseng, Ming-Tso Yan.
Front Med (Lausanne), 2021 Oct 22; 8. PMID: 34671624    Free PMC article.
[Research Progress of Immune Checkpoint Inhibitor-associated Myocarditis].
Yunwei Liu, Yanxin Chen, Zhimin Zeng, Anwen Liu.
Zhongguo Fei Ai Za Zhi, 2021 Sep 16; 24(9). PMID: 34521189    Free PMC article.
Insights into Potential Pathogenesis and Treatment Options for Immune-Checkpoint Inhibitor-Related Pneumonitis.
Hiroyuki Ando, Kunihiro Suzuki, Toyoshi Yanagihara.
Biomedicines, 2021 Oct 24; 9(10). PMID: 34680601    Free PMC article.
A case of non-small cell lung cancer presenting anti-amphiphysin antibody-positive paraneoplastic neurological syndrome.
Koki Nakashima, Yuya Fujii, +3 authors, Tamotsu Ishizuka.
Respir Med Case Rep, 2021 Oct 26; 34. PMID: 34692399    Free PMC article.
Atezolizumab-associated Dermatomyositis in Advanced Small-cell Lung Carcinoma.
Yoshitaka Yamaguchi, Mari Aso, Hikaru Nagasawa, Manabu Wada.
Intern Med, 2021 Mar 30; 60(18). PMID: 33776010    Free PMC article.
Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy.
Eric H Bent, Luis R Millán-Barea, +3 authors, Michael T Hemann.
Nat Commun, 2021 Oct 30; 12(1). PMID: 34711820    Free PMC article.
Pembrolizumab-induced focal segmental glomerulosclerosis: A case report.
Da Woon Kim, Hakeong Jeon, +5 authors, Eun Young Seong.
Medicine (Baltimore), 2021 Oct 30; 100(43). PMID: 34713828    Free PMC article.
Current status of medical oncology in Japan and changes over the most recent 7-year period: results of a questionnaire sent to designated cancer care hospitals.
Makoto Arai, Izumi Ohno, +4 authors, Yuichi Takiguchi.
Jpn J Clin Oncol, 2021 Aug 21; 51(11). PMID: 34414432    Free PMC article.
Risk factors for immune-related adverse events: what have we learned and what lies ahead?
Xiaoyan Liu, Yuequan Shi, +7 authors, Mengzhao Wang.
Biomark Res, 2021 Nov 05; 9(1). PMID: 34732257    Free PMC article.
Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome.
Keitaro Kanie, Genzo Iguchi, +9 authors, Yutaka Takahashi.
Cancer Immunol Immunother, 2021 May 13; 70(12). PMID: 33977343    Free PMC article.
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis.
Anne Zaremba, Rafaela Kramer, +36 authors, Lisa Zimmer.
Front Oncol, 2021 Nov 09; 11. PMID: 34746007    Free PMC article.
Checkpoint Inhibitors in Melanoma Patients with Underlying Autoimmune Disease.
Hilary Dietz, Sophia C Weinmann, April K Salama.
Cancer Manag Res, 2021 Nov 11; 13. PMID: 34754240    Free PMC article.
The clinical features, prognostic significance, and immune heterogeneity of CD37 in diffuse gliomas.
Xuejun Yan, Quanwei Zhou, +6 authors, Caiping Ren.
iScience, 2021 Nov 11; 24(11). PMID: 34755091    Free PMC article.
Proportional Tumor Infiltration of T Cells via Circulation Duplicates the T Cell Receptor Repertoire in a Bilateral Tumor Mouse Model.
Mikiya Tsunoda, Hiroyasu Aoki, +3 authors, Satoshi Ueha.
Front Immunol, 2021 Nov 12; 12. PMID: 34759926    Free PMC article.
Gut microbiome and checkpoint inhibitor colitis.
Kanika Sehgal, Sahil Khanna.
Intest Res, 2020 Nov 30; 19(4). PMID: 33249800    Free PMC article.
Engineered biomaterials for cancer immunotherapy.
Lulu Cai, Jialu Xu, +4 authors, Kam W Leong.
MedComm (2020), 2020 May 27; 1(1). PMID: 34766108    Free PMC article.
PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis.
Xinxin Zhu, Qiyue Shanzhou, +2 authors, Daiyuan Ma.
BMC Cancer, 2021 Nov 12; 21(1). PMID: 34758782    Free PMC article.
Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis.
Harm Westdorp, Mark W D Sweep, +8 authors, I Jolanda M de Vries.
Front Immunol, 2021 Nov 16; 12. PMID: 34777387    Free PMC article.
Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases.
Andreas von Knethen, Jose-Ignacio Rodriguez-Barbosa.
Front Immunol, 2021 Nov 16; 12. PMID: 34777402    Free PMC article.
Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [18F]FDG PET/CT in Metastatic Melanomas and Lung Cancer.
Egesta Lopci.
J Clin Med, 2021 Nov 14; 10(21). PMID: 34768681    Free PMC article.
Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma.
Pei-Yi Chu, Shih-Hsuan Chan.
Cancers (Basel), 2021 Nov 14; 13(21). PMID: 34771459    Free PMC article.
Follow-up Care for Patients Receiving Immune Checkpoint Inhibitors.
Liyan Zhang, Yuhan Lu.
Asia Pac J Oncol Nurs, 2021 Nov 19; 8(6). PMID: 34790843    Free PMC article.
Oral Immune-Related Adverse Events - Current Concepts and their Management.
Mohamed Faizal Asan, Renita Lorina Castelino, +2 authors, Vaibhav Pandita.
Asia Pac J Oncol Nurs, 2021 Nov 19; 8(6). PMID: 34790844    Free PMC article.
Development of a Functional Assessment of Chronic Illness Therapy item library and primary symptom list for the assessment of patient-reported adverse events associated with immune checkpoint modulators.
Kimberly A Webster, Mary L O'Connor, +10 authors, David Cella.
J Cancer Metastasis Treat, 2020 Jan 01; 6. PMID: 34790879    Free PMC article.
Combination of epigenetic regulation with gene therapy-mediated immune checkpoint blockade induces anti-tumour effects and immune response in vivo.
Huapan Fang, Zhaopei Guo, +5 authors, Xuesi Chen.
Nat Commun, 2021 Nov 20; 12(1). PMID: 34795289    Free PMC article.
Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy.
Pan Shen, Xuan Deng, +9 authors, Shenghao Tu.
Front Med (Lausanne), 2021 Nov 23; 8. PMID: 34805229    Free PMC article.
Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation.
E E A P Mulder, L Smit, +4 authors, C A Uyl-de Groot.
ESMO Open, 2021 Nov 16; 6(6). PMID: 34781194    Free PMC article.
Atezolizumab-Induced Hypothyroidism in a Patient With Pre-existing Triiodothyronine (T3) Thyrotoxicosis Due to Graves' Disease: A Case Report and Literature Review.
Samson O Oyibo, Mohamed O Mahgoub.
Cureus, 2021 Nov 24; 13(11). PMID: 34812334    Free PMC article.
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study.
Wenxian Wang, Xiaodong Gu, +11 authors, Zhengbo Song.
Cancer Immunol Immunother, 2021 Nov 25; 71(7). PMID: 34817639
Correlation between immune-related adverse events and the efficacy of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: systematic review and meta-analysis.
Qian Zhang, Wei Wang, +4 authors, Chun-Hua Xu.
Cancer Chemother Pharmacol, 2021 Nov 26; 89(1). PMID: 34821962    Free PMC article.
Systematic Review.
Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors.
Xue-Lin Zou, Wei-Yong Chen, +3 authors, Xiao-Bo Li.
Front Pharmacol, 2021 Nov 26; 12. PMID: 34819857    Free PMC article.
Emerging Developments in Management of Melanoma During the COVID-19 Era.
Andraia R Li, Manuel Valdebran, Daniel Y Reuben.
Front Med (Lausanne), 2021 Nov 26; 8. PMID: 34820401    Free PMC article.
Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis.
Nuttapong Ngamphaiboon, Suthinee Ithimakin, +2 authors, Virote Sriuranpong.
BMC Cancer, 2021 Nov 27; 21(1). PMID: 34823493    Free PMC article.
Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells.
Hiroyuki Ogasawara, Masato Noguchi.
Cells, 2021 Nov 28; 10(11). PMID: 34831128    Free PMC article.
Effects of PD-1 blockade on ovarian follicles in a prepubertal female mouse.
Pauline C Xu, Yi Luan, +3 authors, So-Youn Kim.
J Endocrinol, 2021 Oct 15; 252(1). PMID: 34647523    Free PMC article.
Role of the PD-1/PD-L1 Signaling in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Recent Insights and Future Directions.
Yan Mi, Jinming Han, Jie Zhu, Tao Jin.
Mol Neurobiol, 2021 Sep 05; 58(12). PMID: 34480337    Free PMC article.
Assessment of Ovarian Function in Phase 3 (Neo)adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation.
Wanyuan Cui, Prudence A Francis, +9 authors, Kelly-Anne Phillips.
J Natl Cancer Inst, 2021 May 29;. PMID: 34048575    Free PMC article.
Modulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases.
Kathryn E Blethen, Tasneem A Arsiwala, +10 authors, Paul R Lockman.
Neurooncol Adv, 2021 Dec 04; 3(Suppl 5). PMID: 34859240    Free PMC article.
Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma.
Di Wang, Kai Sun, +5 authors, Jitao Wu.
Front Pharmacol, 2021 Dec 07; 12. PMID: 34867321    Free PMC article.
Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications.
Hannah-Lou Schilling, Gunther Glehr, +9 authors, Katharina Kronenberg.
Front Immunol, 2021 Dec 07; 12. PMID: 34868015    Free PMC article.
Impact of Patient Age on Clinical Efficacy and Toxicity of Checkpoint Inhibitor Therapy.
Selina K Wong, Caroline A Nebhan, Douglas B Johnson.
Front Immunol, 2021 Dec 07; 12. PMID: 34868071    Free PMC article.
Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection.
Muhammad Bilal Latif, Sudhanshu Shukla, +3 authors, Ashish Arunkumar Sharma.
Transl Res, 2021 Dec 07; 241. PMID: 34871809    Free PMC article.
Emerging immunological strategies: recent advances and future directions.
Hongyun Zhao, Fan Luo, +2 authors, Rui-Hua Xu.
Front Med, 2021 Dec 08; 15(6). PMID: 34874513
Prognostic Role of TIGIT Expression in Patients with Solid Tumors: A Meta-Analysis.
Kunmin Xiao, Kunlin Xiao, +2 authors, Shijie Zhu.
J Immunol Res, 2021 Dec 11; 2021. PMID: 34888386    Free PMC article.
A scoring model based on ferroptosis genes for prognosis and immunotherapy response prediction and tumor microenvironment evaluation in liver hepatocellular carcinoma.
Lei Gao, Juan Xue, +3 authors, Liangliang Lei.
Aging (Albany NY), 2021 Nov 29; 13(22). PMID: 34839280    Free PMC article.
Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring.
Bettina Beuthien-Baumann, Christos Sachpekidis, Regula Gnirs, Oliver Sedlaczek.
Cancers (Basel), 2021 Dec 11; 13(23). PMID: 34885129    Free PMC article.
Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy.
Xiujing He, Jing Yu, Hubing Shi.
Front Pharmacol, 2021 Dec 14; 12. PMID: 34899357    Free PMC article.
The Inconsistent and Inadequate Reporting Of Immune-Related Adverse Events in PD-1/PD-L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials.
Tong Xie, Zhening Zhang, +5 authors, Zhi Peng.
Oncologist, 2021 Aug 17; 26(12). PMID: 34396642    Free PMC article.
Systematic Review.
Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury.
Zengfu Zhang, Jialin Zhou, +4 authors, Dawei Chen.
Front Immunol, 2021 Dec 21; 12. PMID: 34925345    Free PMC article.
Immunotherapy: A Case Series.
Tuong Vi C Do, Mythili Kanthi Gudipati, +2 authors, Kamlesh Sajnani.
Cureus, 2021 Dec 23; 13(11). PMID: 34934589    Free PMC article.
The foundations of immune checkpoint blockade and the ipilimumab approval decennial.
Alan J Korman, Sarah C Garrett-Thomson, Nils Lonberg.
Nat Rev Drug Discov, 2021 Dec 24;. PMID: 34937915
Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment.
Cong Wang, Jinyi Lin, +8 authors, Junbo Ge.
Front Pharmacol, 2021 Dec 24; 12. PMID: 34938185    Free PMC article.
Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis.
Naoki Hamada, Ayaka Maeda, +7 authors, YCU irAE Working Group.
Front Immunol, 2021 Dec 24; 12. PMID: 34938300    Free PMC article.
Systematic Review.
Case Report: Cardiac Toxicity Associated With Immune Checkpoint Inhibitors.
Ru Chen, Ling Peng, +4 authors, Feng Zhu.
Front Cardiovasc Med, 2021 Dec 24; 8. PMID: 34938778    Free PMC article.
Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management.
Harish Seethapathy, Sandra M Herrmann, Meghan E Sise.
Kidney Med, 2021 Dec 24; 3(6). PMID: 34939017    Free PMC article.
Nivolumab-Induced Exocrine Pancreatic Insufficiency.
Boudewijn Sweep, Sofie Wilgenhof, Sander Anten.
Case Rep Oncol, 2021 Dec 25; 14(3). PMID: 34950007    Free PMC article.
Correlation Between Immune-Related Adverse Events and Prognosis in Hepatocellular Carcinoma Patients Treated With Immune Checkpoint Inhibitors.
Shuo Xu, Ruixue Lai, +3 authors, Zhanjun Guo.
Front Immunol, 2021 Dec 25; 12. PMID: 34950153    Free PMC article.
IgA Nephropathy Secondary to Ipilimumab Use.
Sean C Dougherty, Nisa Desai, Helen P Cathro, Amanda Renaghan.
Case Rep Nephrol Dial, 2021 Dec 25; 11(3). PMID: 34950709    Free PMC article.
Our current understanding of checkpoint inhibitor therapy in cancer immunotherapy.
Elena Goleva, Taras Lyubchenko, +3 authors, Jeffrey A Kern.
Ann Allergy Asthma Immunol, 2021 Mar 16; 126(6). PMID: 33716146    Free PMC article.
Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors.
Harish Seethapathy, Nifasha Rusibamayila, +7 authors, Meghan E Sise.
Nephrol Dial Transplant, 2020 Dec 30; 36(12). PMID: 33374011    Free PMC article.
Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases.
Kalliopi Klavdianou, Konstantinos Melissaropoulos, Alexandra Filippopoulou, Dimitrios Daoussis.
Mediterr J Rheumatol, 2021 Dec 30; 32(3). PMID: 34964025    Free PMC article.
Intestinal Microbiome Associated With Immune-Related Adverse Events for Patients Treated With Anti-PD-1 Inhibitors, a Real-World Study.
Wenhui Liu, Fang Ma, +5 authors, Zhiying Luo.
Front Immunol, 2022 Jan 04; 12. PMID: 34975845    Free PMC article.
Development of a fully canine anti-canine CTLA4 monoclonal antibody for comparative translational research in dogs with spontaneous tumors.
Nicola J Mason, Nicholas Chester, +6 authors, Don L Siegel.
MAbs, 2021 Dec 04; 13(1). PMID: 34856888    Free PMC article.
Improvement of PD-1 Blockade Efficacy and Elimination of Immune-Related Gastrointestinal Adverse Effect by mTOR Inhibitor.
Xin Bai, Xueyan Wang, +11 authors, Hubing Shi.
Front Immunol, 2022 Jan 07; 12. PMID: 34987517    Free PMC article.
Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer.
Juan C Lopez-Mattei, Eric H Yang, +3 authors, Matthew J Budoff.
JACC CardioOncol, 2022 Jan 07; 3(5). PMID: 34988472    Free PMC article.
Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management.
Liansha Tang, Jialing Wang, +4 authors, Xuelei Ma.
Front Immunol, 2022 Jan 08; 12. PMID: 34992611    Free PMC article.
Overlapping NMDA-R and GFAP Antibody Autoimmune Encephalitis After Nivolumab Therapy.
Felipe A Ayala, Sean C Dougherty, William Swift, David A Lapides.
Neurol Clin Pract, 2022 Jan 08; 11(6). PMID: 34992980    Free PMC article.
A Case Report of Non-Bacterial Cystitis Caused by Immune Checkpoint Inhibitors.
Sihui Zhu, Lijuan Bian, +2 authors, Jie Shen.
Front Immunol, 2022 Jan 11; 12. PMID: 35003107    Free PMC article.
Association between immune-related adverse event timing and treatment outcomes.
David Hsiehchen, Abdul Rafeh Naqash, +9 authors, David E Gerber.
Oncoimmunology, 2022 Jan 11; 11(1). PMID: 35003896    Free PMC article.
Case Report: A Case of Sintilimab-Induced Cystitis/Ureteritis and Review of Sintilimab-Related Adverse Events.
Lingfang Tu, Yuan Ye, +4 authors, Zhijie Pan.
Front Oncol, 2022 Jan 11; 11. PMID: 35004277    Free PMC article.
Dermatologic immune-related adverse events: The toxicity spectrum and recommendations for management.
Zoe Apalla, Bernardo Rapoport, Vincent Sibaud.
Int J Womens Dermatol, 2022 Jan 11; 7(5Part A). PMID: 35005180    Free PMC article.
Immunotherapy toxicity: identification and management.
O Gumusay, J Callan, H S Rugo.
Breast Cancer Res Treat, 2022 Jan 12; 192(1). PMID: 35015209    Free PMC article.
Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses.
Sergio Muñiz-Castrillo, Alberto Vogrig, +3 authors, Jérôme Honnorat.
Cerebellum, 2022 Jan 13;. PMID: 35020135
Immune Checkpoint Inhibitor Treatment and Ophthalmologist Consultations in Patients with Malignant Melanoma or Lung Cancer-A Nationwide Cohort Study.
Maria D'Souza, Mette Bagger, +6 authors, Jens Folke Kiilgaard.
Cancers (Basel), 2022 Jan 12; 14(1). PMID: 35008211    Free PMC article.
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma.
Alexander X Lozano, Aadel A Chaudhuri, +17 authors, Aaron M Newman.
Nat Med, 2022 Jan 15; 28(2). PMID: 35027754    Free PMC article.
Gene Expression Profiling in Kidney Transplants with Immune Checkpoint Inhibitor-Associated Adverse Events.
Benjamin A Adam, Naoka Murakami, +12 authors, Michael Mengel.
Clin J Am Soc Nephrol, 2021 Jul 11; 16(9). PMID: 34244334    Free PMC article.
Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature.
Koki Nakashima, Yoshiki Demura, +6 authors, Tamotsu Ishizuka.
Case Reports Immunol, 2022 Jan 18; 2022. PMID: 35036012    Free PMC article.
Harnessing big data to characterize immune-related adverse events.
Ying Jing, Jingwen Yang, +2 authors, Leng Han.
Nat Rev Clin Oncol, 2022 Jan 19; 19(4). PMID: 35039679
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study.
Ryuji Yasumatsu, Yasushi Shimizu, +23 authors, Akihiro Homma.
Int J Clin Oncol, 2021 Nov 14; 27(1). PMID: 34773525    Free PMC article.
Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review).
Jiachen Lu, Jianing Ding, Zhaoxia Liu, Tingtao Chen.
Int J Oncol, 2022 Jan 05; 60(2). PMID: 34981814    Free PMC article.
Immune checkpoint inhibitor-induced refractory polyarthritis rapidly improved by sarilumab and monitoring with joint ultrasonography: A case report.
Kazuya Abe, Yuichi Ishikawa, +5 authors, Yasuhiko Kita.
Medicine (Baltimore), 2022 Jan 15; 101(2). PMID: 35029182    Free PMC article.
Acute kidney injury in cancer patients.
Shuiying Liu, Jinyuan Zhao, Feng Wang.
Clin Exp Nephrol, 2021 Sep 10; 26(2). PMID: 34499266
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade.
Golnaz Morad, Beth A Helmink, Padmanee Sharma, Jennifer A Wargo.
Cell, 2021 Oct 09; 184(21). PMID: 34624224    Free PMC article.
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by Durvalumab: A Case Report and Literature Review.
Nathathai Pratumchart, Kumutnart Chanprapaph, Nuttapong Topibulpong, Jutamas Tankunakorn.
Clin Cosmet Investig Dermatol, 2022 Jan 21; 15. PMID: 35046689    Free PMC article.
Camrelizumab-Related Myocarditis and Myositis With Myasthenia Gravis: A Case Report and Literature Review.
Jing Bai, Dan Li, +7 authors, Rui Feng.
Front Oncol, 2022 Jan 21; 11. PMID: 35047395    Free PMC article.
Clinical Trial Eligibility Criteria and Recently Approved Cancer Therapies for Patients With Brain Metastases.
Aaron C Tan, Drexell H Boggs, +3 authors, Mustafa Khasraw.
Front Oncol, 2022 Jan 21; 11. PMID: 35047397    Free PMC article.
BTBD10 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma.
Jianhui Li, Xiaojuan Tian, +9 authors, Wenjie Song.
Front Mol Biosci, 2022 Jan 22; 8. PMID: 35059434    Free PMC article.
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions.
Ming Yi, Xiaoli Zheng, +3 authors, Kongming Wu.
Mol Cancer, 2022 Jan 23; 21(1). PMID: 35062949    Free PMC article.
Immune-Related Pneumonitis Was Decreased by Addition of Chemotherapy with PD-1/L1 Inhibitors: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (RCTs).
Yi-Xiu Long, Yue Sun, +8 authors, Ji-Yan Liu.
Curr Oncol, 2022 Jan 21; 29(1). PMID: 35049699    Free PMC article.
Systematic Review.
Immune-checkpoint inhibitors: long-term implications of toxicity.
Douglas B Johnson, Caroline A Nebhan, Javid J Moslehi, Justin M Balko.
Nat Rev Clin Oncol, 2022 Jan 28; 19(4). PMID: 35082367    Free PMC article.
Rheumatological Adverse Events Following Immunotherapy for Cancer.
Ioana Cretu, Bogdan Cretu, +4 authors, Ruxandra Ionescu.
Medicina (Kaunas), 2022 Jan 22; 58(1). PMID: 35056402    Free PMC article.
Patient-Level DNA Damage Repair Pathway Profiles and Anti-Tumor Immunity for Gastric Cancer.
Shenghan Lou, Yufei Wang, +4 authors, Yingwei Xue.
Front Immunol, 2022 Jan 28; 12. PMID: 35082793    Free PMC article.
Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma.
Kimberly Loo, James W Smithy, Michael A Postow, Allison Betof Warner.
Front Immunol, 2022 Jan 29; 12. PMID: 35087529    Free PMC article.
Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis.
Xinqing Lin, Jiaxi Deng, +9 authors, Chengzhi Zhou.
Front Immunol, 2022 Feb 01; 12. PMID: 35095920    Free PMC article.
Immunotherapeutic Strategies in Cancer and Atherosclerosis-Two Sides of the Same Coin.
Felix Sebastian Nettersheim, Felix Simon Ruben Picard, Friedrich Felix Hoyer, Holger Winkels.
Front Cardiovasc Med, 2022 Feb 01; 8. PMID: 35097027    Free PMC article.
Exploration of the prognostic signature reflecting tumor microenvironment of lung adenocarcinoma based on immunologically relevant genes.
Wei Wu, Liye Jia, +3 authors, Yan Qiang.
Bioengineered, 2021 Oct 07; 12(1). PMID: 34612148    Free PMC article.
β Cell replacement: improving on the design.
Roberto Castro-Gutierrez, Aaron W Michels, Holger A Russ.
Curr Opin Endocrinol Diabetes Obes, 2018 May 31; 25(4). PMID: 29846237    Free PMC article.
Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non-Small Cell Lung Cancer.
Jia Luo, Victoria L Martucci, +18 authors, Elad Ziv.
Clin Cancer Res, 2021 Jul 11; 27(18). PMID: 34244291    Free PMC article.
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China.
Yuequan Shi, Jian Fang, +31 authors, Mengzhao Wang.
Thorac Cancer, 2021 Dec 23; 13(3). PMID: 34935288    Free PMC article.
Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy.
Ying Jing, Xue Chen, +13 authors, Leng Han.
J Immunother Cancer, 2022 Jan 22; 10(1). PMID: 35058327    Free PMC article.
A pan-cancer study of PD-1 and CTLA-4 as therapeutic targets.
Zongqiang Cai, Xiaojie Ang, +4 authors, Feng Zhou.
Transl Cancer Res, 2022 Feb 05; 10(9). PMID: 35116697    Free PMC article.
The safety of first and subsequent lines of PD-1/PD-L1 inhibitors monotherapy in non-small cell lung cancer patients: a meta-analysis.
Yilin Yang, Peilin Pang, +3 authors, Lei Zhao.
Transl Cancer Res, 2020 May 01; 9(5). PMID: 35117689    Free PMC article.
Clinical Course and Treatment Implications of Combination Immune Checkpoint Inhibitor-Mediated Hepatitis: A Multicentre Cohort.
Matthew K Smith, Yin Chan, +7 authors, Christopher Ma.
J Can Assoc Gastroenterol, 2022 Feb 05; 5(1). PMID: 35118226    Free PMC article.
The current landscape of immunotherapy for pediatric brain tumors.
Eugene I Hwang, Elias J Sayour, +15 authors, Ian F Pollack.
Nat Cancer, 2022 Feb 06; 3(1). PMID: 35121998
Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies.
Olivier Michielin, Aly-Khan Lalani, +2 authors, Solange Peters.
J Immunother Cancer, 2022 Jan 27; 10(1). PMID: 35078922    Free PMC article.
In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy.
Hirokazu Okada, Ken Takahashi, +8 authors, Hiroshi Seno.
Sci Rep, 2022 Feb 10; 12(1). PMID: 35136110    Free PMC article.
Delivery of CD47 blocker SIRPα-Fc by CAR-T cells enhances antitumor efficacy.
Huanpeng Chen, Yuying Yang, +6 authors, Zhaofeng Huang.
J Immunother Cancer, 2022 Feb 04; 10(2). PMID: 35110357    Free PMC article.
Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy.
Lingyue Liu, Xing Huang, +5 authors, Xueli Bai.
J Exp Clin Cancer Res, 2022 Feb 11; 41(1). PMID: 35139879    Free PMC article.
Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?
Sanne B Schagen, Andrey S Tsvetkov, Annette Compter, Jeffrey S Wefel.
Nat Rev Neurol, 2022 Feb 11; 18(3). PMID: 35140379
Clinicopathological characteristics of kidney injury in non-small cell lung cancer patients under combination therapy including pembrolizumab.
Sae Aratani, Teppei Sugano, +4 authors, Yukinao Sakai.
CEN Case Rep, 2021 Aug 19; 11(1). PMID: 34406602    Free PMC article.
Psychological Symptom Trajectories and Non-Small Cell Lung Cancer Survival: A Joint Model Analysis.
Barbara L Andersen, Joseph P McElroy, +4 authors, Guy N Brock.
Psychosom Med, 2021 Oct 12; 84(2). PMID: 34629425    Free PMC article.
Prognostic significance and therapeutic potentials of immune checkpoints in osteosarcoma.
Vafa Meftahpour, Ali Aghebati-Maleki, +2 authors, Leili Aghebati-Maleki.
EXCLI J, 2022 Feb 12; 21. PMID: 35145371    Free PMC article.
CD19 CAR-T Cell Therapy Induced Immunotherapy Associated Interstitial Pneumonitis: A Case Report.
Zhuanyi Sun, Caiqin Xie, Hui Liu, Xianggui Yuan.
Front Immunol, 2022 Feb 15; 13. PMID: 35154102    Free PMC article.
Applications of Model-Based Meta-Analysis in Drug Development.
Phyllis Chan, Kirill Peskov, Xuyang Song.
Pharm Res, 2022 Feb 18;. PMID: 35174432
Pharmacologic Management of Persistent Pain in Cancer Survivors.
Paul Glare, Karin Aubrey, +3 authors, Sarah Overton.
Drugs, 2022 Feb 18; 82(3). PMID: 35175587    Free PMC article.
Predictors of Rheumatic Immune-Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer.
Amy Cunningham-Bussel, Jiaqi Wang, +12 authors, Jeffrey A Sparks.
Arthritis Rheumatol, 2021 Aug 17; 74(3). PMID: 34397169    Free PMC article.
Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors.
Donald F Chute, Sophia Zhao, +11 authors, Meghan E Sise.
Am J Kidney Dis, 2021 Jun 27; 79(1). PMID: 34174363    Free PMC article.
Therapeutic Perspectives in the Systemic Treatment of Kaposi's Sarcoma.
Marc-Antoine Valantin, Léna Royston, +7 authors, Jean-Pierre Routy.
Cancers (Basel), 2022 Feb 16; 14(3). PMID: 35158752    Free PMC article.
Endocrine Toxicities of Antineoplastic Therapy: The Adrenal Topic.
Agnese Barnabei, Paola Senes, +4 authors, Francesco Torino.
Cancers (Basel), 2022 Feb 16; 14(3). PMID: 35158860    Free PMC article.
Influence of the Metabolism on Myeloid Cell Functions in Cancers: Clinical Perspectives.
Thomas Boyer, Céline Blaye, Nicolas Larmonier, Charlotte Domblides.
Cells, 2022 Feb 16; 11(3). PMID: 35159363    Free PMC article.
The Potential Cardiotoxicity of Immune Checkpoint Inhibitors.
Inbar Nardi Agmon, Osnat Itzhaki Ben Zadok, Ran Kornowski.
J Clin Med, 2022 Feb 16; 11(3). PMID: 35160316    Free PMC article.
Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma.
Junfeng Shi, Donglin Lai, +5 authors, Xuefeng Gu.
Front Cell Dev Biol, 2022 Feb 18; 10. PMID: 35174152    Free PMC article.
A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre.
Parneet K Cheema, Marco A J Iafolla, +11 authors, Henry J Conter.
Curr Oncol, 2022 Feb 25; 29(2). PMID: 35200573    Free PMC article.
Histological Features of Celiac-Disease-like Conditions Related to Immune Checkpoint Inhibitors Therapy: A Signal to Keep in Mind for Pathologists.
Rachele Del Sordo, Umberto Volta, +7 authors, Vincenzo Villanacci.
Diagnostics (Basel), 2022 Feb 26; 12(2). PMID: 35204486    Free PMC article.
Cardiovascular Magnetic Resonance in Myocarditis.
Christian L Polte, Emanuele Bobbio, +5 authors, Sinsia A Gao.
Diagnostics (Basel), 2022 Feb 26; 12(2). PMID: 35204490    Free PMC article.
Immune-Related Thyroiditis as a Predictor for Survival in Metastatic Renal Cell Carcinoma.
Shira Sagie, Moran Gadot, +4 authors, Ruth Percik.
Cancers (Basel), 2022 Feb 26; 14(4). PMID: 35205622    Free PMC article.
Immune Checkpoint Inhibitors as a Threat to the Hypothalamus-Pituitary Axis: A Completed Puzzle.
Agnese Barnabei, Andrea Corsello, +4 authors, Francesco Torino.
Cancers (Basel), 2022 Feb 26; 14(4). PMID: 35205804    Free PMC article.
The Diagnosis and Management of Immune Checkpoint Inhibitor Cardiovascular Toxicity: Myocarditis and Beyond.
Dan Gilon, Zaza Iakobishvili, David Leibowitz.
Vaccines (Basel), 2022 Feb 27; 10(2). PMID: 35214762    Free PMC article.
Interleukin-10 Is a Promising Marker for Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer Receiving Immunotherapy.
Haowei Wang, Fei Zhou, +5 authors, Xiaoxia Chen.
Front Immunol, 2022 Mar 01; 13. PMID: 35222434    Free PMC article.
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma.
Kennedy Yao Yi Ng, Sze Huey Tan, +7 authors, Joycelyn Jie Xin Lee.
Liver Cancer, 2022 Mar 01; 11(1). PMID: 35222504    Free PMC article.
Isolated Gastritis Secondary to Immune Checkpoint Inhibitors Complicated by Superimposed Cytomegalovirus Infection.
Anita H Nguyen, Babak Torabi Sagvand, +2 authors, Raymond K Cross.
ACG Case Rep J, 2022 Mar 01; 9(2). PMID: 35224125    Free PMC article.
Colorectal liver metastasis: molecular mechanism and interventional therapy.
Hui Zhou, Zhongtao Liu, +8 authors, Yu Wen.
Signal Transduct Target Ther, 2022 Mar 06; 7(1). PMID: 35246503    Free PMC article.